Query 012107
Match_columns 471
No_of_seqs 271 out of 1551
Neff 6.1
Searched_HMMs 46136
Date Thu Mar 28 23:07:26 2013
Command hhsearch -i /work/01045/syshi/csienesis_hhblits_a3m/012107.a3m -d /work/01045/syshi/HHdatabase/Cdd.hhm -o /work/01045/syshi/hhsearch_cdd/012107hhsearch_cdd -cpu 12 -v 0
No Hit Prob E-value P-value Score SS Cols Query HMM Template HMM
1 TIGR01793 cit_synth_euk citrat 100.0 1E-125 3E-130 986.6 41.9 426 38-463 2-427 (427)
2 cd06105 ScCit1-2_like Saccharo 100.0 8E-122 2E-126 958.7 44.1 427 40-466 1-427 (427)
3 KOG2617 Citrate synthase [Ener 100.0 3E-120 7E-125 912.0 35.7 430 36-469 23-452 (458)
4 PRK09569 type I citrate syntha 100.0 1E-118 3E-123 936.7 44.2 430 39-469 2-433 (437)
5 cd06106 ScCit3_like Saccharomy 100.0 6E-118 1E-122 929.9 42.4 424 40-463 1-428 (428)
6 cd06103 ScCS-like Saccharomyce 100.0 6E-115 1E-119 907.6 42.4 424 40-463 1-426 (426)
7 PLN02456 citrate synthase 100.0 3E-106 7E-111 847.8 34.4 405 36-466 30-447 (455)
8 cd06115 AthCS_per_like Arabido 100.0 4.9E-99 1E-103 785.3 37.7 383 54-464 9-405 (410)
9 COG0372 GltA Citrate synthase 100.0 2.3E-98 5E-103 772.4 35.2 370 68-468 9-385 (390)
10 cd06107 EcCS_AthCS-per_like Es 100.0 3.9E-98 8E-103 773.5 37.0 362 76-461 6-382 (382)
11 cd06116 CaCS_like Chloroflexus 100.0 8.5E-98 2E-102 771.4 35.6 362 76-465 6-379 (384)
12 cd06109 BsCS-I_like Bacillus s 100.0 6.9E-97 2E-101 757.1 37.9 346 77-461 1-349 (349)
13 PRK12351 methylcitrate synthas 100.0 3.3E-96 7E-101 757.7 37.3 354 77-465 10-370 (378)
14 TIGR01798 cit_synth_I citrate 100.0 2.3E-96 5E-101 765.6 35.4 374 54-463 19-408 (412)
15 cd06117 Ec2MCS_like_1 Subgroup 100.0 1.4E-95 3E-100 751.3 36.8 353 78-465 2-361 (366)
16 PRK05614 gltA type II citrate 100.0 9.2E-96 2E-100 763.1 35.9 372 55-462 33-419 (419)
17 PRK14036 citrate synthase; Pro 100.0 1.3E-95 3E-100 754.0 35.5 360 75-466 4-369 (377)
18 cd06108 Ec2MCS_like Escherichi 100.0 2.4E-95 5E-100 748.3 36.5 351 77-464 1-357 (363)
19 PRK14032 citrate synthase; Pro 100.0 4.7E-95 1E-99 762.5 38.7 395 46-465 10-439 (447)
20 cd06112 citrate_synt_like_1_1 100.0 6.7E-95 1.5E-99 748.7 36.7 360 76-465 2-368 (373)
21 PRK14035 citrate synthase; Pro 100.0 2.2E-94 4.8E-99 743.0 37.0 356 75-466 3-364 (371)
22 cd06113 citrate_synt_like_1_2 100.0 8.8E-94 1.9E-98 746.7 38.6 368 81-461 10-406 (406)
23 PRK14034 citrate synthase; Pro 100.0 1.6E-93 3.5E-98 736.8 36.4 353 76-464 4-362 (372)
24 PRK14037 citrate synthase; Pro 100.0 3.9E-93 8.5E-98 735.6 37.1 357 75-465 4-369 (377)
25 cd06114 EcCS_like Escherichia 100.0 5.7E-93 1.2E-97 739.4 36.1 359 75-461 27-400 (400)
26 cd06111 DsCS_like Cold-active 100.0 3.1E-90 6.6E-95 711.5 36.6 352 77-463 1-358 (362)
27 PF00285 Citrate_synt: Citrate 100.0 6E-91 1.3E-95 717.1 30.9 348 78-455 1-356 (356)
28 PRK12349 citrate synthase 3; P 100.0 4.4E-90 9.5E-95 712.0 36.8 352 77-463 7-365 (369)
29 cd06118 citrate_synt_like_1 Ci 100.0 8.9E-90 1.9E-94 708.6 36.8 352 77-459 1-358 (358)
30 cd06110 BSuCS-II_like Bacillus 100.0 5E-89 1.1E-93 702.3 36.8 350 77-461 1-356 (356)
31 TIGR01800 cit_synth_II 2-methy 100.0 8.9E-89 1.9E-93 702.7 36.5 355 77-466 1-361 (368)
32 PRK14033 citrate synthase; Pro 100.0 2.1E-88 4.5E-93 700.5 36.5 356 75-465 9-370 (375)
33 PRK12350 citrate synthase 2; P 100.0 1.3E-88 2.8E-93 694.6 32.9 337 77-463 3-348 (353)
34 cd06101 citrate_synt Citrate s 100.0 7.3E-73 1.6E-77 560.9 25.9 259 77-459 1-265 (265)
35 cd06102 citrate_synt_like_2 Ci 100.0 6.2E-65 1.3E-69 506.5 26.9 266 81-461 17-282 (282)
36 cd06099 CS_ACL-C_CCL Citrate s 100.0 7E-59 1.5E-63 447.7 21.2 208 241-459 1-213 (213)
37 PRK06224 citrate synthase; Pro 100.0 1.4E-57 2.9E-62 451.7 24.8 243 84-462 8-257 (263)
38 PLN02522 ATP citrate (pro-S)-l 100.0 2.3E-50 5E-55 435.1 24.2 182 259-455 401-599 (608)
39 cd06100 CCL_ACL-C Citryl-CoA l 100.0 3.3E-50 7.1E-55 391.1 21.9 207 239-456 10-220 (227)
40 KOG1254 ATP-citrate lyase [Ene 99.7 1.4E-17 3E-22 172.7 5.9 186 255-455 389-591 (600)
41 cd06100 CCL_ACL-C Citryl-CoA l 97.8 0.0014 3.1E-08 64.2 16.8 72 102-184 1-78 (227)
42 KOG2617 Citrate synthase [Ener 95.2 0.01 2.2E-07 62.1 1.9 173 69-251 257-454 (458)
43 cd06099 CS_ACL-C_CCL Citrate s 79.5 7.3 0.00016 37.9 7.6 61 123-183 2-64 (213)
44 PRK14037 citrate synthase; Pro 69.5 16 0.00034 38.8 7.5 62 122-183 151-214 (377)
45 PRK14035 citrate synthase; Pro 61.4 22 0.00047 37.7 6.7 61 121-183 150-214 (371)
46 PRK12349 citrate synthase 3; P 60.1 30 0.00065 36.6 7.5 60 122-183 154-217 (369)
47 PRK14034 citrate synthase; Pro 59.3 24 0.00053 37.3 6.7 61 122-184 151-215 (372)
48 cd06112 citrate_synt_like_1_1 59.2 18 0.00039 38.2 5.7 61 122-184 152-216 (373)
49 PRK14036 citrate synthase; Pro 57.6 29 0.00063 36.8 6.9 61 122-184 153-217 (377)
50 PRK12351 methylcitrate synthas 49.8 57 0.0012 34.7 7.6 60 122-183 158-221 (378)
51 PRK14033 citrate synthase; Pro 47.7 61 0.0013 34.3 7.4 60 122-183 158-221 (375)
52 cd06111 DsCS_like Cold-active 46.8 62 0.0013 34.1 7.3 61 122-184 148-212 (362)
53 cd06108 Ec2MCS_like Escherichi 45.6 64 0.0014 34.1 7.2 60 122-183 146-209 (363)
54 cd06113 citrate_synt_like_1_2 44.3 67 0.0015 34.4 7.2 60 122-183 175-240 (406)
55 cd06117 Ec2MCS_like_1 Subgroup 42.9 84 0.0018 33.2 7.5 60 122-183 149-212 (366)
56 TIGR01800 cit_synth_II 2-methy 42.1 90 0.002 32.9 7.7 62 120-183 146-211 (368)
57 PRK14032 citrate synthase; Pro 39.5 94 0.002 33.8 7.4 60 122-183 205-270 (447)
58 cd06118 citrate_synt_like_1 Ci 38.3 1E+02 0.0022 32.3 7.3 60 122-183 148-211 (358)
59 cd06110 BSuCS-II_like Bacillus 38.1 1E+02 0.0022 32.4 7.3 60 122-183 148-211 (356)
60 cd06101 citrate_synt Citrate s 36.6 1.5E+02 0.0032 29.9 7.9 76 103-183 37-116 (265)
61 PF07583 PSCyt2: Protein of un 36.3 43 0.00094 32.6 3.9 36 125-165 29-64 (208)
62 cd06109 BsCS-I_like Bacillus s 36.3 1.1E+02 0.0023 32.2 7.0 60 122-183 137-200 (349)
63 PTZ00096 40S ribosomal protein 34.7 29 0.00062 31.9 2.2 22 98-129 15-36 (143)
64 cd04448 DEP_PIKfyve DEP (Dishe 32.6 67 0.0015 26.4 3.9 51 93-154 8-63 (81)
65 PRK04038 rps19p 30S ribosomal 31.3 36 0.00078 31.0 2.3 14 98-111 7-20 (134)
66 PF00285 Citrate_synt: Citrate 30.6 1.8E+02 0.004 30.4 7.7 61 122-184 148-214 (356)
67 cd07622 BAR_SNX4 The Bin/Amphi 30.4 1.4E+02 0.003 28.8 6.3 81 357-448 10-91 (201)
68 PRK13890 conjugal transfer pro 28.3 2.8E+02 0.006 24.4 7.4 40 100-147 16-56 (120)
69 TIGR01025 rpsS_arch ribosomal 28.3 43 0.00092 30.6 2.2 14 98-111 5-18 (135)
70 PLN00179 acyl- [acyl-carrier p 26.8 8.1E+02 0.018 26.3 12.6 83 280-373 231-314 (390)
71 PRK08558 adenine phosphoribosy 25.3 1.4E+02 0.003 29.6 5.4 56 103-166 24-80 (238)
72 PF03461 TRCF: TRCF domain; I 24.6 1E+02 0.0022 26.3 3.7 43 134-184 28-71 (101)
73 PRK13755 putative mercury tran 24.2 53 0.0011 29.6 2.0 23 426-448 57-79 (139)
74 PF10805 DUF2730: Protein of u 21.1 1.8E+02 0.004 25.0 4.8 61 123-184 19-79 (106)
75 PF09702 Cas_Csa5: CRISPR-asso 20.2 1E+02 0.0023 26.8 2.9 19 132-150 69-87 (105)
No 1
>TIGR01793 cit_synth_euk citrate (Si)-synthase, eukaryotic. This model includes both mitochondrial and peroxisomal forms of citrate synthase. Citrate synthase is the entry point to the TCA cycle from acetyl-CoA. Peroxisomal forms, such as SP:P08679 from yeast (recognized by the C-terminal targeting motif SKL) act in the glyoxylate cycle. Eukaryotic homologs excluded by the high trusted cutoff of this model include a Tetrahymena thermophila citrate synthase that doubles as a filament protein, a putative citrate synthase from Plasmodium falciparum (no TCA cycle), and a methylcitrate synthase from Aspergillus nidulans.
Probab=100.00 E-value=1.2e-125 Score=986.58 Aligned_cols=426 Identities=79% Similarity=1.302 Sum_probs=411.5
Q ss_pred hhHHHHHHhHCHHHHHHHHHHHHhhCCCcccceeecccccccccccccccccceecCCCCeeecCCCHHHHhhhCCCCCC
Q 012107 38 LDLHSQLKEMIPEQQERLKKVKSELGKAQLGNITVDMVIGGMRGMTGLLWETSLLDPDEGIRFRGLSIPECQKLLPAAKP 117 (471)
Q Consensus 38 ~~l~~~~~~~ip~~~~~~~~l~~~~g~~~~g~~t~~~~~~Glrgv~~~~t~iS~lD~~~Gi~yRGy~I~eL~~~~p~~~~ 117 (471)
++||++++++||.+++++++||++||+++||++||+|+++||||+++++|+||+||+++||+||||+|+||++.+|++.+
T Consensus 2 ~~lk~~~~~~i~~~~~~~~~l~~~~g~~~~~~~t~~~~~~Glrgv~~~~t~iS~iD~~~Gl~yRGy~I~dl~~~~~~~~~ 81 (427)
T TIGR01793 2 LDLKEQLKEKIPEQQEKVKKLRAEHGKVVLGNITVDMVYGGMRGMKGLVWETSVLDPEEGIRFRGLSIPECQKLLPKAKG 81 (427)
T ss_pred ccHHHHHHHHHHHHHHHHHHHHHHcCCceeeeeeHhhccCccCCCcccceeceEEcCCCCeEECCeeHHHHHHHhccCCc
Confidence 46999999999999999999999999999999999999999999999999999999999999999999999987777778
Q ss_pred CCCCCHHHHHHHHHhCCCCCHHHHHHHHHHHHhhCCCcHHHHHHHHcCCCCCChHHHHHHHHHHhcccchhHHHhhhccC
Q 012107 118 DGEPLPEGLLWLLLTGKVPSKEQVDGLSKELRDRATVPDYVYKAIDALPVTAHPMTQFASGVMALQVQSEFQEAYEKGIH 197 (471)
Q Consensus 118 ~~~~~~Eev~~LLl~G~lPt~~ql~~f~~~l~~~~~lp~~v~~~i~~lP~~~hPM~~l~~avsal~~~s~f~~~y~~~~~ 197 (471)
++++.||||+||||||+|||++|+++|+++|.+++.+|++|.++|++||+++|||++|+++|++|++++.|+++|+.+.+
T Consensus 82 ~~~~~fEev~~LLl~G~lPt~~el~~f~~~L~~~~~lp~~v~~~i~~~p~~~hPM~~L~~~vsaL~~~~~f~~~y~~~~~ 161 (427)
T TIGR01793 82 GEEPLPEGLLWLLLTGKVPSEEQVDALSAEWRARADLPEHVYKTIDALPVTLHPMAQFATAVMALQVESEFAKAYAKGIH 161 (427)
T ss_pred cccCCHHHHHHHHHcCCCCCHHHHHHHHHHHHHcCCCCHHHHHHHHhCCCCCCHHHHHHHHHHhcccccchhhhcccCcc
Confidence 89999999999999999999999999999999999999999999999999999999999999999999999999988888
Q ss_pred CCCCCcchHHHHHHHHhhhhHHHHHHHHHHhcCCcccCCCCCCCHHHHHHhhhcCCchHHHHHHHHHHHHhccCCCCCCc
Q 012107 198 KSKYWEPTYEDSLNLIARVPVVAAYVYQRIYKDGKIIPKDDSLDYGGNFSHMLGFDDPKMLELMRLYVTIHSDHEGGNVS 277 (471)
Q Consensus 198 k~~~~e~~~e~al~LiA~~p~i~a~iyr~~~~~~~~~~p~~~l~~~~n~~~ml~~~~~~~~~~l~~~LvL~aDHeg~n~S 277 (471)
+.+||++.++++++|||++|+|+|+|||+++++|..++||+++||++||++||+++++.++++||++|||||||||+|+|
T Consensus 162 ~~~~~~~~~e~~~~LiAk~P~i~A~~yr~~~~~g~~i~p~~~l~~a~Nfl~Ml~~~~~~~~~~l~~~LiLhADHeg~NaS 241 (427)
T TIGR01793 162 KTKYWEYTYEDSMDLIAKLPTVAAYIYRNMYKDGQSISIDDSKDYSANFAHMLGYDSPSFQELMRLYLTIHSDHEGGNVS 241 (427)
T ss_pred ccccHHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCccCCCCCccHHHHHHHHhcCCCHHHHHHHHHHHhhhcccccccch
Confidence 88999999999999999999999999998777776789999999999999999989999999999999999999989999
Q ss_pred hhHHHHhhccCCChHHHHHHHHhcccccccccchHHHHHHHHHHHHhcCCCCChhhHHHHHHHHHhCCCcccccCCCCCC
Q 012107 278 AHTGHLVASALSDPYLSFAAALNGLAGPLHGLANQEVLLWIKSVVDECGENVTTEQLKDYVWKTLNSGKVVPGFGHGVLR 357 (471)
Q Consensus 278 t~aarvvaSt~sd~y~avaAgl~aL~GplHGgA~e~v~~~l~~i~~~ig~~~~~~~i~~~v~~~l~~g~~IpGfGH~vyk 357 (471)
|||+||||||++|||+|++|||++|+||+||||||+|++||.++.+.+|.+.+++++++||++.+++|++||||||+|||
T Consensus 242 TfaarvvaSt~ad~y~~v~Agi~aL~GPlHGgAn~~vl~~l~ei~~~ig~~~s~~~v~~~i~~~l~~g~~i~GfGH~vyr 321 (427)
T TIGR01793 242 AHTGHLVGSALSDPYLSFAAALNGLAGPLHGLANQEVLLWLKSVVSECGENVTKEQLKDYIWKTLNSGKVVPGYGHAVLR 321 (427)
T ss_pred hHHHHHhhccCCCHHHHHHHHHhhccCCccCCcHHHHHHHHHHHHHhcCCCCCHHHHHHHHHHHHhCCCcccCCCCCCCC
Confidence 99999999999999999999999999999999999999999999887887778999999999999999999999999999
Q ss_pred CCCchHHHHHHHHHhhCCCChHHHHHHHHHHhhhhhHHhcCCCCCCCCchhhHHHHHHhccCCCccccchhhhhhhhhhh
Q 012107 358 KTDPRYTCQREFALKHLPDDPLFQLVSKLFEVVPPILTKLGKVKNPWPNVDAHSGVLLNHFGLAEARYYTVLFGVSRSLG 437 (471)
Q Consensus 358 ~~DPRa~~l~~~a~~~~~~~~~~~la~~le~~~~~~l~~~~k~k~l~pNVD~~sg~l~~~lGlp~~~~~t~lF~vsR~~G 437 (471)
.+|||+.+|++++++..+++++++++.++++++++++.++++.||+|||||||+|+|+++||||+.++||++|++||++|
T Consensus 322 ~~DPRa~~l~~~~~~~~~~~~~~~~~~~~~~~a~~~l~~~~~~~~~~pNVD~~sg~l~~~lGip~~~~~t~lFavsR~~G 401 (427)
T TIGR01793 322 KTDPRYICQREFALKHLPDDPLFKLVSNLYKIVPGILTELGKVKNPWPNVDAHSGVLLQYYGLTEARYYTVLFGVSRALG 401 (427)
T ss_pred CCCCCcHHHHHHHHHHcCCChHHHHHHHHHHHHHHHHHHhhcccCCCCCcHHHHHHHHHHcCCCchhhhhhHhhhhccch
Confidence 99999999999999998899999999999999999999999999999999999999999999985589999999999999
Q ss_pred HHHHHHHHHHcCCCccCCCccchhHH
Q 012107 438 ICSQLIWDRALGLPLERPKSVTLDWI 463 (471)
Q Consensus 438 wlAH~ieq~~~~~pI~RP~s~~~~~~ 463 (471)
|+||++||++.+.||+||+|+|++++
T Consensus 402 w~AH~ieq~~~~~~I~RP~s~~~~~~ 427 (427)
T TIGR01793 402 ILSQLIWDRALGLPLERPKSVSTEWL 427 (427)
T ss_pred HHHHHHHHHHcCCCccCCcccccccC
Confidence 99999999999999999999999874
No 2
>cd06105 ScCit1-2_like Saccharomyces cerevisiae (Sc) citrate synthases Cit1-2_like. Citrate synthases (CS) catalyzes the condensation of acetyl coenzyme A (AcCoA) with oxaloacetate (OAA) to form citrate and coenzyme A (CoA), the first step in the citric acid cycle (TCA or Krebs cycle). Some CS proteins function as 2-methylcitrate synthase (2MCS). 2MCS catalyzes the condensation of propionyl-coenzyme A (PrCoA) and OAA to form 2-methylcitrate and CoA during propionate metabolism. The overall CS reaction is thought to proceed through three partial reactions and involves both closed and open conformational forms of the enzyme: a) the carbanion or equivalent is generated from AcCoA by base abstraction of a proton, b) the nucleophilic attack of this carbanion on OAA to generate citryl-CoA, and c) the hydrolysis of citryl-CoA to produce citrate and CoA. There are two types of CSs: type I CS and type II CSs. Type I CSs are found in eukarya, gram-positive bacteria, archaea, and in some gram-neg
Probab=100.00 E-value=7.9e-122 Score=958.71 Aligned_cols=427 Identities=68% Similarity=1.173 Sum_probs=410.3
Q ss_pred HHHHHHhHCHHHHHHHHHHHHhhCCCcccceeecccccccccccccccccceecCCCCeeecCCCHHHHhhhCCCCCCCC
Q 012107 40 LHSQLKEMIPEQQERLKKVKSELGKAQLGNITVDMVIGGMRGMTGLLWETSLLDPDEGIRFRGLSIPECQKLLPAAKPDG 119 (471)
Q Consensus 40 l~~~~~~~ip~~~~~~~~l~~~~g~~~~g~~t~~~~~~Glrgv~~~~t~iS~lD~~~Gi~yRGy~I~eL~~~~p~~~~~~ 119 (471)
|||+++++||.+++++++|+++||+++||++|+|++++||||+++++|+||+|||++||+||||+|+||++++|++.+++
T Consensus 1 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~d~~~~Gl~g~~~~~t~iS~iDg~~Gl~YRGy~I~dLa~~~~~~~~~~ 80 (427)
T cd06105 1 LKDRLAELIPKEQARIKKFRKEHGKTVVGEVTVDMVYGGMRGIKGLVWETSVLDPEEGIRFRGLSIPECQKLLPKAPGGE 80 (427)
T ss_pred ChHHHHHHHHHHHHHHHHHHHHcCCcceeeeecCcccCCCCCceecceeceeEcCCCCeEECCccHHHHHhhCccccccc
Confidence 69999999999999999999999999999999999999999999999999999999999999999999999998766788
Q ss_pred CCCHHHHHHHHHhCCCCCHHHHHHHHHHHHhhCCCcHHHHHHHHcCCCCCChHHHHHHHHHHhcccchhHHHhhhccCCC
Q 012107 120 EPLPEGLLWLLLTGKVPSKEQVDGLSKELRDRATVPDYVYKAIDALPVTAHPMTQFASGVMALQVQSEFQEAYEKGIHKS 199 (471)
Q Consensus 120 ~~~~Eev~~LLl~G~lPt~~ql~~f~~~l~~~~~lp~~v~~~i~~lP~~~hPM~~l~~avsal~~~s~f~~~y~~~~~k~ 199 (471)
+++||||+||||||+|||++|+++|+++|.+++.+|++|.++|++||+++|||++|+++|++|+++|+|+++|+++.++.
T Consensus 81 ~~~fEev~yLLl~G~LPt~~el~~f~~~L~~~~~lp~~v~~~i~~~p~~~hPM~~L~~~vsaL~~~d~f~~~~~~~~~~~ 160 (427)
T cd06105 81 EPLPEGLFWLLLTGEVPTKEQVSALSKEWAARAALPSHVVTMLDNFPTNLHPMSQLSAAITALNSESKFAKAYAEGIHKS 160 (427)
T ss_pred ccCHHHHHHHHHcCCCCCHHHHHHHHHHHHHcCCCCHHHHHHHHhCCCCCCHHHHHHHHHHhhhcccchhhhcccccccc
Confidence 99999999999999999999999999999999999999999999999999999999999999999998988888888888
Q ss_pred CCCcchHHHHHHHHhhhhHHHHHHHHHHhcCCcccCCCCCCCHHHHHHhhhcCCchHHHHHHHHHHHHhccCCCCCCchh
Q 012107 200 KYWEPTYEDSLNLIARVPVVAAYVYQRIYKDGKIIPKDDSLDYGGNFSHMLGFDDPKMLELMRLYVTIHSDHEGGNVSAH 279 (471)
Q Consensus 200 ~~~e~~~e~al~LiA~~p~i~a~iyr~~~~~~~~~~p~~~l~~~~n~~~ml~~~~~~~~~~l~~~LvL~aDHeg~n~St~ 279 (471)
++|++.++++++|||++|+|+|++||++++++++++||+++||++||++||++.++...++||++|||||||||+|+|||
T Consensus 161 ~~~~~~~~~~~~LiAk~p~i~A~~yr~~~~g~~~~~pd~~ls~a~Nfl~Ml~~~~~~~~~~l~~~lvLhADHeg~NaSTf 240 (427)
T cd06105 161 KYWEYVYEDSMDLIAKLPCVAAKIYRNLYRGGKIIAIDSNLDWSANFANMLGYTDPQFTELMRLYLTIHSDHEGGNVSAH 240 (427)
T ss_pred ccHHHHHHHHHHHHHHHHHHHHHHHHHHhCCCCcCCCCCCcCHHHHHHHHhcCCCHHHHHHHHHHHhhhccccCccchHH
Confidence 89999999999999999999999999866556789999999999999999998778899999999999999998899999
Q ss_pred HHHHhhccCCChHHHHHHHHhcccccccccchHHHHHHHHHHHHhcCCCCChhhHHHHHHHHHhCCCcccccCCCCCCCC
Q 012107 280 TGHLVASALSDPYLSFAAALNGLAGPLHGLANQEVLLWIKSVVDECGENVTTEQLKDYVWKTLNSGKVVPGFGHGVLRKT 359 (471)
Q Consensus 280 aarvvaSt~sd~y~avaAgl~aL~GplHGgA~e~v~~~l~~i~~~ig~~~~~~~i~~~v~~~l~~g~~IpGfGH~vyk~~ 359 (471)
|+|+||||++|+|+|++||+++|+||+||||||+|++||.++.+++|.+++++++++||++.+++|++||||||+|||..
T Consensus 241 aarvvaSt~ad~ysav~agi~aL~GplHGGA~e~v~~~l~ei~~~~g~~~~~~~v~~~i~~~l~~g~~i~GFGHrvyk~~ 320 (427)
T cd06105 241 TTHLVGSALSDPYLSFAAAMNGLAGPLHGLANQEVLVWLTKLQKEVGKDVSDEQLREYVWKTLNSGRVVPGYGHAVLRKT 320 (427)
T ss_pred HHHHHhccCCCHHHHHHHHHhhcCCCCCCCcHHHHHHHHHHHHHHhCCCCCHHHHHHHHHHHHhCCCcccCCCCCCCCCC
Confidence 99999999999999999999999999999999999999999988888777889999999999999999999999999999
Q ss_pred CchHHHHHHHHHhhCCCChHHHHHHHHHHhhhhhHHhcCCCCCCCCchhhHHHHHHhccCCCccccchhhhhhhhhhhHH
Q 012107 360 DPRYTCQREFALKHLPDDPLFQLVSKLFEVVPPILTKLGKVKNPWPNVDAHSGVLLNHFGLAEARYYTVLFGVSRSLGIC 439 (471)
Q Consensus 360 DPRa~~l~~~a~~~~~~~~~~~la~~le~~~~~~l~~~~k~k~l~pNVD~~sg~l~~~lGlp~~~~~t~lF~vsR~~Gwl 439 (471)
|||+++|++++.++.++++++++++++++++++++.++++.+|+|||||||+|+++++||||+.++||++|++||++||+
T Consensus 321 DPRa~~lk~~~~~~~~~~~~~~~~~~ie~~a~~~l~~~~~~~~l~pNVDfysg~l~~~lGip~~~~ft~lFa~sR~~GW~ 400 (427)
T cd06105 321 DPRYTCQREFALKHLPNDPLFKLVSQLYKIVPPVLTEQGKAKNPWPNVDAHSGVLLQYYGLTEMNYYTVLFGVSRALGVL 400 (427)
T ss_pred CCCcHHHHHHHHHHcCCCHHHHHHHHHHHHHHHHHHHhccCCCCCCChhHHHHHHHHHcCCCchhhhHHHHHHHHHHHHH
Confidence 99999999999999889999999999999999988999999999999999999999999999558999999999999999
Q ss_pred HHHHHHHHcCCCccCCCccchhHHHHH
Q 012107 440 SQLIWDRALGLPLERPKSVTLDWIEKN 466 (471)
Q Consensus 440 AH~ieq~~~~~pI~RP~s~~~~~~~~~ 466 (471)
||++||++.+.||+||+|+|+++++++
T Consensus 401 AH~~Eq~~~~~~I~RP~s~~~~~~~~~ 427 (427)
T cd06105 401 SQLIWDRALGLPLERPKSVSTDGLEKL 427 (427)
T ss_pred HHHHHHHhCCCCccCCcchhHHHHhhC
Confidence 999999998889999999999999863
No 3
>KOG2617 consensus Citrate synthase [Energy production and conversion]
Probab=100.00 E-value=3.1e-120 Score=911.99 Aligned_cols=430 Identities=61% Similarity=1.043 Sum_probs=420.1
Q ss_pred cchhHHHHHHhHCHHHHHHHHHHHHhhCCCcccceeecccccccccccccccccceecCCCCeeecCCCHHHHhhhCCCC
Q 012107 36 ADLDLHSQLKEMIPEQQERLKKVKSELGKAQLGNITVDMVIGGMRGMTGLLWETSLLDPDEGIRFRGLSIPECQKLLPAA 115 (471)
Q Consensus 36 ~~~~l~~~~~~~ip~~~~~~~~l~~~~g~~~~g~~t~~~~~~Glrgv~~~~t~iS~lD~~~Gi~yRGy~I~eL~~~~p~~ 115 (471)
+..+||++|++.||++++++|+++++|| ++|+||++++++||||++.+.||+|++|+++||+|||++|+||+..+|++
T Consensus 23 ~~~~LK~~l~~~ip~~~~~~k~~~~ehG--~vg~v~i~~i~gGmrg~~~~~~e~s~Ld~~~gI~frg~~i~e~q~~lp~~ 100 (458)
T KOG2617|consen 23 SAATLKGNLAIVIPRTGDEYKKFVSEHG--TVGNVTLKKIYGGMRGKGLLLWETSVLDPEEGIRFRGGDIPECQKRLPPA 100 (458)
T ss_pred ccccHHHHHHhhChhhHHHhhhhHhhcC--cccceeHHHhhcccCCCCceeecCcccchhhCeeecCCCHHHHHhhCCCC
Confidence 4455999999999999999999999999 79999999999999999999999999999999999999999999999999
Q ss_pred CCCCCCCHHHHHHHHHhCCCCCHHHHHHHHHHHHhhCCCcHHHHHHHHcCCCCCChHHHHHHHHHHhcccchhHHHhhhc
Q 012107 116 KPDGEPLPEGLLWLLLTGKVPSKEQVDGLSKELRDRATVPDYVYKAIDALPVTAHPMTQFASGVMALQVQSEFQEAYEKG 195 (471)
Q Consensus 116 ~~~~~~~~Eev~~LLl~G~lPt~~ql~~f~~~l~~~~~lp~~v~~~i~~lP~~~hPM~~l~~avsal~~~s~f~~~y~~~ 195 (471)
+++.||+||+++|||+||++||++|+++++.+|++|+.+|++|.++|+++|+++|||.||++|+++|+.+|+|+++|..|
T Consensus 101 ~~~~e~lpe~~~wLL~tG~vPt~~Q~~~~~~~~a~rs~vP~~v~~~idsmP~d~HPM~q~~~a~~al~~~s~fa~ay~~G 180 (458)
T KOG2617|consen 101 EEGAEPLPEELFWLLLTGNVPTQSQVAALSFELAQRSAVPQGVLDMIDSMPKDLHPMAQLAAAVLALKIFSPFAKAYLRG 180 (458)
T ss_pred ccCCcCCHHHHHHHHHhCCCCCHHHHHHHHHHHHHhccccHHHHHHHHhCCcccchHHHHHHHHHhccccccchhhhhhc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cCCCCCCcchHHHHHHHHhhhhHHHHHHHHHHhcCCcccCCCCCCCHHHHHHhhhcCCchHHHHHHHHHHHHhccCCCCC
Q 012107 196 IHKSKYWEPTYEDSLNLIARVPVVAAYVYQRIYKDGKIIPKDDSLDYGGNFSHMLGFDDPKMLELMRLYVTIHSDHEGGN 275 (471)
Q Consensus 196 ~~k~~~~e~~~e~al~LiA~~p~i~a~iyr~~~~~~~~~~p~~~l~~~~n~~~ml~~~~~~~~~~l~~~LvL~aDHeg~n 275 (471)
+.|.+||++++|||++|||++|+|+|++|++.+++|.+. |++++||++||++|+|+.++.++++||+|+++|+||||+|
T Consensus 181 ~~k~~yw~~~~ed~l~Liak~p~iAa~iY~~~~~dg~~~-~~~~~dys~Nf~~mlg~~~~~f~~lmrly~~iHadHE~gn 259 (458)
T KOG2617|consen 181 IGKYKYWQYTYEDCLVLIAKLPTIAAAIYRNIYADGIPK-PDPNLDYSANFARMLGSRQPDFAQLMRLYVGIHADHEGGN 259 (458)
T ss_pred cchhhcccccHHHHHHHHHhccHHHHHHHHHHhcCCCCC-CCcccchhHhHHHHHccCChHHHHHHHHeeeeecccccCc
Confidence 999999999999999999999999999999999988544 4999999999999999999999999999999999999999
Q ss_pred CchhHHHHhhccCCChHHHHHHHHhcccccccccchHHHHHHHHHHHHhcCCCCChhhHHHHHHHHHhCCCcccccCCCC
Q 012107 276 VSAHTGHLVASALSDPYLSFAAALNGLAGPLHGLANQEVLLWIKSVVDECGENVTTEQLKDYVWKTLNSGKVVPGFGHGV 355 (471)
Q Consensus 276 ~St~aarvvaSt~sd~y~avaAgl~aL~GplHGgA~e~v~~~l~~i~~~ig~~~~~~~i~~~v~~~l~~g~~IpGfGH~v 355 (471)
+|+||.|+++|++ |||.|++||+++|+||+||+|||+|++||..+.++||++.+.|++++|+|+++++|++||||||+|
T Consensus 260 VsAh~~HLvGSal-dpyls~aa~~~GLaGPLHGlAnqEvl~~L~~~~~Eig~~~s~e~ikeyiw~~ln~~rvvpGyGHav 338 (458)
T KOG2617|consen 260 VSAHTGHLVGSAL-DPYLSFAAGMNGLAGPLHGLANQEVLRFLGKLIEEIGKDLSKENIKEYIWKTLNSGRVVPGYGHAV 338 (458)
T ss_pred HHHHhcccccccc-chhHHHHHhhcccccccccCchHHHHHHHHHhHHHhccccchhhhhHhhHHhhccccccccccccc
Confidence 9999999999999 999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCCchHHHHHHHHHhhCCCChHHHHHHHHHHhhhhhHHhcCCCCCCCCchhhHHHHHHhccCCCccccchhhhhhhhh
Q 012107 356 LRKTDPRYTCQREFALKHLPDDPLFQLVSKLFEVVPPILTKLGKVKNPWPNVDAHSGVLLNHFGLAEARYYTVLFGVSRS 435 (471)
Q Consensus 356 yk~~DPRa~~l~~~a~~~~~~~~~~~la~~le~~~~~~l~~~~k~k~l~pNVD~~sg~l~~~lGlp~~~~~t~lF~vsR~ 435 (471)
||++|||+.+++++|.+++++||+++++..++++++.++.|++|.||+|||||+|+|++++++|+++..|||++|+|||+
T Consensus 339 lr~tDPR~~~~~efA~k~~~~d~l~~l~~~l~~~~p~vl~e~gk~knp~PNVD~~SGvll~~yGl~e~~fyTVLFgVsRa 418 (458)
T KOG2617|consen 339 LRKTDPRYKVQREFALKHLPDDPLFLLVSALYKIAPGVLTEHGKVKNPYPNVDAHSGVLLQYYGLPELFFYTVLFGVSRA 418 (458)
T ss_pred ccCCCchhhHHHHHHHhcCCCCcchhhhHHHHHhChHHHHHhcccCCCCCcHHHHHHHHHHhcCCcHHHHHHHHHHHhhh
Confidence 99999999999999999999999999999999999999999999999999999999999999999986677999999999
Q ss_pred hhHHHHHHHHHHcCCCccCCCccchhHHHHHhhh
Q 012107 436 LGICSQLIWDRALGLPLERPKSVTLDWIEKNCKK 469 (471)
Q Consensus 436 ~GwlAH~ieq~~~~~pI~RP~s~~~~~~~~~~~~ 469 (471)
+|.++|++|+|+.+.||+||+|+|++++.++++.
T Consensus 419 ~Gvlsqliw~ralg~pieRPks~~t~~~~~~~~~ 452 (458)
T KOG2617|consen 419 LGVLSQLIWDRALGLPIERPKSVSTDWLHRFTNM 452 (458)
T ss_pred HHHHHHHHHHHHhCCcccCccccchHHHHHHHHH
Confidence 9999999999999999999999999999999875
No 4
>PRK09569 type I citrate synthase; Reviewed
Probab=100.00 E-value=1.4e-118 Score=936.69 Aligned_cols=430 Identities=52% Similarity=0.914 Sum_probs=408.8
Q ss_pred hHHHHHHhHCHHHHHHHHHHHHhhCCCcccceeecccccccccccccccccceecCCCCeeecCCCHHHHhhhCCCCCCC
Q 012107 39 DLHSQLKEMIPEQQERLKKVKSELGKAQLGNITVDMVIGGMRGMTGLLWETSLLDPDEGIRFRGLSIPECQKLLPAAKPD 118 (471)
Q Consensus 39 ~l~~~~~~~ip~~~~~~~~l~~~~g~~~~g~~t~~~~~~Glrgv~~~~t~iS~lD~~~Gi~yRGy~I~eL~~~~p~~~~~ 118 (471)
+|||+++++||.||++|++|+++||+++||++|+||+.+|||||++++|+||+||+++||+||||+|+||++++|+++++
T Consensus 2 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~t~~~~~~GL~gv~~~~t~IS~iDg~~Gl~YRGy~I~dL~~~~p~~~~~ 81 (437)
T PRK09569 2 QLKETLKQKIEEHRPRTTRLVKEFGSVVIDEVTIEQCIGGARDIRSLVTDISYLDPQEGIRFRGKTIPETFEALPKAPGS 81 (437)
T ss_pred CHHHHHHHHHHHHHHHHHHHHHHcCCeeeeeeeHhhhcccccCCeecceeceeecCCCceeECCccHHHHHhhCcccccc
Confidence 49999999999999999999999999999999999999999999999999999999999999999999999999988778
Q ss_pred CCCCHHHHHHHHHhCCCCCHHHHHHHHHHHHhhCCCcHHHHHHHHcCCCCCChHHHHHHHHHHhcccchhHHHhhhc-cC
Q 012107 119 GEPLPEGLLWLLLTGKVPSKEQVDGLSKELRDRATVPDYVYKAIDALPVTAHPMTQFASGVMALQVQSEFQEAYEKG-IH 197 (471)
Q Consensus 119 ~~~~~Eev~~LLl~G~lPt~~ql~~f~~~l~~~~~lp~~v~~~i~~lP~~~hPM~~l~~avsal~~~s~f~~~y~~~-~~ 197 (471)
++++||||+||||||+|||++|+++|+++|.+++.+|++|.++|++||+++|||++|+++|++|+++|.|+..|+++ .+
T Consensus 82 ~~~~fEev~~LLl~G~LPt~~el~~f~~~L~~~~~lp~~v~~~i~~~p~~~hPM~~L~~~vs~l~~~s~~~~~y~~~~~~ 161 (437)
T PRK09569 82 EYPTVESFWYFLLTGEVPTQEQVQEVVAEWKKRQNVPQYVIDAIRALPRDSHPMVMLSVGILAMQRESKFAKFYNEGKFN 161 (437)
T ss_pred CCCCHHHHHHHHHcCCCCCHHHHHHHHHHHHHcCCCCHHHHHHHHhCCCCCCHHHHHHHHHHhccccchhhhhccccccc
Confidence 78899999999999999999999999999999999999999999999999999999999999999999999888776 56
Q ss_pred CCCCCcchHHHHHHHHhhhhHHHHHHHHHHhcCCcccCCCCCCCHHHHHHhhhcCCchHHHHHHHHHHHHhccCCCCCCc
Q 012107 198 KSKYWEPTYEDSLNLIARVPVVAAYVYQRIYKDGKIIPKDDSLDYGGNFSHMLGFDDPKMLELMRLYVTIHSDHEGGNVS 277 (471)
Q Consensus 198 k~~~~e~~~e~al~LiA~~p~i~a~iyr~~~~~~~~~~p~~~l~~~~n~~~ml~~~~~~~~~~l~~~LvL~aDHeg~n~S 277 (471)
+.++|++.++++++|||++|+|+|++||++++++++++|++++||++||++||+++ +...++||++||||||||++|+|
T Consensus 162 ~~~~~~~~~~~~~rliA~~p~i~A~~yr~~~~g~~~~~p~~~ls~a~NFl~Ml~~~-~~~~~~l~~~LiL~ADHe~~naS 240 (437)
T PRK09569 162 KMDAWEYMYEDASDLVARIPVIAAYIYNLKYKGDKQIPSDPELDYGANFAHMIGQP-KPYKDVARMYFILHSDHESGNVS 240 (437)
T ss_pred ccccHHHHHHHHHHHHHHHHHHHHHHHHHHhCCCCCCCCCCCcCHHHHHHHHhcCC-chHHHHHHHHHhhhhccCCCcch
Confidence 66789999999999999999999999999876667899999999999999999986 45679999999999999978999
Q ss_pred hhHHHHhhccCCChHHHHHHHHhcccccccccchHHHHHHHHHHHHhcC-CCCChhhHHHHHHHHHhCCCcccccCCCCC
Q 012107 278 AHTGHLVASALSDPYLSFAAALNGLAGPLHGLANQEVLLWIKSVVDECG-ENVTTEQLKDYVWKTLNSGKVVPGFGHGVL 356 (471)
Q Consensus 278 t~aarvvaSt~sd~y~avaAgl~aL~GplHGgA~e~v~~~l~~i~~~ig-~~~~~~~i~~~v~~~l~~g~~IpGfGH~vy 356 (471)
|||+|+++||++|+|+|++|||++|+||+||||||+|++||.++.+.+| ...+++++++||++.+++|++|||||||||
T Consensus 241 TfaaRvvaSt~ad~ysav~Agi~aL~GplHGGA~e~v~~~l~~i~~~~~~~~~~~~~~~~~v~~~l~~~~ri~GFGHrvy 320 (437)
T PRK09569 241 AHTTHLVASALSDAYYSYSAGLNGLAGPLHGLANQEVLGWIQQFQEKLGGEEPTKEQVEQALWDTLNAGQVIPGYGHAVL 320 (437)
T ss_pred HHHHHHHhccCCCHHHHHHHHHHhccCCccCCchHHHHHHHHHHHHhhccCCCCHHHHHHHHHHHHhcCCcccCCCCCCC
Confidence 9999999999999999999999999999999999999999999987764 334789999999999999999999999999
Q ss_pred CCCCchHHHHHHHHHhhCCCChHHHHHHHHHHhhhhhHHhcCCCCCCCCchhhHHHHHHhccCCCccccchhhhhhhhhh
Q 012107 357 RKTDPRYTCQREFALKHLPDDPLFQLVSKLFEVVPPILTKLGKVKNPWPNVDAHSGVLLNHFGLAEARYYTVLFGVSRSL 436 (471)
Q Consensus 357 k~~DPRa~~l~~~a~~~~~~~~~~~la~~le~~~~~~l~~~~k~k~l~pNVD~~sg~l~~~lGlp~~~~~t~lF~vsR~~ 436 (471)
|..|||+++|+++++++.++++++++++++++++.+++.++++.|+++||||||+|++++.||||+.++||++|++||++
T Consensus 321 k~~DPRa~~L~~~a~~~~~~~~~~~ia~~~e~v~~~~~~~~~~~~~l~pNVD~~sg~l~~~lGip~~~~~t~lFaisR~~ 400 (437)
T PRK09569 321 RKTDPRYTAQREFCLKHLPDDPLFKLVAMIFEVAPGVLTEHGKTKNPWPNVDAQSGVIQWYYGVKEWDFYTVLFGVGRAL 400 (437)
T ss_pred CCCCCchHHHHHHHHHHcCCCHHHHHHHHHHHHHHHHHHHhcccCCCCCChHHHHHHHHHHcCCCchhhhHHHHHHHHHH
Confidence 99999999999999999888999999999999999888899999999999999999999999999448999999999999
Q ss_pred hHHHHHHHHHHcCCCccCCCccchhHHHHHhhh
Q 012107 437 GICSQLIWDRALGLPLERPKSVTLDWIEKNCKK 469 (471)
Q Consensus 437 GwlAH~ieq~~~~~pI~RP~s~~~~~~~~~~~~ 469 (471)
||+||++||+..+.||+||+++|+|++++.|++
T Consensus 401 Gw~AH~iEq~~~~~~i~RP~~~Y~G~~~~~~~~ 433 (437)
T PRK09569 401 GVMANITWDRGLGYAIERPKSVTTEMLEKWAAE 433 (437)
T ss_pred HHHHHHHHHHhCCCCccCCccccchHHHHHHhh
Confidence 999999999987878999999999999999964
No 5
>cd06106 ScCit3_like Saccharomyces cerevisiae (Sc) 2-methylcitrate synthase Cit3-like. 2-methylcitrate synthase (2MCS) catalyzes the condensation of propionyl-coenzyme A (PrCoA) and oxaloacetate (OAA) to form 2-methylcitrate and CoA. Citrate synthase (CS) catalyzes the condensation of acetyl coenzyme A (AcCoA) with OAA to form citrate and CoA, the first step in the citric acid cycle (TCA or Krebs cycle). The overall CS reaction is thought to proceed through three partial reactions and involves both closed and open conformational forms of the enzyme: a) the carbanion or equivalent is generated from AcCoA by base abstraction of a proton, b) the nucleophilic attack of this carbanion on OAA to generate citryl-CoA, and c) the hydrolysis of citryl-CoA to produce citrate and CoA. There are two types of CSs: type I CS and type II CSs. Type I CSs are found in eukarya, gram-positive bacteria, archaea, and in some gram-negative bacteria and are homodimers with both subunits participating in the a
Probab=100.00 E-value=5.7e-118 Score=929.91 Aligned_cols=424 Identities=58% Similarity=1.017 Sum_probs=397.7
Q ss_pred HHHHHHhHCHHHHHHHHHHHHhhCCCcccceeecccccccccccccccccceecCCCCeeecCCCHHHHhhhCCCCCCCC
Q 012107 40 LHSQLKEMIPEQQERLKKVKSELGKAQLGNITVDMVIGGMRGMTGLLWETSLLDPDEGIRFRGLSIPECQKLLPAAKPDG 119 (471)
Q Consensus 40 l~~~~~~~ip~~~~~~~~l~~~~g~~~~g~~t~~~~~~Glrgv~~~~t~iS~lD~~~Gi~yRGy~I~eL~~~~p~~~~~~ 119 (471)
||++++++||.+|+++++|+++||+++||++|++++++|||||++++|+||+||+++||+||||+|+||++++|+..++.
T Consensus 1 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~t~~~~~~GL~gv~~~~t~is~idg~~Gl~YRGy~I~dLa~~~~~~~~~~ 80 (428)
T cd06106 1 LKEALKEVIPAKREQLKKLKAEYGETVVGDVKVSNVLGGMRGLKSMLWEGSVLDAEEGIRFHGKTIPECQKELPKAPIGG 80 (428)
T ss_pred ChHHHHHHHHHHHHHHHHHHHHcCCCeeeeeeHHHhcccccCCeeeeecCeEECCCCCeeECCCcHHHHHhhCccccccC
Confidence 69999999999999999999999999999999999999999999999999999999999999999999999998764444
Q ss_pred CCCHHHHHHHHHhCCCCCHHHHHHHHHHHHhhCCCcHHHHHHHHcCCCCCChHHHHHHHHHHhcccchhHHHhhhccCCC
Q 012107 120 EPLPEGLLWLLLTGKVPSKEQVDGLSKELRDRATVPDYVYKAIDALPVTAHPMTQFASGVMALQVQSEFQEAYEKGIHKS 199 (471)
Q Consensus 120 ~~~~Eev~~LLl~G~lPt~~ql~~f~~~l~~~~~lp~~v~~~i~~lP~~~hPM~~l~~avsal~~~s~f~~~y~~~~~k~ 199 (471)
...||||+||||+|+|||++|+++|+++|.+++.+|+.|.++|+++|+++|||++|+++|++|+.++.|..+|+.+..+.
T Consensus 81 ~f~~Eev~yLLl~G~LPt~~el~~f~~~L~~~~~lp~~v~~~i~~~p~~~hPM~~L~~~vs~L~~~~~~~~~y~~~~~~~ 160 (428)
T cd06106 81 EMLPESMLWLLLTGKVPTFEQARGLSKELAERGKLPHYIEKLLDSLPKTLHPMTQLSIGVAALNHDSKFAAAYEKGIKKT 160 (428)
T ss_pred CccHHHHHHHHHcCcCCCHHHHHHHHHHHHHcCCCCHHHHHHHHhCCCCCCHHHHHHHHHHhccccchhhhhcccCcccc
Confidence 44559999999999999999999999999999999999999999999999999999999999999888877787776666
Q ss_pred CCCcchHHHHHHHHhhhhHHHHHHHHHHhcCCc-ccCCCCCCCHHHHHHhhhcC-CchHHHHHHHHHHHHhccCCCCCCc
Q 012107 200 KYWEPTYEDSLNLIARVPVVAAYVYQRIYKDGK-IIPKDDSLDYGGNFSHMLGF-DDPKMLELMRLYVTIHSDHEGGNVS 277 (471)
Q Consensus 200 ~~~e~~~e~al~LiA~~p~i~a~iyr~~~~~~~-~~~p~~~l~~~~n~~~ml~~-~~~~~~~~l~~~LvL~aDHeg~n~S 277 (471)
++|++.++++++|||++|+|+|++||++++++. +++|++++||++||++||+. |++.+.++||++|||||||||+|+|
T Consensus 161 ~~~~~~~~~~~rLiAk~ptI~A~~yr~~~g~~~~~~~p~~~ls~a~NFL~Mlg~~p~~~~~~~l~~~LiL~ADHeg~NaS 240 (428)
T cd06106 161 EYWEPTLEDSLNLIARLPALAARIYRNVYGEGHGLGKIDPEVDWSYNFTSMLGYGDNLDFVDLLRLYIALHGDHEGGNVS 240 (428)
T ss_pred cchHHHHHHHHHHHHHHHHHHHHHHHHHhCCCCCCCCCCCCcCHHHHHHHHhCCCCChHHHHHHHHHHhhhcccCCccch
Confidence 789999999999999999999999999886554 55699999999999999965 7889999999999999999988999
Q ss_pred hhHHHHhhccCCChHHHHHHHHhcccccccccchHHHHHHHHHHHHhcCCCCChhhHHHHHHHHHhCCCcccccCCCCCC
Q 012107 278 AHTGHLVASALSDPYLSFAAALNGLAGPLHGLANQEVLLWIKSVVDECGENVTTEQLKDYVWKTLNSGKVVPGFGHGVLR 357 (471)
Q Consensus 278 t~aarvvaSt~sd~y~avaAgl~aL~GplHGgA~e~v~~~l~~i~~~ig~~~~~~~i~~~v~~~l~~g~~IpGfGH~vyk 357 (471)
|||+||+|||++|+|+|++|||++|+||+|||||++|++||.++.+++|+..+++++++||++.+++|++||||||||||
T Consensus 241 TfaarvvaST~ad~ysav~agi~aL~GPlHGGAne~v~~~l~e~~~~ig~~~~~~~~~~~i~~~l~~g~~i~GfGHrvYk 320 (428)
T cd06106 241 AHTTHLVGSALSDPYLSYSAGLMGLAGPLHGLAAQEVLRWILEMQKNIGSKATDQDIRDYLWKTLKSGRVVPGYGHAVLR 320 (428)
T ss_pred HHHHHHHhccCCCHHHHHHHHHHhcCCCcccChHHHHHHHHHHHHHHhcCCCCHHHHHHHHHHHHhCCCcccCCCCCCCC
Confidence 99999999999999999999999999999999999999999999888886556799999999999999999999999999
Q ss_pred CCCchHHHHHHHHHhhC--CCChHHHHHHHHHHhhhhhHHhcCCCCCCCCchhhHHHHHHhccCCCccccchhhhhhhhh
Q 012107 358 KTDPRYTCQREFALKHL--PDDPLFQLVSKLFEVVPPILTKLGKVKNPWPNVDAHSGVLLNHFGLAEARYYTVLFGVSRS 435 (471)
Q Consensus 358 ~~DPRa~~l~~~a~~~~--~~~~~~~la~~le~~~~~~l~~~~k~k~l~pNVD~~sg~l~~~lGlp~~~~~t~lF~vsR~ 435 (471)
..|||+++|+++++++. ..++++++++++++++.+++.++++.|+++||||||+|+++++||||+.++||++|++||+
T Consensus 321 ~~DPRa~~l~~~~~~l~~~~~~~~~~~a~~ie~~~~~~l~~~~~~~~l~pNVDfysg~v~~~lGip~~~~ft~lFaisR~ 400 (428)
T cd06106 321 KPDPRFTALMEFAQTRPELENDPVVQLVQKLSEIAPGVLTEHGKTKNPFPNVDAASGVLFYHYGIREFLYYTVIFGVSRA 400 (428)
T ss_pred CCCCCcHHHHHHHHHHHhccCCHHHHHHHHHHHHHHHHHHHhccccCCCCCchhHHHHHHHHcCCChhhcchHHHHHHHH
Confidence 99999999999999874 4579999999999999888888888899999999999999999999965689999999999
Q ss_pred hhHHHHHHHHHHcCCCccCCCccchhHH
Q 012107 436 LGICSQLIWDRALGLPLERPKSVTLDWI 463 (471)
Q Consensus 436 ~GwlAH~ieq~~~~~pI~RP~s~~~~~~ 463 (471)
+||+||++||++.+.||+||+|+|++++
T Consensus 401 ~GW~AHi~eq~~~~~~I~RP~s~~~~~~ 428 (428)
T cd06106 401 LGPLTQLVWDRILGLPIERPKSLSLEGL 428 (428)
T ss_pred HHHHHHHHHHHhCCCCCcCCCccccccC
Confidence 9999999999988889999999999874
No 6
>cd06103 ScCS-like Saccharomyces cerevisiae (Sc) citrate synthase (CS)-like. CS catalyzes the condensation of acetyl coenzyme A (AcCoA) with oxaloacetate (OAA) to form citrate and coenzyme A (CoA), the first step in the citric acid cycle (TCA or Krebs cycle). Some CS proteins function as 2-methylcitrate synthase (2MCS). 2MCS catalyzes the condensation of propionyl-coenzyme A (PrCoA) and OAA to form 2-methylcitrate and CoA during propionate metabolism. The overall CS reaction is thought to proceed through three partial reactions and involves both closed and open conformational forms of the enzyme: a) the carbanion or equivalent is generated from AcCoA by base abstraction of a proton, b) the nucleophilic attack of this carbanion on OAA to generate citryl-CoA, and c) the hydrolysis of citryl-CoA to produce citrate and CoA. There are two types of CSs: type I CS and type II CSs. Type I CSs are found in eukarya, gram-positive bacteria, archaea, and in some gram-negative bacteria and are homo
Probab=100.00 E-value=5.9e-115 Score=907.64 Aligned_cols=424 Identities=64% Similarity=1.136 Sum_probs=401.1
Q ss_pred HHHHHHhHCHHHHHHHHHHHHhhCCCcccceeecccccccccccccccccceecCCCCeeecCCCHHHHhhhCCCCCCCC
Q 012107 40 LHSQLKEMIPEQQERLKKVKSELGKAQLGNITVDMVIGGMRGMTGLLWETSLLDPDEGIRFRGLSIPECQKLLPAAKPDG 119 (471)
Q Consensus 40 l~~~~~~~ip~~~~~~~~l~~~~g~~~~g~~t~~~~~~Glrgv~~~~t~iS~lD~~~Gi~yRGy~I~eL~~~~p~~~~~~ 119 (471)
|||+++++||.|+++++.|+++||+++++++|++++.+||||+++++|+||+||+++||+||||+|+||++++|+++.+.
T Consensus 1 l~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GL~gv~~~~t~Is~iDg~~Gl~YRGy~I~dLa~~~~~~~~~~ 80 (426)
T cd06103 1 LKDKLAELIPKKQARIKELRKKYGNTKLGQITVDQVIGGMRGMKGLVYETSVLDPDEGIRFRGKTIPECQELLPKADGGG 80 (426)
T ss_pred ChHHHHHHHHHHHHHHHHHHHHcCCccccccchhhhccCcCCCeeeeeeCeeEcCCCCeEECCccHHHHHhhCccccccC
Confidence 69999999999999999999999999999999999999999999999999999999999999999999999998766555
Q ss_pred CCCHHHHHHHHHhCCCCCHHHHHHHHHHHHhhCCCcHHHHHHHHcCCCCCChHHHHHHHHHHhcccchhHHHhhhc-cCC
Q 012107 120 EPLPEGLLWLLLTGKVPSKEQVDGLSKELRDRATVPDYVYKAIDALPVTAHPMTQFASGVMALQVQSEFQEAYEKG-IHK 198 (471)
Q Consensus 120 ~~~~Eev~~LLl~G~lPt~~ql~~f~~~l~~~~~lp~~v~~~i~~lP~~~hPM~~l~~avsal~~~s~f~~~y~~~-~~k 198 (471)
+++||||+||||+|+|||++|+++|+++|.+++.+|+.|.++++++|+++|||++|+++|++|+++++|+..|+++ +++
T Consensus 81 ~~~fEev~yLLl~G~LPt~~el~~f~~~L~~~~~lp~~v~~~i~~~p~~~hPM~~L~~~vs~L~~~~~~~~~~~~~~~~~ 160 (426)
T cd06103 81 EPLPEGLFWLLLTGEVPTEEQVDELSKEWAKRAEVPSHVVKMIDNLPRNLHPMTQLSAAILALQSESKFAKAYAEGKINK 160 (426)
T ss_pred cCcHHHHHHHHHCCCCCCHHHHHHHHHHHHHcCCCCHHHHHHHHhCCCCCChHHHHHHHHHhccccccchhhcccccccc
Confidence 5679999999999999999999999999999999999999999999999999999999999999998888778765 667
Q ss_pred CCCCcchHHHHHHHHhhhhHHHHHHHHHHh-cCCcccCCCCCCCHHHHHHhhhcCCchHHHHHHHHHHHHhccCCCCCCc
Q 012107 199 SKYWEPTYEDSLNLIARVPVVAAYVYQRIY-KDGKIIPKDDSLDYGGNFSHMLGFDDPKMLELMRLYVTIHSDHEGGNVS 277 (471)
Q Consensus 199 ~~~~e~~~e~al~LiA~~p~i~a~iyr~~~-~~~~~~~p~~~l~~~~n~~~ml~~~~~~~~~~l~~~LvL~aDHeg~n~S 277 (471)
+++|+..++++++|||++|+|+|++||+++ .++++++|++++||++||++||+++++..+++||++|||||||||+|+|
T Consensus 161 ~~~~~~~~~~a~~liA~~p~I~A~~yr~~~~~g~~~~~p~~~ls~aeNfl~ml~~~~~~~~~~l~~~LiL~ADHe~~NaS 240 (426)
T cd06103 161 TTYWEYVYEDAMDLIAKLPVVAAKIYRRKYRKGGEIGAIDSKLDWSANFAHMLGYEDEEFTDLMRLYLTLHSDHEGGNVS 240 (426)
T ss_pred cccHHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCccCCCCCcCHHHHHHHHhCCCCHHHHHHHHHHHhhhhccCCccch
Confidence 788999999999999999999999999875 4556889999999999999999876688899999999999999978999
Q ss_pred hhHHHHhhccCCChHHHHHHHHhcccccccccchHHHHHHHHHHHHhcCCCCChhhHHHHHHHHHhCCCcccccCCCCCC
Q 012107 278 AHTGHLVASALSDPYLSFAAALNGLAGPLHGLANQEVLLWIKSVVDECGENVTTEQLKDYVWKTLNSGKVVPGFGHGVLR 357 (471)
Q Consensus 278 t~aarvvaSt~sd~y~avaAgl~aL~GplHGgA~e~v~~~l~~i~~~ig~~~~~~~i~~~v~~~l~~g~~IpGfGH~vyk 357 (471)
|||+|++|||++|+|+|++|||++|+||+|||||+.|++||.++.+.+|...+++++++||++.+++|++||||||||||
T Consensus 241 TfaaRvvaSt~ad~ysav~agi~aL~GplHGGA~e~v~~~l~ei~~~ig~~~~~~~~~~~v~~~l~~~~~i~GfGHrvYk 320 (426)
T cd06103 241 AHTSHLVGSALSDPYLSFSAALNGLAGPLHGLANQEVLKWLLKMQKELGKDVSDEELEKYIWDTLNSGRVVPGYGHAVLR 320 (426)
T ss_pred HHHHHHHhccCCCHHHHHHHHHhhcCCCcccchHHHHHHHHHHHHHhccCCCCHHHHHHHHHHHHHCCCcccCCCCCCCC
Confidence 99999999999999999999999999999999999999999999877886667899999999999999999999999999
Q ss_pred CCCchHHHHHHHHHhhCCCChHHHHHHHHHHhhhhhHHhcCCCCCCCCchhhHHHHHHhccCCCccccchhhhhhhhhhh
Q 012107 358 KTDPRYTCQREFALKHLPDDPLFQLVSKLFEVVPPILTKLGKVKNPWPNVDAHSGVLLNHFGLAEARYYTVLFGVSRSLG 437 (471)
Q Consensus 358 ~~DPRa~~l~~~a~~~~~~~~~~~la~~le~~~~~~l~~~~k~k~l~pNVD~~sg~l~~~lGlp~~~~~t~lF~vsR~~G 437 (471)
..|||+++|+++++++...++++++++++++++.+++.++++.|+++||||||+|++++.||||+.++||++|++||++|
T Consensus 321 ~~DPRa~~L~~~~~~~~~~~~~~~~a~~ie~~~~~~~~~~~~~k~l~pNVDfysa~v~~~lGip~~~~ft~lFa~sR~~G 400 (426)
T cd06103 321 KTDPRFTCQREFALKHLPDDPLFKLVAQCYKIIPGVLKEHGKVKNPYPNVDAHSGVLLQHYGMTEPQYYTVLFGVSRALG 400 (426)
T ss_pred CCCCchHHHHHHHHHHhcCCHHHHHHHHHHHHHHHHHHHhcccCCCCCChHhHHHHHHHHcCCChhhhhhHHHhHhhcch
Confidence 99999999999999998888999999999999988878888889999999999999999999995489999999999999
Q ss_pred HHHHHHHHHHcCCCccCCCccchhHH
Q 012107 438 ICSQLIWDRALGLPLERPKSVTLDWI 463 (471)
Q Consensus 438 wlAH~ieq~~~~~pI~RP~s~~~~~~ 463 (471)
|+||++||++.|.+|+||+|+|++.+
T Consensus 401 w~AH~~Eq~~~~~~i~RP~s~~~~~~ 426 (426)
T cd06103 401 VLAQLVWSRALGLPIERPKSMSTEGL 426 (426)
T ss_pred HHHHHHHHHhCCCCCCCCCccccccC
Confidence 99999999999989999999999753
No 7
>PLN02456 citrate synthase
Probab=100.00 E-value=3.3e-106 Score=847.81 Aligned_cols=405 Identities=47% Similarity=0.695 Sum_probs=379.8
Q ss_pred cchhHHHHHHhHCHHHHHHHHHHHHhhCCCcccceeecccccccccccccccccceecCCCCe-eecCCCHHHHhhhCCC
Q 012107 36 ADLDLHSQLKEMIPEQQERLKKVKSELGKAQLGNITVDMVIGGMRGMTGLLWETSLLDPDEGI-RFRGLSIPECQKLLPA 114 (471)
Q Consensus 36 ~~~~l~~~~~~~ip~~~~~~~~l~~~~g~~~~g~~t~~~~~~Glrgv~~~~t~iS~lD~~~Gi-~yRGy~I~eL~~~~p~ 114 (471)
+.++++..+.+.+|+++..|++|++ |++.+|.+|+| +||+|+.+++|+||+||+++|+ +||||+|+||++++
T Consensus 30 ~g~~~~~~i~~~~~~~~~~~~~l~~--~~~~~g~~~~d---~Gl~~~~~~~s~IS~iDg~~G~L~YRGy~I~dLa~~~-- 102 (455)
T PLN02456 30 TGKDYESPLSELGPVQAERLKKIKA--GKDDLGLKTVD---PGYRNTAPVLSEISLIDGDEGILRFRGYPIEELAEKS-- 102 (455)
T ss_pred CCcEEEEehhccCCcccchhhhccc--CcCccCCEecC---cccCCceeeeeeceEEeCCCCEEEECCccHHHHHhcC--
Confidence 5677999999889999999999998 88999999998 6999999999999999999996 99999999999987
Q ss_pred CCCCCCCCHHHHHHHHHhCCCCCHHHHHHHHHHHHhhCCCcHHHHHHHHcCCCCCChHHHHHHHHHHhcccchhHHHhhh
Q 012107 115 AKPDGEPLPEGLLWLLLTGKVPSKEQVDGLSKELRDRATVPDYVYKAIDALPVTAHPMTQFASGVMALQVQSEFQEAYEK 194 (471)
Q Consensus 115 ~~~~~~~~~Eev~~LLl~G~lPt~~ql~~f~~~l~~~~~lp~~v~~~i~~lP~~~hPM~~l~~avsal~~~s~f~~~y~~ 194 (471)
.||||+||||||+|||++|+++|+++|.+++.+|++|.+++++||+++|||++|+++|++|+++++++..|..
T Consensus 103 -------~feevayLLl~G~LPt~~el~~f~~~L~~~~~lp~~v~~~i~~~p~~~hPM~~L~~~vsal~~~~~~~~~~~~ 175 (455)
T PLN02456 103 -------PFEEVAYLLLYGNLPTKEQLADWEAELRQHSAVPEHVLDVIDALPHDAHPMTQLVSGVMALSTFSPDANAYLR 175 (455)
T ss_pred -------CHHHHHHHHHcCcCCCHHHHHHHHHHHHHhcCCCHHHHHHHHhCCCcCCcHHHHHHHHHhhhhcCcchhhhhc
Confidence 4999999999999999999999999999999999999999999999999999999999999999999888888
Q ss_pred ccCCCCCCcchHHHHHHHHhhhhHHHHHHHHHHhcCCcccCCCCCCCHHHHHHhhhcC-------CchHHHHHHHHHHHH
Q 012107 195 GIHKSKYWEPTYEDSLNLIARVPVVAAYVYQRIYKDGKIIPKDDSLDYGGNFSHMLGF-------DDPKMLELMRLYVTI 267 (471)
Q Consensus 195 ~~~k~~~~e~~~e~al~LiA~~p~i~a~iyr~~~~~~~~~~p~~~l~~~~n~~~ml~~-------~~~~~~~~l~~~LvL 267 (471)
|.++.++|+..++++++|||++|+|+|++||++++.+ ++.|++++||++||++||++ +++..+++||++|||
T Consensus 176 g~~~~~~~~~~~~~a~rliAk~p~iaA~~yr~~~g~~-~~~P~~~ls~a~Nfl~Ml~~~~~~~~~p~~~~~~~l~~~LiL 254 (455)
T PLN02456 176 GQHKYKSWEVRDEDIVRLIGKLPTLAAAIYRRMYGRG-PVIPDNSLDYAENFLYMLGSLGDRSYKPDPRLARLLDLYFII 254 (455)
T ss_pred ccCcccCHHHHHHHHHHHHHHHHHHHHHHHHHHcCCC-CCCCCCCCCHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHHee
Confidence 8777778999999999999999999999999988654 67799999999999999986 788999999999999
Q ss_pred hccCCCCCCchhHHHHhh-ccCCChHHHHHHHHhcccccccccchHHHHHHHHHHHHhcCCCCChhhHHHHHHHHHhCCC
Q 012107 268 HSDHEGGNVSAHTGHLVA-SALSDPYLSFAAALNGLAGPLHGLANQEVLLWIKSVVDECGENVTTEQLKDYVWKTLNSGK 346 (471)
Q Consensus 268 ~aDHeg~n~St~aarvva-St~sd~y~avaAgl~aL~GplHGgA~e~v~~~l~~i~~~ig~~~~~~~i~~~v~~~l~~g~ 346 (471)
||||| +|+|||++|+++ ||++|+|+|++|||++|+||+||||||+|++||.+| | +++++++||++.+++|+
T Consensus 255 hADHe-~n~ST~aar~~a~St~ad~ysavaAgi~aL~GPlHGGA~e~v~~~l~ei----~---~~~~v~~~v~~~l~~~~ 326 (455)
T PLN02456 255 HADHE-GGCSTAAARHLVGSSGVDPYTSVAAGVNALAGPLHGGANEAVLKMLKEI----G---TVENIPEYVEGVKNSKK 326 (455)
T ss_pred eccCC-CCchhHHHHHHHhccCCCHHHHHHHHhhhcCCCcccChHHHHHHHHHHh----C---CHHHHHHHHHHHHhCCC
Confidence 99999 999999999999 999999999999999999999999999999999987 5 57899999999999999
Q ss_pred cccccCCCCCCCCCchHHHHHHHHHhh---CCCChHHHHHHHHHHhhhhhHHhcCCCCCCCCchhhHHHHHHhccCCCcc
Q 012107 347 VVPGFGHGVLRKTDPRYTCQREFALKH---LPDDPLFQLVSKLFEVVPPILTKLGKVKNPWPNVDAHSGVLLNHFGLAEA 423 (471)
Q Consensus 347 ~IpGfGH~vyk~~DPRa~~l~~~a~~~---~~~~~~~~la~~le~~~~~~l~~~~k~k~l~pNVD~~sg~l~~~lGlp~~ 423 (471)
+||||||||||..|||+++|+++|+++ .+++|+++++.++|+++. .+++++.|++|||||||+|+|+++||||+
T Consensus 327 ~l~GFGHrvyk~~DPRa~~L~~~a~~l~~~~~~~~~~~ia~~le~~~~--~~~~~~~r~l~pNVDfysg~l~~~lGip~- 403 (455)
T PLN02456 327 VLPGFGHRVYKNYDPRAKCIREFALEVFKHVGDDPLFKVASALEEVAL--LDEYFKVRKLYPNVDFYSGVLLRALGFPE- 403 (455)
T ss_pred cccCCCCCCCCCCCCCHHHHHHHHHHHHHhcCCCHHHHHHHHHHHHHH--HHHhcCCCCCCcCcHHHHHHHHHHcCcCh-
Confidence 999999999999999999999999965 468999999999999873 36788999999999999999999999995
Q ss_pred ccchhhhhhhhhhhHHHHHHHHHHcC-CCccCCCccchhHHHHH
Q 012107 424 RYYTVLFGVSRSLGICSQLIWDRALG-LPLERPKSVTLDWIEKN 466 (471)
Q Consensus 424 ~~~t~lF~vsR~~GwlAH~ieq~~~~-~pI~RP~s~~~~~~~~~ 466 (471)
++||++|++||++||+||++||...+ .+|+||+|+|+|...+.
T Consensus 404 ~~~t~lFaisR~~Gw~AH~~E~~~~~~~ri~RP~~~Y~G~~~~~ 447 (455)
T PLN02456 404 EFFTVLFAVSRAAGYLSQWDEALGLPDERIMRPKQVYTGEWLRH 447 (455)
T ss_pred hhccchhhhhhHHHHHHHHHHHHhCCcccccCCCccccCCCccc
Confidence 99999999999999999999998763 47999999999985543
No 8
>cd06115 AthCS_per_like Arabidopsis thaliana (Ath) peroxisomal (Per) CS_like. CS catalyzes the condensation of acetyl coenzyme A (AcCoA) and oxalacetate (OAA) to form citrate and coenzyme A (CoA), the first step in the citric acid cycle (TCA or Krebs cycle). The overall CS reaction is thought to proceed through three partial reactions and involves both closed and open conformational forms of the enzyme: a) the carbanion or equivalent is generated from AcCoA by base abstraction of a proton, b) the nucleophilic attack of this carbanion on OAA to generate citryl-CoA, and c) the hydrolysis of citryl-CoA to produce citrate and CoA. This group contains three Arabidopsis peroxisomal CS proteins, CYS1, -2, and -3 which are involved in the glyoxylate cycle. AthCYS1, in addition to a peroxisomal targeting sequence, has a predicted secretory signal peptide; it may be targeted to both the secretory pathway and the peroxisomes and is thought to be located in the extracellular matrix. AthCSY1 is expr
Probab=100.00 E-value=4.9e-99 Score=785.26 Aligned_cols=383 Identities=26% Similarity=0.387 Sum_probs=342.0
Q ss_pred HHHHHHHhhCCCcccceeecccccccccccccccccceecCCCCe-eecCCCHHHHhhhCCCCCCCCCCCHHHHHHHHHh
Q 012107 54 RLKKVKSELGKAQLGNITVDMVIGGMRGMTGLLWETSLLDPDEGI-RFRGLSIPECQKLLPAAKPDGEPLPEGLLWLLLT 132 (471)
Q Consensus 54 ~~~~l~~~~g~~~~g~~t~~~~~~Glrgv~~~~t~iS~lD~~~Gi-~yRGy~I~eL~~~~p~~~~~~~~~~Eev~~LLl~ 132 (471)
.|++|++.-+ ..|-.+++ .||+|+.+++|+||+||+++|+ +||||+|+||++++ .||||+||||+
T Consensus 9 d~~~~~~~~~--~~g~~~~~---~Gl~~~~~~~t~Is~iDg~~G~L~YRGy~I~dLa~~~---------~feEv~~LLl~ 74 (410)
T cd06115 9 DFKKIKAGKD--DKGLRLYD---PGYLNTAVVRSKISYIDGDKGILRYRGYPIEELAEKS---------TFLEVAYLLIY 74 (410)
T ss_pred eHHHhcCCcc--cCCCcccC---CccCCceEEEeeCeeEeCCCCeEEECCccHHHHHhcC---------CHHHHHHHHHc
Confidence 4678877222 24567765 4999999999999999999996 99999999999986 49999999999
Q ss_pred CCCCCHHHHHHHHHHHHhhCCCcHHHHHHHHcCCCCCChHHHHHHHHHHhcccchhHHH-hh-hccCCCCCCcchHHHHH
Q 012107 133 GKVPSKEQVDGLSKELRDRATVPDYVYKAIDALPVTAHPMTQFASGVMALQVQSEFQEA-YE-KGIHKSKYWEPTYEDSL 210 (471)
Q Consensus 133 G~lPt~~ql~~f~~~l~~~~~lp~~v~~~i~~lP~~~hPM~~l~~avsal~~~s~f~~~-y~-~~~~k~~~~e~~~e~al 210 (471)
|+|||++|+++|+++|.+++.+|+.|.++|++||+++|||++|+++|++|+.+++.... .. .++.+ .++..+++++
T Consensus 75 G~LPt~~el~~f~~~L~~~~~lp~~v~~~i~~~p~~~hPM~~L~~~vs~l~~~~~~~~~~~~~~~~~~--~~~~~~~~a~ 152 (410)
T cd06115 75 GNLPTKSQLSDWEFAVSQHTAVPTGVLDMIKSFPHDAHPMGMLVSAISALSAFHPEANPALAGQDIYK--NKQVRDKQIV 152 (410)
T ss_pred CCCcCHHHHHHHHHHHHHccCCCHHHHHHHHhCCCCCCHHHHHHHHHHHHhccCcccccccccccccc--CHHHHHHHHH
Confidence 99999999999999999999999999999999999999999999999999976533100 00 01111 2356788999
Q ss_pred HHHhhhhHHHHHHHHHHhcCCcccCCCCCCCHHHHHHhhhcC-------CchHHHHHHHHHHHHhccCCCCCCchhHHHH
Q 012107 211 NLIARVPVVAAYVYQRIYKDGKIIPKDDSLDYGGNFSHMLGF-------DDPKMLELMRLYVTIHSDHEGGNVSAHTGHL 283 (471)
Q Consensus 211 ~LiA~~p~i~a~iyr~~~~~~~~~~p~~~l~~~~n~~~ml~~-------~~~~~~~~l~~~LvL~aDHeg~n~St~aarv 283 (471)
+|||++|+|+|++||++.+. ++++|++++||++||++||++ |++..+++||.+|||||||| +|+||||+|+
T Consensus 153 rliA~~p~i~A~~~r~~~g~-~~~~p~~~ls~a~NFl~Ml~g~~~~~~~p~~~~~~~l~~~liL~ADH~-~naSTfaarv 230 (410)
T cd06115 153 RILGKAPTIAAAAYRRRAGR-PPNLPSQDLSYTENFLYMLDSLGERKYKPNPRLARALDILFILHAEHE-MNCSTAAVRH 230 (410)
T ss_pred HHHHHHHHHHHHHHHHHcCC-CCcCCCCCCCHHHHHHHHhcCCCCcCCCCCHHHHHHHHHHHHHhhccC-CCchHHHHHH
Confidence 99999999999999988764 588999999999999999975 56788999999999999998 9999999999
Q ss_pred hhccCCChHHHHHHHHhcccccccccchHHHHHHHHHHHHhcCCCCChhhHHHHHHHHHhCCCcccccCCCCCCCCCchH
Q 012107 284 VASALSDPYLSFAAALNGLAGPLHGLANQEVLLWIKSVVDECGENVTTEQLKDYVWKTLNSGKVVPGFGHGVLRKTDPRY 363 (471)
Q Consensus 284 vaSt~sd~y~avaAgl~aL~GplHGgA~e~v~~~l~~i~~~ig~~~~~~~i~~~v~~~l~~g~~IpGfGH~vyk~~DPRa 363 (471)
+|||++|+|+|++|||++|+||+||||||+|++||+++ + +++++++||++.+++|++||||||||||..|||+
T Consensus 231 ~aSt~ad~ysav~agi~aL~GplHGGA~e~v~~~l~ei----~---~~~~~~~~v~~~~~~~~ri~GFGHrvYk~~DPRa 303 (410)
T cd06115 231 LASSGVDVYTAVAGAVGALYGPLHGGANEAVLRMLAEI----G---TVENIPAFIEGVKNRKRKLSGFGHRVYKNYDPRA 303 (410)
T ss_pred HHhcCCCHHHHHHHHHhhccCCcccchHHHHHHHHHHh----C---ChHHHHHHHHHHHhcCCcccCCCCCCCCCCCccH
Confidence 99999999999999999999999999999999999887 5 5689999999999999999999999999999999
Q ss_pred HHHHHHHHhhC---CCChHHHHHHHHHHhhhhhHHhcCCCCCCCCchhhHHHHHHhccCCCccccchhhhhhhhhhhHHH
Q 012107 364 TCQREFALKHL---PDDPLFQLVSKLFEVVPPILTKLGKVKNPWPNVDAHSGVLLNHFGLAEARYYTVLFGVSRSLGICS 440 (471)
Q Consensus 364 ~~l~~~a~~~~---~~~~~~~la~~le~~~~~~l~~~~k~k~l~pNVD~~sg~l~~~lGlp~~~~~t~lF~vsR~~GwlA 440 (471)
++|+++++++. ++++++++++++|+++.+ .++++.|+++||||||+|++++.||||+ ++||++|++||++||+|
T Consensus 304 ~~L~~~~~~l~~~~~~~~~~~~a~~~e~~~~~--~~~~~~k~l~pNVD~ysa~l~~~lG~p~-~~~t~lFa~sR~~Gw~A 380 (410)
T cd06115 304 KIIKKLADEVFEIVGKDPLIEIAVALEKAALS--DEYFVKRKLYPNVDFYSGLIYRAMGFPT-DFFPVLFAIPRMAGYLA 380 (410)
T ss_pred HHHHHHHHHHHhhcCCcHHHHHHHHHHHHHHh--hhhhcccCCCCChHHHHHHHHHHcCCCh-HhhhhHHHHHhhhhHHH
Confidence 99999999974 467999999999998865 4567789999999999999999999996 99999999999999999
Q ss_pred HHHHHHHcC-CCccCCCccchhHHH
Q 012107 441 QLIWDRALG-LPLERPKSVTLDWIE 464 (471)
Q Consensus 441 H~ieq~~~~-~pI~RP~s~~~~~~~ 464 (471)
|++||+..+ .+|+||++.|+|...
T Consensus 381 H~~Eq~~~~~~~i~RP~~~Y~G~~~ 405 (410)
T cd06115 381 HWRESLDDPDTKIMRPQQLYTGVWL 405 (410)
T ss_pred HHHHHHhCCCCcccCcccccCCCCC
Confidence 999999874 579999999999643
No 9
>COG0372 GltA Citrate synthase [Energy production and conversion]
Probab=100.00 E-value=2.3e-98 Score=772.37 Aligned_cols=370 Identities=31% Similarity=0.447 Sum_probs=335.3
Q ss_pred cceeecccccccccccccccccceecCCCC-eeecCCCHHHHhhhCCCCCCCCCCCHHHHHHHHHhCCCCCHHHHHHHHH
Q 012107 68 GNITVDMVIGGMRGMTGLLWETSLLDPDEG-IRFRGLSIPECQKLLPAAKPDGEPLPEGLLWLLLTGKVPSKEQVDGLSK 146 (471)
Q Consensus 68 g~~t~~~~~~Glrgv~~~~t~iS~lD~~~G-i~yRGy~I~eL~~~~p~~~~~~~~~~Eev~~LLl~G~lPt~~ql~~f~~ 146 (471)
++.+..++.+||+|+.+++|.||+||+++| ++||||+|+||+++. +|||++||||+|+|||.+|+++|++
T Consensus 9 ~~~~~~~~~~Gl~~v~~~~t~is~id~~~g~L~yrGy~i~dla~~~---------~feev~~LLl~G~lPt~~el~~~~~ 79 (390)
T COG0372 9 SDVGRFTYDPGLEGVAACETAISYIDGDGGILRYRGYDIEDLAEKS---------SFEEVAYLLLYGELPTKAELAAFFA 79 (390)
T ss_pred CCccccccCCcccccceeeeeeeEecCCCceEEECCccHHHHHhhc---------CHHHHHHHHHcCcCCChHHHHHHHH
Confidence 567778888999999999999999999999 599999999999994 5999999999999999999999999
Q ss_pred HHHhhCCCcHHHHHHHHcCCCCCChHHHHHHHHHHhcccchhHHHhhhccCCCCCCcchHHHHHHHHhhhhHHHHHHHHH
Q 012107 147 ELRDRATVPDYVYKAIDALPVTAHPMTQFASGVMALQVQSEFQEAYEKGIHKSKYWEPTYEDSLNLIARVPVVAAYVYQR 226 (471)
Q Consensus 147 ~l~~~~~lp~~v~~~i~~lP~~~hPM~~l~~avsal~~~s~f~~~y~~~~~k~~~~e~~~e~al~LiA~~p~i~a~iyr~ 226 (471)
++..++.+|+++.+++..+|++.|||++|+++|++|+..+.. -... ....+.+++|+|++|+|+|++||.
T Consensus 80 ~~~~~~~~~~~~~~~~~~~p~~~hpm~~l~~~vs~l~~~~~~------~~~~----~~~~~~a~rlia~~pti~a~~yr~ 149 (390)
T COG0372 80 KLAARRTLPEQVIRLLESLPRDAHPMAVLRTAVSALSAFYPD------KLDL----NDRREAALRLIAKLPTIAAAVYRY 149 (390)
T ss_pred HHHHhcCccHHHHHHHHhCCCCcCcHHHHHHHHHHhcccccc------cccc----chhHHHHHHHHHHhhHHHHHHHHH
Confidence 999999999999999999999999999999999888764321 1111 116788999999999999999999
Q ss_pred HhcCCcccCCCCCCCHHHHHHhhhcC--Cc-hHHHHHHHHHHHHhccCCCCCCchhHHHHhhccCCChHHHHHHHHhccc
Q 012107 227 IYKDGKIIPKDDSLDYGGNFSHMLGF--DD-PKMLELMRLYVTIHSDHEGGNVSAHTGHLVASALSDPYLSFAAALNGLA 303 (471)
Q Consensus 227 ~~~~~~~~~p~~~l~~~~n~~~ml~~--~~-~~~~~~l~~~LvL~aDHeg~n~St~aarvvaSt~sd~y~avaAgl~aL~ 303 (471)
..+. +++.|+++++|++||++||.+ |+ |.++++||.+|||||||| +|+||||+||++||+||+|+|++|||++|+
T Consensus 150 ~~g~-~~i~p~~~~s~a~nfL~ml~g~~p~~~~~~~a~d~~LiL~ADHe-~NASTftarvvaST~sd~ys~i~agi~aL~ 227 (390)
T COG0372 150 SRGE-PPIAPDPDLSYAENFLYMLFGEPPSPPVEARAMDRALILHADHE-LNASTFTARVVASTGSDLYACIAAGIGALK 227 (390)
T ss_pred hcCC-CCccCCCCccHHHHHHHHHcCCCCCcHHHHHHHHHHHHHHhccC-CCcHHHHHHHHHhcCCcHHHHHHHHHHHcC
Confidence 8765 467799999999999999987 55 589999999999999999 999999999999999999999999999999
Q ss_pred ccccccchHHHHHHHHHHHHhcCCCCChhhHHHHHHHHHhCCCcccccCCCCCCCCCchHHHHHHHHHhhC---CCChHH
Q 012107 304 GPLHGLANQEVLLWIKSVVDECGENVTTEQLKDYVWKTLNSGKVVPGFGHGVLRKTDPRYTCQREFALKHL---PDDPLF 380 (471)
Q Consensus 304 GplHGgA~e~v~~~l~~i~~~ig~~~~~~~i~~~v~~~l~~g~~IpGfGH~vyk~~DPRa~~l~~~a~~~~---~~~~~~ 380 (471)
||+||||||+|++||++| ++ ..+++++||++.+++|++||||||||||++|||+++|+++++++. ++++++
T Consensus 228 GPlHGGAne~v~~ml~ei----~~--~~~~~~~~v~~~l~~~~~imGFGHRVYk~~DPRa~~lk~~a~~l~~~~g~~~~~ 301 (390)
T COG0372 228 GPLHGGANEAVMKMLEEI----GS--SGESAEAYVRKALDRKERIMGFGHRVYKNYDPRAKVLKELAEKLGKELGDLKLY 301 (390)
T ss_pred CCccCChHHHHHHHHHHH----cc--cchhHHHHHHHHHhCCCCcCCCCCCCCCCCCchHHHHHHHHHHHHhhcCchhHH
Confidence 999999999999999998 43 233499999999999999999999999999999999999999984 455899
Q ss_pred HHHHHHHHhhhhhHHhcCCCCCCCCchhhHHHHHHhccCCCccccchhhhhhhhhhhHHHHHHHHHHcCCCccCCCccch
Q 012107 381 QLVSKLFEVVPPILTKLGKVKNPWPNVDAHSGVLLNHFGLAEARYYTVLFGVSRSLGICSQLIWDRALGLPLERPKSVTL 460 (471)
Q Consensus 381 ~la~~le~~~~~~l~~~~k~k~l~pNVD~~sg~l~~~lGlp~~~~~t~lF~vsR~~GwlAH~ieq~~~~~pI~RP~s~~~ 460 (471)
+++.++|+++.+. .+ +.|++|||||||+|++++.||||. ++||+||++||++||+||++||+.++.+|+||++.|+
T Consensus 302 ~~a~~~e~~~l~~--~~-~~k~l~PNvDfysg~v~~~lGiP~-~~fT~lFaiaR~~GW~AH~~Eq~~~~~riiRPr~~Y~ 377 (390)
T COG0372 302 EIAEELEEIALED--LG-FEKKLYPNVDFYSGIVYRALGIPT-DMFTPLFAIARTVGWIAHWIEQKEDGNKIIRPRALYT 377 (390)
T ss_pred HHHHHHHHHHHHh--hh-cccCCCCccccchHHHHHHcCCCH-HhhhhhhhhhhHHHHHHHHHHHHhccCCccCChhhhc
Confidence 9999999998652 22 389999999999999999999996 8999999999999999999999999558999999999
Q ss_pred hHHHHHhh
Q 012107 461 DWIEKNCK 468 (471)
Q Consensus 461 ~~~~~~~~ 468 (471)
|...+.+.
T Consensus 378 G~~~r~~~ 385 (390)
T COG0372 378 GPEERDYV 385 (390)
T ss_pred Cccccccc
Confidence 99877553
No 10
>cd06107 EcCS_AthCS-per_like Escherichia coli (Ec) citrate synthase (CS) gltA and Arabidopsis thaliana (Ath) peroxisomal (Per) CS_like. CS catalyzes the condensation of acetyl coenzyme A (AcCoA) and oxalacetate (OAA) to form citrate and coenzyme A (CoA), the first step in the citric acid cycle (TCA or Krebs cycle). The overall CS reaction is thought to proceed through three partial reactions and involves both closed and open conformational forms of the enzyme: a) the carbanion or equivalent is generated from AcCoA by base abstraction of a proton, b) the nucleophilic attack of this carbanion on OAA to generate citryl-CoA, and c) the hydrolysis of citryl-CoA to produce citrate and CoA. There are two types of CSs: type I CS and type II CSs. Type I CSs are found in eukarya, gram-positive bacteria, archaea, and in some gram-negative bacteria and are homodimers with both subunits participating in the active site. Type II CSs are unique to gram-negative bacteria and are homohexamers of ide
Probab=100.00 E-value=3.9e-98 Score=773.47 Aligned_cols=362 Identities=28% Similarity=0.440 Sum_probs=330.5
Q ss_pred ccccccccccccccceecCCCCe-eecCCCHHHHhhhCCCCCCCCCCCHHHHHHHHHhCCCCCHHHHHHHHHHHHhhCCC
Q 012107 76 IGGMRGMTGLLWETSLLDPDEGI-RFRGLSIPECQKLLPAAKPDGEPLPEGLLWLLLTGKVPSKEQVDGLSKELRDRATV 154 (471)
Q Consensus 76 ~~Glrgv~~~~t~iS~lD~~~Gi-~yRGy~I~eL~~~~p~~~~~~~~~~Eev~~LLl~G~lPt~~ql~~f~~~l~~~~~l 154 (471)
..||+||.+++|.||+||+++|+ +||||+|+||+++. +||||+||||+|+|||++|+++|+++|.+++.+
T Consensus 6 ~~GL~~v~~~~t~Is~iDg~~G~L~YRGy~I~dLa~~~---------~feev~yLLl~G~LPt~~el~~f~~~L~~~~~l 76 (382)
T cd06107 6 DPGYLNTAVCESSITYIDGDKGILLYRGYPIEQLAESS---------TYEEVAYLLLWGELPTQEQYDEFQRRLSEHMMV 76 (382)
T ss_pred CCCcCCeeeEeeeCeeEeCCCCeEEECCccHHHHHhcC---------CHHHHHHHHhCCCCCCHHHHHHHHHHHHHccCC
Confidence 35999999999999999999995 99999999999985 599999999999999999999999999999999
Q ss_pred cHHHHHHHHcCCCCCChHHHHHHHHHHhcccchhHHHhhhccCCCCCC---cchHHHHHHHHhhhhHHHHHHHHHHhcCC
Q 012107 155 PDYVYKAIDALPVTAHPMTQFASGVMALQVQSEFQEAYEKGIHKSKYW---EPTYEDSLNLIARVPVVAAYVYQRIYKDG 231 (471)
Q Consensus 155 p~~v~~~i~~lP~~~hPM~~l~~avsal~~~s~f~~~y~~~~~k~~~~---e~~~e~al~LiA~~p~i~a~iyr~~~~~~ 231 (471)
|++|.++|+++|+++|||++|+++|++|+++++.......+ +.|| +..++++++|||++|+|+|++||++.+ .
T Consensus 77 p~~v~~~i~~~p~~~hPM~~L~~~vs~l~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~liA~~p~i~A~~yr~~~g-~ 152 (382)
T cd06107 77 PESVHRLIQTFPRDAHPMGILCAGLSALSAFYPEAIPAHTG---DLYQNNPEVRDKQIIRTLAKMPTIAAAAYCHRIG-R 152 (382)
T ss_pred CHHHHHHHHhCCCCCCcHHHHHHHHHhhcccCccccchhhc---cccccCHHHHHHHHHHHHHHHHHHHHHHHHHhCC-C
Confidence 99999999999999999999999999999865432111111 3455 567788999999999999999998754 3
Q ss_pred cccCCCCCCCHHHHHHhhhcC-------CchHHHHHHHHHHHHhccCCCCCCchhHHHHhhccCCChHHHHHHHHhcccc
Q 012107 232 KIIPKDDSLDYGGNFSHMLGF-------DDPKMLELMRLYVTIHSDHEGGNVSAHTGHLVASALSDPYLSFAAALNGLAG 304 (471)
Q Consensus 232 ~~~~p~~~l~~~~n~~~ml~~-------~~~~~~~~l~~~LvL~aDHeg~n~St~aarvvaSt~sd~y~avaAgl~aL~G 304 (471)
++++|++++||++||++||++ |+++.+++||++|||||||| +|+||||+|+++||++|+|+|++||+++|+|
T Consensus 153 ~~~~P~~~ls~a~NFL~Ml~g~~~~~~~p~~~~~~~l~~~LiL~aDHg-~n~ST~aaRv~aSt~ad~~s~v~aai~al~G 231 (382)
T cd06107 153 PFVYPRANLSYIENFLYMMGYVDQEPYEPNPRLARALDRLWILHADHE-MNCSTSAARHTGSSLADPISCMAAAIAALYG 231 (382)
T ss_pred CCCCCCCCCCHHHHHHHHhcCCCcCCCCCCHHHHHHHHHHHHHhcccC-CcchhHHHHHHHhcCCcHHHHHHHHHhhccC
Confidence 588999999999999999975 56889999999999999998 9999999999999999999999999999999
Q ss_pred cccccchHHHHHHHHHHHHhcCCCCChhhHHHHHHHHHhCCCcccccCCCCCCCCCchHHHHHHHHHhhC---CCChHHH
Q 012107 305 PLHGLANQEVLLWIKSVVDECGENVTTEQLKDYVWKTLNSGKVVPGFGHGVLRKTDPRYTCQREFALKHL---PDDPLFQ 381 (471)
Q Consensus 305 plHGgA~e~v~~~l~~i~~~ig~~~~~~~i~~~v~~~l~~g~~IpGfGH~vyk~~DPRa~~l~~~a~~~~---~~~~~~~ 381 (471)
|+|||||++|++||+++ + +++++++||++.+++|++||||||||||..|||+.+|+++++++. +++++++
T Consensus 232 plHGGA~e~v~~~l~ei----~---~~~~~~~~v~~~~~~~~ri~GFGHrvyk~~DPRa~~L~~~~~~l~~~~~~~~~~~ 304 (382)
T cd06107 232 PLHGGANEAALKMLREI----G---TPENVPAFIERVKNGKRRLMGFGHRVYKNYDPRAKVIREILHEVLTEVEKDPLLK 304 (382)
T ss_pred CcccchHHHHHHHHHHh----C---ChHHHHHHHHHHHhcCCCcCCCCCCCCCCCCccHHHHHHHHHHHHHhcCCcHHHH
Confidence 99999999999999987 5 568999999999999999999999999999999999999999874 4589999
Q ss_pred HHHHHHHhhhhhHHhcCCCCCCCCchhhHHHHHHhccCCCccccchhhhhhhhhhhHHHHHHHHHHcC-CCccCCCccch
Q 012107 382 LVSKLFEVVPPILTKLGKVKNPWPNVDAHSGVLLNHFGLAEARYYTVLFGVSRSLGICSQLIWDRALG-LPLERPKSVTL 460 (471)
Q Consensus 382 la~~le~~~~~~l~~~~k~k~l~pNVD~~sg~l~~~lGlp~~~~~t~lF~vsR~~GwlAH~ieq~~~~-~pI~RP~s~~~ 460 (471)
++++||+++.+ +++++.|+++||||||+|+++++||||+ ++||++|++||++||+||++||+..+ .+|+||+++|+
T Consensus 305 ~a~~ie~~~~~--~~~~~~k~l~pNvD~~sa~~~~~lG~p~-~~~t~lf~~sR~~Gw~AH~~Eq~~~~~~~i~RP~~~Y~ 381 (382)
T cd06107 305 VAMELERIALE--DEYFVSRKLYPNVDFYSGFIYKALGFPP-EFFTVLFAVARTSGWMAHWREMMEDPLQRIWRPRQVYT 381 (382)
T ss_pred HHHHHHHHHHH--HhhhccCCCCcChHHHHHHHHHHcCCCh-hhhhHHHHHHHHHHHHHHHHHHHhCCCCceeCcccccC
Confidence 99999998754 4566789999999999999999999996 99999999999999999999999986 57999999998
Q ss_pred h
Q 012107 461 D 461 (471)
Q Consensus 461 ~ 461 (471)
|
T Consensus 382 G 382 (382)
T cd06107 382 G 382 (382)
T ss_pred C
Confidence 6
No 11
>cd06116 CaCS_like Chloroflexus aurantiacus (Ca) citrate synthase (CS)_like. CS catalyzes the condensation of acetyl coenzyme A (AcCoA) and oxalacetate (OAA) to form citrate and coenzyme A (CoA), the first step in the citric acid cycle (TCA or Krebs cycle). This group is similar to gram-negative Escherichia coli (Ec) CS (type II, gltA) and Arabidopsis thaliana (Ath) peroxisomal (Per) CS. However EcCS and AthPerCS are not found in this group. The overall CS reaction is thought to proceed through three partial reactions and involves both closed and open conformational forms of the enzyme: a) the carbanion or equivalent is generated from AcCoA by base abstraction of a proton, b) the nucleophilic attack of this carbanion on OAA to generate citryl-CoA, and c) the hydrolysis of citryl-CoA to produce citrate and CoA. There are two types of CSs: type I CS and type II CSs. Type I CSs are found in eukarya, gram-positive bacteria, archaea, and in some gram-negative bacteria and are homodimers w
Probab=100.00 E-value=8.5e-98 Score=771.44 Aligned_cols=362 Identities=27% Similarity=0.408 Sum_probs=330.5
Q ss_pred ccccccccccccccceecCCCCe-eecCCCHHHHhhhCCCCCCCCCCCHHHHHHHHHhCCCCCHHHHHHHHHHHHhhCCC
Q 012107 76 IGGMRGMTGLLWETSLLDPDEGI-RFRGLSIPECQKLLPAAKPDGEPLPEGLLWLLLTGKVPSKEQVDGLSKELRDRATV 154 (471)
Q Consensus 76 ~~Glrgv~~~~t~iS~lD~~~Gi-~yRGy~I~eL~~~~p~~~~~~~~~~Eev~~LLl~G~lPt~~ql~~f~~~l~~~~~l 154 (471)
..||+|+.+++|+||+||+++|+ +||||+|+||++++ .||||+||||+|+|||++|+++|+++|.+++.+
T Consensus 6 ~~Gl~~v~~~~t~Is~iDg~~G~L~YRGy~I~dL~~~~---------~feEv~yLLl~G~lPt~~el~~f~~~L~~~~~l 76 (384)
T cd06116 6 DPAYLNTASCKSAITYIDGEKGILRYRGYPIEQLAEQS---------SYLEVAYLLLHGELPTKERLAQWVYDITRHTMT 76 (384)
T ss_pred CCCcCCeeEEeeEeeeEeCCCCeEEECCccHHHHhccC---------CHHHHHHHHHCCCCCCHHHHHHHHHHHHHccCC
Confidence 35999999999999999999996 99999999999986 499999999999999999999999999999999
Q ss_pred cHHHHHHHHcCCCCCChHHHHHHHHHHhcccchhHHHhhhccCCCCCCcchHHHHHHHHhhhhHHHHHHHHHHhcCCccc
Q 012107 155 PDYVYKAIDALPVTAHPMTQFASGVMALQVQSEFQEAYEKGIHKSKYWEPTYEDSLNLIARVPVVAAYVYQRIYKDGKII 234 (471)
Q Consensus 155 p~~v~~~i~~lP~~~hPM~~l~~avsal~~~s~f~~~y~~~~~k~~~~e~~~e~al~LiA~~p~i~a~iyr~~~~~~~~~ 234 (471)
|+++.+++++||+++|||++|+++|++|++++++...+ ...+...+++++|+|++|+|+|++||++++. +++
T Consensus 77 p~~v~~~l~~~p~~~hPM~~L~~~vs~l~~~~~~~~~~-------~~~~~~~~~~~rliA~~p~i~A~~~r~~~g~-~~~ 148 (384)
T cd06116 77 HENLKKFMDGFRYDAHPMGILISSVAALSTFYPEAKNI-------GDEEQRNKQIIRLIGKMPTIAAFAYRHRLGL-PYV 148 (384)
T ss_pred CHHHHHHHHhcCcCCCcHHHHHHHHHhhhhcCcccccc-------CCHHHHHHHHHHHHHHHHHHHHHHHHHHcCC-Ccc
Confidence 99999999999999999999999999999876543111 1224556788999999999999999988753 588
Q ss_pred CCCCCCCHHHHHHhhhcC-------CchHHHHHHHHHHHHhccCCCCCCchhHHHHhhccCCChHHHHHHHHhccccccc
Q 012107 235 PKDDSLDYGGNFSHMLGF-------DDPKMLELMRLYVTIHSDHEGGNVSAHTGHLVASALSDPYLSFAAALNGLAGPLH 307 (471)
Q Consensus 235 ~p~~~l~~~~n~~~ml~~-------~~~~~~~~l~~~LvL~aDHeg~n~St~aarvvaSt~sd~y~avaAgl~aL~GplH 307 (471)
+|++++||++||++||++ |+++.+++||++|||||||| +|+||||+|+++||++|+|+|++||+++|+||+|
T Consensus 149 ~p~~~ls~a~Nfl~Ml~g~~~~~~~p~~~~~~~l~~~LiL~ADH~-~n~STfaarv~aSt~ad~ysav~agi~aL~GplH 227 (384)
T cd06116 149 LPDNDLSYTGNFLSMLFKMTEPKYEPNPVLAKALDVLFILHADHE-QNCSTSAMRSVGSSRADPYTAVAAAVAALYGPLH 227 (384)
T ss_pred CCCCCCCHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHhhhccCC-CCchhHHHhhhhccCCCHHHHHHHHHHhccCCcc
Confidence 999999999999999975 57889999999999999998 9999999999999999999999999999999999
Q ss_pred ccchHHHHHHHHHHHHhcCCCCChhhHHHHHHHHHhCCCcccccCCCCCCCCCchHHHHHHHHHhhC---CCChHHHHHH
Q 012107 308 GLANQEVLLWIKSVVDECGENVTTEQLKDYVWKTLNSGKVVPGFGHGVLRKTDPRYTCQREFALKHL---PDDPLFQLVS 384 (471)
Q Consensus 308 GgA~e~v~~~l~~i~~~ig~~~~~~~i~~~v~~~l~~g~~IpGfGH~vyk~~DPRa~~l~~~a~~~~---~~~~~~~la~ 384 (471)
|||||+|++||+++ + +++++++||++.+++|++||||||||||..|||+++|+++++++. +.+++++++.
T Consensus 228 GGA~e~v~~~l~ei----~---~~~~~~~~v~~~~~~~~ri~GFGHrvyk~~DPRa~~L~~~~~~l~~~~~~~~~~~ia~ 300 (384)
T cd06116 228 GGANEAVLRMLQQI----G---SPKNIPDFIETVKQGKERLMGFGHRVYKNYDPRARIIKKIADEVFEATGRNPLLDIAV 300 (384)
T ss_pred cchHHHHHHHHHHh----C---ChHHHHHHHHHHHhcCCcccCCCCCCCCCCChHHHHHHHHHHHHHHhhCCCHHHHHHH
Confidence 99999999999887 5 568999999999999999999999999999999999999999874 4578999999
Q ss_pred HHHHhhhhhHHhcCCCCCCCCchhhHHHHHHhccCCCccccchhhhhhhhhhhHHHHHHHHHHcC-CCccCCCccchhHH
Q 012107 385 KLFEVVPPILTKLGKVKNPWPNVDAHSGVLLNHFGLAEARYYTVLFGVSRSLGICSQLIWDRALG-LPLERPKSVTLDWI 463 (471)
Q Consensus 385 ~le~~~~~~l~~~~k~k~l~pNVD~~sg~l~~~lGlp~~~~~t~lF~vsR~~GwlAH~ieq~~~~-~pI~RP~s~~~~~~ 463 (471)
++|+++.+ .++++.|+++||||||+|+++++||||+ ++||++|++||++||+||++||+..+ .+|+||+++|+|..
T Consensus 301 ~~e~~~~~--~~~~~~k~l~pNvD~ysa~l~~~lGip~-~~~t~lf~isR~~Gw~AH~~Eq~~~~~~~i~RP~~~Y~G~~ 377 (384)
T cd06116 301 ELEKIALE--DEYFISRKLYPNVDFYSGLIYQALGFPT-EAFTVLFAIPRTSGWLAQWIEMLRDPEQKIARPRQVYTGPR 377 (384)
T ss_pred HHHHHHHH--hhhhcccCCCCChHHHHHHHHHHhCCCh-hhccchhhhhhhchHHHHHHHHHhCcCCcccCccccccCCC
Confidence 99998765 4567789999999999999999999996 99999999999999999999999864 57999999999975
Q ss_pred HH
Q 012107 464 EK 465 (471)
Q Consensus 464 ~~ 465 (471)
.+
T Consensus 378 ~~ 379 (384)
T cd06116 378 DR 379 (384)
T ss_pred CC
Confidence 43
No 12
>cd06109 BsCS-I_like Bacillus subtilis (Bs) citrate synthase CS-I_like. CS catalyzes the condensation of acetyl coenzyme A (AcCoA) and oxalacetate (OAA) to form citrate and coenzyme A (CoA), the first step in the citric acid cycle (TCA or Krebs cycle). 2MCS catalyzes the condensation of propionyl-coenzyme A (PrCoA) and OAA to form 2-methylcitrate and coenzyme A (CoA) during propionate metabolism. The overall CS reaction is thought to proceed through three partial reactions and involves both closed and open conformational forms of the enzyme: a) the carbanion or equivalent is generated from AcCoA by base abstraction of a proton, b) the nucleophilic attack of this carbanion on OAA to generate citryl-CoA, and c) the hydrolysis of citryl-CoA to produce citrate and CoA. This group contains proteins similar to BsCS-I, one of two CS isozymes in the gram-positive B. subtilis. The majority of CS activity in B. subtilis is provided by the other isozyme, BsCS-II (not included in this group). BsCS-
Probab=100.00 E-value=6.9e-97 Score=757.12 Aligned_cols=346 Identities=25% Similarity=0.348 Sum_probs=327.6
Q ss_pred cccccccccccccceecCCCC-eeecCCCHHHHhhhCCCCCCCCCCCHHHHHHHHHhCCCCCHHHHHHHHHHHHhhCCCc
Q 012107 77 GGMRGMTGLLWETSLLDPDEG-IRFRGLSIPECQKLLPAAKPDGEPLPEGLLWLLLTGKVPSKEQVDGLSKELRDRATVP 155 (471)
Q Consensus 77 ~Glrgv~~~~t~iS~lD~~~G-i~yRGy~I~eL~~~~p~~~~~~~~~~Eev~~LLl~G~lPt~~ql~~f~~~l~~~~~lp 155 (471)
.||+|+.+++|+||+||+++| ++||||+|+||++++ +||||+||||+|+|||++|+++|+++|.+++.+|
T Consensus 1 ~Gl~gv~~~~t~Is~idg~~G~L~YRGy~i~dL~~~~---------~feev~~LLl~G~lP~~~el~~f~~~l~~~~~lp 71 (349)
T cd06109 1 PGLEGVVAAETVLSDVDGEAGRLIIRGYSVEDLAGSA---------SFEDVAALLWNGFFPDLPELEEFRAALAAARALP 71 (349)
T ss_pred CCcCCceeeeeeceeEeCCCCeEEECCccHHHHHhhC---------CHHHHHHHHHcCCCCCHHHHHHHHHHHHhcCCCC
Confidence 499999999999999999999 699999999999986 5999999999999999999999999999999999
Q ss_pred HHHHHHHHcCCCCCChHHHHHHHHHHhcccchhHHHhhhccCCCCCCcchHHHHHHHHhhhhHHHHHHHHHHhcCCcccC
Q 012107 156 DYVYKAIDALPVTAHPMTQFASGVMALQVQSEFQEAYEKGIHKSKYWEPTYEDSLNLIARVPVVAAYVYQRIYKDGKIIP 235 (471)
Q Consensus 156 ~~v~~~i~~lP~~~hPM~~l~~avsal~~~s~f~~~y~~~~~k~~~~e~~~e~al~LiA~~p~i~a~iyr~~~~~~~~~~ 235 (471)
+.|.+++++| +++|||++|+++|++++.+ ..++++++|+|++|+|+|++||++.+. +++.
T Consensus 72 ~~v~~~~~~~-~~~~pm~~l~~~~s~~~~~------------------~~~~~a~~liA~~p~i~a~~~r~~~g~-~~~~ 131 (349)
T cd06109 72 DVVAALLPAL-AGLDPMDALRALLALLPDS------------------PDLATALRLLAAAPVITAALLRLSRGK-QPIA 131 (349)
T ss_pred HHHHHHHHhC-CCcCHHHHHHHHHHhcCch------------------hHHHHHHHHHHHHHHHHHHHHHHHcCC-CCcC
Confidence 9999999999 8999999999999999752 246889999999999999999987653 5889
Q ss_pred CCCCCCHHHHHHhhhcC--CchHHHHHHHHHHHHhccCCCCCCchhHHHHhhccCCChHHHHHHHHhcccccccccchHH
Q 012107 236 KDDSLDYGGNFSHMLGF--DDPKMLELMRLYVTIHSDHEGGNVSAHTGHLVASALSDPYLSFAAALNGLAGPLHGLANQE 313 (471)
Q Consensus 236 p~~~l~~~~n~~~ml~~--~~~~~~~~l~~~LvL~aDHeg~n~St~aarvvaSt~sd~y~avaAgl~aL~GplHGgA~e~ 313 (471)
|++++||++||++||++ |++.++++||++|||||||| +|+||||+|+++||++|+|+|++|||++|+||+|||||++
T Consensus 132 p~~~ls~a~nfl~ml~g~~p~~~~~~~l~~~Lvl~ADHg-~n~ST~aaRv~aSt~ad~~savaagi~al~GplHGGA~e~ 210 (349)
T cd06109 132 PDPSLSHAADYLRMLTGEPPSEAHVRALDAYLVTVADHG-MNASTFTARVIASTEADLTSAVLGAIGALKGPLHGGAPGP 210 (349)
T ss_pred CCCCCCHHHHHHHHhCCCCCChHHHHHHHHHHhHhcccC-CCchhhHHHHHhccCCcHHHHHHHHHHhccCCcccChHHH
Confidence 99999999999999987 78889999999999999997 9999999999999999999999999999999999999999
Q ss_pred HHHHHHHHHHhcCCCCChhhHHHHHHHHHhCCCcccccCCCCCCCCCchHHHHHHHHHhhCCCChHHHHHHHHHHhhhhh
Q 012107 314 VLLWIKSVVDECGENVTTEQLKDYVWKTLNSGKVVPGFGHGVLRKTDPRYTCQREFALKHLPDDPLFQLVSKLFEVVPPI 393 (471)
Q Consensus 314 v~~~l~~i~~~ig~~~~~~~i~~~v~~~l~~g~~IpGfGH~vyk~~DPRa~~l~~~a~~~~~~~~~~~la~~le~~~~~~ 393 (471)
|++||+++ + +++++++||++.+++|++||||||||||..|||+++|+++++++..+++++++++++|+++.++
T Consensus 211 v~~~l~ei----~---~~~~~~~~v~~~l~~~~~i~GfGH~vyk~~DPRa~~L~~~~~~~~~~~~~~~~a~~ie~~~~~~ 283 (349)
T cd06109 211 VLDMLDAI----G---TPENAEAWLREALARGERLMGFGHRVYRVRDPRADVLKAAAERLGAPDERLEFAEAVEQAALAL 283 (349)
T ss_pred HHHHHHHh----C---ChhhHHHHHHHHHHcCCeecCCCCCCCCCCCcCHHHHHHHHHHhccCChHHHHHHHHHHHHHHH
Confidence 99999887 4 4689999999999999999999999999999999999999999988899999999999999888
Q ss_pred HHhcCCCCCCCCchhhHHHHHHhccCCCccccchhhhhhhhhhhHHHHHHHHHHcCCCccCCCccchh
Q 012107 394 LTKLGKVKNPWPNVDAHSGVLLNHFGLAEARYYTVLFGVSRSLGICSQLIWDRALGLPLERPKSVTLD 461 (471)
Q Consensus 394 l~~~~k~k~l~pNVD~~sg~l~~~lGlp~~~~~t~lF~vsR~~GwlAH~ieq~~~~~pI~RP~s~~~~ 461 (471)
+.++++.|+++||||||+|+++++||||+ ++||++|++||++||+||++||+..+ +|+||+++|+|
T Consensus 284 ~~~~~~~r~l~pNvD~~sg~l~~~lGip~-~~~t~lF~isR~~Gw~AH~~Eq~~~~-~~~RP~~~Y~G 349 (349)
T cd06109 284 LREYKPGRPLETNVEFYTALLLEALGLPR-EAFTPTFAAGRTAGWTAHVLEQARTG-RLIRPQSRYVG 349 (349)
T ss_pred HHHhcCCCCCCCCchhhHHHHHHHhCCCh-hhhhhHHHHHhHHHHHHHHHHHHhcC-CCcCCCcccCC
Confidence 88888889999999999999999999996 99999999999999999999999977 58899999986
No 13
>PRK12351 methylcitrate synthase; Provisional
Probab=100.00 E-value=3.3e-96 Score=757.67 Aligned_cols=354 Identities=24% Similarity=0.357 Sum_probs=325.1
Q ss_pred cccccccccccccceecCCCC-eeecCCCHHHHhhhCCCCCCCCCCCHHHHHHHHHhCCCCCHHHHHHHHHHHHhhCCCc
Q 012107 77 GGMRGMTGLLWETSLLDPDEG-IRFRGLSIPECQKLLPAAKPDGEPLPEGLLWLLLTGKVPSKEQVDGLSKELRDRATVP 155 (471)
Q Consensus 77 ~Glrgv~~~~t~iS~lD~~~G-i~yRGy~I~eL~~~~p~~~~~~~~~~Eev~~LLl~G~lPt~~ql~~f~~~l~~~~~lp 155 (471)
.||+||.+.+|.||.+|+++| |+||||+|+||++++ +||||+||||+|+|||++|+++|+++|.+++.+|
T Consensus 10 ~GL~gv~~~~T~is~i~~~~g~L~YRGy~I~dLa~~~---------~feeva~LL~~G~LP~~~el~~f~~~L~~~~~lp 80 (378)
T PRK12351 10 VALSGVVAGNTALCTVGKSGNDLHYRGYDILDLAEHC---------EFEEVAHLLVHGKLPTQAELAAYKTKLKALRGLP 80 (378)
T ss_pred CCCCCeeeccccCeeEecCCCEEEECCccHHHHHhcC---------CHHHHHHHHHCCCCCCHHHHHHHHHHHHHhCCCC
Confidence 699999999999999999988 699999999999986 4999999999999999999999999999999999
Q ss_pred HHHHHHHHcCCCCCChHHHHHHHHHHhcccchhHHHhhhccCCCCCCcchHHHHHHHHhhhhHHHHHHHHHHhcCCcccC
Q 012107 156 DYVYKAIDALPVTAHPMTQFASGVMALQVQSEFQEAYEKGIHKSKYWEPTYEDSLNLIARVPVVAAYVYQRIYKDGKIIP 235 (471)
Q Consensus 156 ~~v~~~i~~lP~~~hPM~~l~~avsal~~~s~f~~~y~~~~~k~~~~e~~~e~al~LiA~~p~i~a~iyr~~~~~~~~~~ 235 (471)
++|.++|++||+++|||++|+++|++|+++++.. .+..++..++++++|||++|+|+|++||++.++ +++.
T Consensus 81 ~~v~~~i~~~p~~~hPM~~L~~~vs~l~~~d~~~--------~~~~~~~~~~~a~rliA~~p~i~a~~~r~~~~~-~~~~ 151 (378)
T PRK12351 81 AAVKTVLEAIPAAAHPMDVMRTGVSVLGCLLPEK--------EDHNFSGARDIADRLLASLGSILLYWYHYSHNG-RRIE 151 (378)
T ss_pred HHHHHHHHhCCccCCHHHHHHHHHHhhcccCccc--------ccCChHHHHHHHHHHHHHHHHHHHHHHHHHhCC-CccC
Confidence 9999999999999999999999999999865331 112245678899999999999999999988764 4554
Q ss_pred -CCCCCCHHHHHHhhhcC--CchHHHHHHHHHHHHhccCCCCCCchhHHHHhhccCCChHHHHHHHHhcccccccccchH
Q 012107 236 -KDDSLDYGGNFSHMLGF--DDPKMLELMRLYVTIHSDHEGGNVSAHTGHLVASALSDPYLSFAAALNGLAGPLHGLANQ 312 (471)
Q Consensus 236 -p~~~l~~~~n~~~ml~~--~~~~~~~~l~~~LvL~aDHeg~n~St~aarvvaSt~sd~y~avaAgl~aL~GplHGgA~e 312 (471)
|++++||++||++||++ |++.++++||++|||||||| +|+||||+|+++||++|+|+|++|||++|+||+||||||
T Consensus 152 p~~~~ls~a~Nfl~ml~g~~p~~~~~~~l~~~LvL~ADH~-~naST~aaRvvaSt~ad~~sav~agi~aL~GplHGGA~e 230 (378)
T PRK12351 152 VETDDDSIGGHFLHLLHGKKPSESWVKAMHTSLILYAEHE-FNASTFTARVIAGTGSDMYSAITGAIGALRGPKHGGANE 230 (378)
T ss_pred CCCCcCCHHHHHHHHhcCCCCCHHHHHHHHHHHHHhcccC-CchHHHHHHHHhccCCCHHHHHHHHHHhccCCccCchHH
Confidence 57789999999999976 78899999999999999998 999999999999999999999999999999999999999
Q ss_pred HHHHHHHHHHHhcCCCCChhhHHHHHHHHHhCCCcccccCCCCCCCCCchHHHHHHHHHhh---CCCChHHHHHHHHHHh
Q 012107 313 EVLLWIKSVVDECGENVTTEQLKDYVWKTLNSGKVVPGFGHGVLRKTDPRYTCQREFALKH---LPDDPLFQLVSKLFEV 389 (471)
Q Consensus 313 ~v~~~l~~i~~~ig~~~~~~~i~~~v~~~l~~g~~IpGfGH~vyk~~DPRa~~l~~~a~~~---~~~~~~~~la~~le~~ 389 (471)
+|++||+++ + +++++++||++.+++|++||||||||||..|||+++|+++++++ .+++++++++++++++
T Consensus 231 ~v~~ml~~i----~---~~~~~~~~v~~~l~~~~~l~GFGHrvyk~~DPRa~~L~~~~~~l~~~~~~~~~~~~a~~ie~~ 303 (378)
T PRK12351 231 VAFEIQQRY----D---TPDEAEADIRRRVENKEVVIGFGHPVYTISDPRNKVIKEVAKKLSKEAGDTKLYDIAERLETV 303 (378)
T ss_pred HHHHHHHHh----C---CHHHHHHHHHHHHhCCCccccCCCCCCCCCCccHHHHHHHHHHHHHhcCCCHHHHHHHHHHHH
Confidence 999999886 5 57899999999999999999999999999999999999999986 3567999999999998
Q ss_pred hhhhHHhcCCCCCCCCchhhHHHHHHhccCCCccccchhhhhhhhhhhHHHHHHHHHHcCCCccCCCccchhHHHH
Q 012107 390 VPPILTKLGKVKNPWPNVDAHSGVLLNHFGLAEARYYTVLFGVSRSLGICSQLIWDRALGLPLERPKSVTLDWIEK 465 (471)
Q Consensus 390 ~~~~l~~~~k~k~l~pNVD~~sg~l~~~lGlp~~~~~t~lF~vsR~~GwlAH~ieq~~~~~pI~RP~s~~~~~~~~ 465 (471)
+.+ .|+++||||||+|+++++||||+ ++||++|++||++||+||++||+.++ +|+||++.|+|.-.+
T Consensus 304 ~~~-------~k~l~pNvD~ysg~l~~~lG~p~-~~~t~lF~~sR~~Gw~AH~~Eq~~~~-~~iRP~~~Y~G~~~~ 370 (378)
T PRK12351 304 MWE-------EKKMFPNLDWFSAVSYHMMGVPT-AMFTPLFVISRTTGWAAHVIEQRQDN-KIIRPSANYTGPEDR 370 (378)
T ss_pred HHH-------HhCCCCChHHHHHHHHHHcCCCH-HhhhhHHHHHHHHHHHHHHHHHHhcC-CccCCcceecCCCCC
Confidence 854 37999999999999999999996 99999999999999999999999987 588999999997543
No 14
>TIGR01798 cit_synth_I citrate synthase I (hexameric type). This model describes one of several distinct but closely homologous classes of citrate synthase, the protein that brings carbon (from acetyl-CoA) into the TCA cycle. This form, class I, is known to be hexameric and allosterically inhibited by NADH in Escherichia coli, Acinetobacter anitratum, Azotobacter vinelandii, Pseudomonas aeruginosa, etc. In most species with a class I citrate synthase, a dimeric class II isozyme is found. The class II enzyme may act primarily on propionyl-CoA to make 2-methylcitrate or be bifunctional, may be found among propionate utilization enzymes, and may be constitutive or induced by propionate. Some members of this model group as class I enzymes, and may be hexameric, but have shown regulatory properties more like class II enzymes.
Probab=100.00 E-value=2.3e-96 Score=765.62 Aligned_cols=374 Identities=26% Similarity=0.399 Sum_probs=332.4
Q ss_pred HHHHHHHhhCCCcccceeecccccccccccccccccceecCCCCe-eecCCCHHHHhhhCCCCCCCCCCCHHHHHHHHHh
Q 012107 54 RLKKVKSELGKAQLGNITVDMVIGGMRGMTGLLWETSLLDPDEGI-RFRGLSIPECQKLLPAAKPDGEPLPEGLLWLLLT 132 (471)
Q Consensus 54 ~~~~l~~~~g~~~~g~~t~~~~~~Glrgv~~~~t~iS~lD~~~Gi-~yRGy~I~eL~~~~p~~~~~~~~~~Eev~~LLl~ 132 (471)
.+++++.+.| ..++ ..||+|+.+++|+||+||+++|+ +||||+|+||++++ .||||+||||+
T Consensus 19 ~~~~~~~~~~-----~~~~---~~GL~~v~~~~s~Is~iDg~~G~L~YRGy~I~dL~~~~---------~feEv~yLLl~ 81 (412)
T TIGR01798 19 DIRKLYKQTG-----LFTF---DPGFTSTASCESKITFIDGDKGILLYRGYPIDQLATKS---------DYLEVCYLLLN 81 (412)
T ss_pred hhHhhhhcCC-----CCcC---CCCCCCceeEeeeCeeEeCCCCEEEECCccHHHHhccC---------CHHHHHHHHHc
Confidence 3666666543 3343 46999999999999999999995 99999999999986 49999999999
Q ss_pred CCCCCHHHHHHHHHHHHhhCCCcHHHHHHHHcCCCCCChHHHHHHHHHHhcccchhHHHhhhccCCCCCCcchHHHHHHH
Q 012107 133 GKVPSKEQVDGLSKELRDRATVPDYVYKAIDALPVTAHPMTQFASGVMALQVQSEFQEAYEKGIHKSKYWEPTYEDSLNL 212 (471)
Q Consensus 133 G~lPt~~ql~~f~~~l~~~~~lp~~v~~~i~~lP~~~hPM~~l~~avsal~~~s~f~~~y~~~~~k~~~~e~~~e~al~L 212 (471)
|+|||++|+++|+++|.+++.+|+.|.++|++||+++|||++|+++|++|+.++ ++... ...-+...+++++|
T Consensus 82 G~LPt~~el~~f~~~L~~~~~lp~~v~~~i~~~p~~~hPM~~L~~~vs~l~~~~------~~~~~-~~~~~~~~~~a~~l 154 (412)
T TIGR01798 82 GELPTAEQKDEFDDTVTRHTMVHEQVTRFFNGFRRDAHPMAVMVGVVGALSAFY------HDSLD-INDPRHREIAAIRL 154 (412)
T ss_pred CCCCCHHHHHHHHHHHHHccCCCHHHHHHHHhCCCcCChHHHHHHHHHHHhhhC------ccccc-cCCHHHHHHHHHHH
Confidence 999999999999999999999999999999999999999999999999998642 11111 01123456789999
Q ss_pred HhhhhHHHHHHHHHHhcCCcccCCCCCCCHHHHHHhhhcC-------CchHHHHHHHHHHHHhccCCCCCCchhHHHHhh
Q 012107 213 IARVPVVAAYVYQRIYKDGKIIPKDDSLDYGGNFSHMLGF-------DDPKMLELMRLYVTIHSDHEGGNVSAHTGHLVA 285 (471)
Q Consensus 213 iA~~p~i~a~iyr~~~~~~~~~~p~~~l~~~~n~~~ml~~-------~~~~~~~~l~~~LvL~aDHeg~n~St~aarvva 285 (471)
||++|+|+|++||++.+ .++++|++++||++||++||++ +++..+++||++|||||||| +|+||||+|+++
T Consensus 155 iA~~p~i~A~~yr~~~g-~~~i~p~~~ls~a~Nfl~Ml~g~~~~~~~p~~~~~~~l~~~LiL~aDHg-~n~STfaaRv~a 232 (412)
T TIGR01798 155 IAKIPTLAAMSYKYSIG-QPFVYPRNDLSYAENFLHMMFATPCEDYKVNPVLARAMDRIFILHADHE-QNASTSTVRLAG 232 (412)
T ss_pred HHHHHHHHHHHHHHhCC-CCCcCCCCCCCHHHHHHHHhcCCCCccCCCCHHHHHHHHHHHHHhhcCC-CCcccceeeeee
Confidence 99999999999997654 3588999999999999999974 57789999999999999998 999999999999
Q ss_pred ccCCChHHHHHHHHhcccccccccchHHHHHHHHHHHHhcCCCCChhhHHHHHHHHHhCC--CcccccCCCCCCCCCchH
Q 012107 286 SALSDPYLSFAAALNGLAGPLHGLANQEVLLWIKSVVDECGENVTTEQLKDYVWKTLNSG--KVVPGFGHGVLRKTDPRY 363 (471)
Q Consensus 286 St~sd~y~avaAgl~aL~GplHGgA~e~v~~~l~~i~~~ig~~~~~~~i~~~v~~~l~~g--~~IpGfGH~vyk~~DPRa 363 (471)
||++|+|+|++|||++|+||+|||||++|++||.++ + +++++++||++.++++ ++||||||||||..|||+
T Consensus 233 St~ad~ysav~agi~aL~GplHGGA~e~v~~ml~ei----~---~~~~~~~~v~~~~~~~~~~~i~GFGHrvyk~~DPRa 305 (412)
T TIGR01798 233 SSGANPFACIAAGIAALWGPAHGGANEAALKMLEEI----G---SVKNIPEFIKKVKDKNDPFRLMGFGHRVYKNYDPRA 305 (412)
T ss_pred cCCCCHHHHHHHHhhhccCccccchHHHHHHHHHHh----C---ChhHHHHHHHHHHhcCCCccccCCCCCCCCCCCccH
Confidence 999999999999999999999999999999999887 5 4689999999999888 599999999999999999
Q ss_pred HHHHHHHHhhC-----CCChHHHHHHHHHHhhhhhHHhcCCCCCCCCchhhHHHHHHhccCCCccccchhhhhhhhhhhH
Q 012107 364 TCQREFALKHL-----PDDPLFQLVSKLFEVVPPILTKLGKVKNPWPNVDAHSGVLLNHFGLAEARYYTVLFGVSRSLGI 438 (471)
Q Consensus 364 ~~l~~~a~~~~-----~~~~~~~la~~le~~~~~~l~~~~k~k~l~pNVD~~sg~l~~~lGlp~~~~~t~lF~vsR~~Gw 438 (471)
++|+++++++. ..++++++++++|+++.+ .++++.|+++||||||+|+++++||||+ ++||++|++||++||
T Consensus 306 ~~L~~~a~~l~~~~g~~~~~~~~~a~~~e~~~~~--~~~~~~k~l~pNvD~~sa~l~~~lG~p~-~~~t~lFaisR~~Gw 382 (412)
T TIGR01798 306 KVMRETCHEVLKELGLHDDPLFKLAMELEKIALN--DPYFIERKLYPNVDFYSGIILKAMGIPT-SMFTVIFALARTVGW 382 (412)
T ss_pred HHHHHHHHHHHHHcCCCccHHHHHHHHHHHHHHh--hhhhccCCCCcChHHHHHHHHHHcCCCh-hhhhhHHHHHhhhhH
Confidence 99999998752 247899999999998754 4567789999999999999999999996 999999999999999
Q ss_pred HHHHHHHHHcC-CCccCCCccchhHH
Q 012107 439 CSQLIWDRALG-LPLERPKSVTLDWI 463 (471)
Q Consensus 439 lAH~ieq~~~~-~pI~RP~s~~~~~~ 463 (471)
+||++||...+ .+|+||+++|+|..
T Consensus 383 ~AH~~Eq~~~~~~~l~RP~~~Y~G~~ 408 (412)
T TIGR01798 383 ISHWSEMISDPGQKIGRPRQLYTGEE 408 (412)
T ss_pred HHHHHHHHhCCCCcccCchhccCCCC
Confidence 99999999874 58999999999864
No 15
>cd06117 Ec2MCS_like_1 Subgroup of Escherichia coli (Ec) 2-methylcitrate synthase (2MCS)_like. 2MCS catalyzes the condensation of propionyl-coenzyme A (PrCoA) and oxalacetate (OAA) to form 2-methylcitrate and coenzyme A (CoA) during propionate metabolism. Citrate synthase (CS) catalyzes the condensation of acetyl coenzyme A (AcCoA) and OAA to form citrate and coenzyme A (CoA), the first step in the citric acid cycle (TCA or Krebs cycle). This group contains proteins similar to the E. coli 2MCS, EcPrpC. EcPrpC is one of two CS isozymes in the gram-negative E. coli. EcPrpC is a dimeric (type I ) CS; it is induced during growth on propionate and prefers PrCoA as a substrate, but has a partial CS activity with AcCoA. This group also includes Salmonella typhimurium PrpC and Ralstonia eutropha (Re) 2-MCS1 which are also induced during growth on propionate, prefer PrCoA as substrate, but can also can use AcCoA. Re 2-MCS1 at a low rate can use butyryl-CoA and valeryl-CoA. A second Ralstonia eu
Probab=100.00 E-value=1.4e-95 Score=751.28 Aligned_cols=353 Identities=25% Similarity=0.357 Sum_probs=323.3
Q ss_pred ccccccccccccceecCCCC-eeecCCCHHHHhhhCCCCCCCCCCCHHHHHHHHHhCCCCCHHHHHHHHHHHHhhCCCcH
Q 012107 78 GMRGMTGLLWETSLLDPDEG-IRFRGLSIPECQKLLPAAKPDGEPLPEGLLWLLLTGKVPSKEQVDGLSKELRDRATVPD 156 (471)
Q Consensus 78 Glrgv~~~~t~iS~lD~~~G-i~yRGy~I~eL~~~~p~~~~~~~~~~Eev~~LLl~G~lPt~~ql~~f~~~l~~~~~lp~ 156 (471)
||+||.+.+|.||++|+++| |+||||+|+||++++ +||||+||||+|+|||++|+++|+++|.+++.+|+
T Consensus 2 GL~gv~~~~T~is~v~~~~g~L~YRGy~i~dLa~~~---------~FEeva~LL~~G~lPt~~el~~f~~~L~~~~~lp~ 72 (366)
T cd06117 2 ALSGVAAGNTALCTVGRSGNDLHYRGYDILDLAEKC---------EFEEVAHLLVHGKLPTKSELAAYKTKLKSLRGLPA 72 (366)
T ss_pred CCCCeeEecccCeeeecccCEEEECCccHHHHHhcC---------CHHHHHHHHHcCCCCCHHHHHHHHHHHHHccCCCH
Confidence 99999999999999999998 599999999999986 49999999999999999999999999999999999
Q ss_pred HHHHHHHcCCCCCChHHHHHHHHHHhcccchhHHHhhhccCCCCCCcchHHHHHHHHhhhhHHHHHHHHHHhcCCcccCC
Q 012107 157 YVYKAIDALPVTAHPMTQFASGVMALQVQSEFQEAYEKGIHKSKYWEPTYEDSLNLIARVPVVAAYVYQRIYKDGKIIPK 236 (471)
Q Consensus 157 ~v~~~i~~lP~~~hPM~~l~~avsal~~~s~f~~~y~~~~~k~~~~e~~~e~al~LiA~~p~i~a~iyr~~~~~~~~~~p 236 (471)
.|.++|++||+++|||++|+++|++|++++++.. +...+..++++++|||++|+|+|++||++.+ ++++.|
T Consensus 73 ~v~~~i~~~p~~~hpm~~l~~~vs~l~~~~~~~~--------~~~~~~~~~~a~rlia~~p~i~a~~~r~~~~-~~~i~p 143 (366)
T cd06117 73 NVKTALEQLPAAAHPMDVMRTGVSVLGCVLPEKE--------DHPVSGARDIADRLMASLGSILLYWYHYSHN-GKRIEV 143 (366)
T ss_pred HHHHHHHhCCccCCHHHHHHHHHhhhcccCcccc--------cCChHHHHHHHHHHHHHHHHHHHHHHHHhcC-CCccCC
Confidence 9999999999999999999999999998765521 1123456788999999999999999998764 455655
Q ss_pred -CCCCCHHHHHHhhhcC--CchHHHHHHHHHHHHhccCCCCCCchhHHHHhhccCCChHHHHHHHHhcccccccccchHH
Q 012107 237 -DDSLDYGGNFSHMLGF--DDPKMLELMRLYVTIHSDHEGGNVSAHTGHLVASALSDPYLSFAAALNGLAGPLHGLANQE 313 (471)
Q Consensus 237 -~~~l~~~~n~~~ml~~--~~~~~~~~l~~~LvL~aDHeg~n~St~aarvvaSt~sd~y~avaAgl~aL~GplHGgA~e~ 313 (471)
++++||++||++||++ |++...++||++|||||||| +|+||||+|+++||++|+|+|++||+++|+||+||||||.
T Consensus 144 ~~~~~s~a~Nfl~ml~g~~p~~~~~~~l~~~LvL~ADHg-~n~ST~aarv~aSt~ad~~sav~agi~aL~GplHGGA~e~ 222 (366)
T cd06117 144 ETDDDSIGGHFLHLLHGEKPSESWEKAMHISLILYAEHE-FNASTFTARVIAGTGSDMYSAITGAIGALRGPKHGGANEV 222 (366)
T ss_pred CCCcCCHHHHHHHHhcCCCCCHHHHHHHHHHHHHhcccC-CchHHHHHHHHHccCCcHHHHHHHHHHhccCCccCchHHH
Confidence 6689999999999977 78999999999999999998 9999999999999999999999999999999999999999
Q ss_pred HHHHHHHHHHhcCCCCChhhHHHHHHHHHhCCCcccccCCCCCCCCCchHHHHHHHHHhhC---CCChHHHHHHHHHHhh
Q 012107 314 VLLWIKSVVDECGENVTTEQLKDYVWKTLNSGKVVPGFGHGVLRKTDPRYTCQREFALKHL---PDDPLFQLVSKLFEVV 390 (471)
Q Consensus 314 v~~~l~~i~~~ig~~~~~~~i~~~v~~~l~~g~~IpGfGH~vyk~~DPRa~~l~~~a~~~~---~~~~~~~la~~le~~~ 390 (471)
|++||.++ + +++++++||++.+++|++||||||||||..|||+++|+++++++. ++++++++++++++++
T Consensus 223 v~~~l~~i----~---~~~~~~~~i~~~~~~~~~i~GFGHrvyk~~DPRa~~L~~~~~~l~~~~~~~~~~~~~~~ie~~~ 295 (366)
T cd06117 223 AFEIQQRY----E---SADEAEADIRRRVENKEVVIGFGHPVYTIADPRNQVIKEVAKQLSKEGGDMKMFDIAERLETVM 295 (366)
T ss_pred HHHHHHHh----C---CHHHHHHHHHHHHhcCCcccCCCCCCCCCCCchHHHHHHHHHHHHHhcCCcHHHHHHHHHHHHH
Confidence 99999876 5 578999999999999999999999999999999999999999874 4578999999999987
Q ss_pred hhhHHhcCCCCCCCCchhhHHHHHHhccCCCccccchhhhhhhhhhhHHHHHHHHHHcCCCccCCCccchhHHHH
Q 012107 391 PPILTKLGKVKNPWPNVDAHSGVLLNHFGLAEARYYTVLFGVSRSLGICSQLIWDRALGLPLERPKSVTLDWIEK 465 (471)
Q Consensus 391 ~~~l~~~~k~k~l~pNVD~~sg~l~~~lGlp~~~~~t~lF~vsR~~GwlAH~ieq~~~~~pI~RP~s~~~~~~~~ 465 (471)
.+ .|+++||||||+|+++++||||+ ++||++|++||++||+||++||+..+ +|+||+++|+|...+
T Consensus 296 ~~-------~k~l~pNvD~~s~~l~~~lG~p~-~~~t~lf~isR~~Gw~AH~~Eq~~~~-~~~RP~~~Y~G~~~~ 361 (366)
T cd06117 296 WE-------EKKMFPNLDWFSAVSYHMMGVPT-AMFTPLFVIARTTGWSAHIIEQRQDG-KIIRPSANYTGPEDL 361 (366)
T ss_pred HH-------HhCCCcCcHHHHHHHHHHcCcCh-hhhhHHHHHHHHHHHHHHHHHHHhcC-CCccccceecCCCCC
Confidence 43 47999999999999999999996 99999999999999999999999987 588999999996443
No 16
>PRK05614 gltA type II citrate synthase; Reviewed
Probab=100.00 E-value=9.2e-96 Score=763.13 Aligned_cols=372 Identities=26% Similarity=0.416 Sum_probs=333.2
Q ss_pred HHHHHHhhCCCcccceeecccccccccccccccccceecCCCCe-eecCCCHHHHhhhCCCCCCCCCCCHHHHHHHHHhC
Q 012107 55 LKKVKSELGKAQLGNITVDMVIGGMRGMTGLLWETSLLDPDEGI-RFRGLSIPECQKLLPAAKPDGEPLPEGLLWLLLTG 133 (471)
Q Consensus 55 ~~~l~~~~g~~~~g~~t~~~~~~Glrgv~~~~t~iS~lD~~~Gi-~yRGy~I~eL~~~~p~~~~~~~~~~Eev~~LLl~G 133 (471)
+++++++.| .+++| .||+|+.+++|+||+||+++|+ +||||+|+||+++. +||||+||||+|
T Consensus 33 ~~~~~~~~~-----~~~~~---~Gl~~~~~~~S~Is~iDg~~G~L~YRGy~i~dLa~~~---------~feEva~LLl~G 95 (419)
T PRK05614 33 IRKLYGSTG-----YFTYD---PGFTSTASCESKITYIDGDKGILLYRGYPIEQLAEKS---------DFLEVCYLLLYG 95 (419)
T ss_pred hHhhhhccC-----CcccC---CccCCceeeeeeceeEeCCCCEEEECCccHHHHHhcC---------CHHHHHHHHHcC
Confidence 667777644 44554 5999999999999999999996 99999999999986 499999999999
Q ss_pred CCCCHHHHHHHHHHHHhhCCCcHHHHHHHHcCCCCCChHHHHHHHHHHhcccchhHHHhhhccCCCCCCcchHHHHHHHH
Q 012107 134 KVPSKEQVDGLSKELRDRATVPDYVYKAIDALPVTAHPMTQFASGVMALQVQSEFQEAYEKGIHKSKYWEPTYEDSLNLI 213 (471)
Q Consensus 134 ~lPt~~ql~~f~~~l~~~~~lp~~v~~~i~~lP~~~hPM~~l~~avsal~~~s~f~~~y~~~~~k~~~~e~~~e~al~Li 213 (471)
+|||++|+++|+++|.+++.+|+.+.++|+++|+++|||++|+++|++|+.++ ++...+.+. +...+++++||
T Consensus 96 ~LP~~~el~~f~~~L~~~~~lp~~v~~~i~~~p~~~hPM~~L~~~vs~l~~~~------~~~~~~~~~-~~~~~~a~rli 168 (419)
T PRK05614 96 ELPTAEQKAEFDTTVTRHTMVHEQLKRFFRGFRRDAHPMAVLCGVVGALSAFY------HDSLDINDP-EHREIAAIRLI 168 (419)
T ss_pred cCCCHHHHHHHHHhHhhccCCCHHHHHHHHhcCCCCCHHHHHHHHHHHHhhcC------ccccCCCCH-HHHHHHHHHHH
Confidence 99999999999999999999999999999999999999999999999998652 222222333 34567899999
Q ss_pred hhhhHHHHHHHHHHhcCCcccCCCCCCCHHHHHHhhhcC-------CchHHHHHHHHHHHHhccCCCCCCchhHHHHhhc
Q 012107 214 ARVPVVAAYVYQRIYKDGKIIPKDDSLDYGGNFSHMLGF-------DDPKMLELMRLYVTIHSDHEGGNVSAHTGHLVAS 286 (471)
Q Consensus 214 A~~p~i~a~iyr~~~~~~~~~~p~~~l~~~~n~~~ml~~-------~~~~~~~~l~~~LvL~aDHeg~n~St~aarvvaS 286 (471)
|++|+|+|++||++.+ .++++|++++||++||++|+.+ +++..+++||++|||||||| +|+||||+|+++|
T Consensus 169 a~~p~i~A~~~r~~~g-~~~~~p~~~ls~a~nfl~ml~g~~~~~~~~~~~~~~~ld~~LiL~ADH~-~n~STfa~RvvaS 246 (419)
T PRK05614 169 AKMPTLAAMAYKYSIG-QPFVYPRNDLSYAENFLRMMFATPCEEYEVNPVLVRALDRIFILHADHE-QNASTSTVRLAGS 246 (419)
T ss_pred HHHHHHHHHHHHHhCC-CCCCCCCCccCHHHHHHHHHhCCCCccCCCCHHHHHHHHHHHhhhccCC-CCcchHHHhhhhc
Confidence 9999999999998654 3588999999999999999964 46778999999999999998 9999999999999
Q ss_pred cCCChHHHHHHHHhcccccccccchHHHHHHHHHHHHhcCCCCChhhHHHHHHHHHh--CCCcccccCCCCCCCCCchHH
Q 012107 287 ALSDPYLSFAAALNGLAGPLHGLANQEVLLWIKSVVDECGENVTTEQLKDYVWKTLN--SGKVVPGFGHGVLRKTDPRYT 364 (471)
Q Consensus 287 t~sd~y~avaAgl~aL~GplHGgA~e~v~~~l~~i~~~ig~~~~~~~i~~~v~~~l~--~g~~IpGfGH~vyk~~DPRa~ 364 (471)
|++|+|+|++|||++|+||+|||||++|++||+++ + +++++++||+++++ +|++||||||||||..|||++
T Consensus 247 t~adlysav~agi~aL~GplHGGA~e~v~~~l~~i----~---~~~~~~~~i~~~~~~~~~~~i~GFGHrvyk~~DPRa~ 319 (419)
T PRK05614 247 SGANPFACIAAGIAALWGPAHGGANEAVLKMLEEI----G---SVDNIPEFIARAKDKNDGFRLMGFGHRVYKNYDPRAK 319 (419)
T ss_pred cCCCHHHHHHHHHhhcCCCcccChHHHHHHHHHHh----C---CchhHHHHHHHHHhccCCccccCCCCCCCCCCCCCHH
Confidence 99999999999999999999999999999999887 5 46899999999976 456999999999999999999
Q ss_pred HHHHHHHhh---CC-CChHHHHHHHHHHhhhhhHHhcCCCCCCCCchhhHHHHHHhccCCCccccchhhhhhhhhhhHHH
Q 012107 365 CQREFALKH---LP-DDPLFQLVSKLFEVVPPILTKLGKVKNPWPNVDAHSGVLLNHFGLAEARYYTVLFGVSRSLGICS 440 (471)
Q Consensus 365 ~l~~~a~~~---~~-~~~~~~la~~le~~~~~~l~~~~k~k~l~pNVD~~sg~l~~~lGlp~~~~~t~lF~vsR~~GwlA 440 (471)
+|+++++++ .+ +++++++++++|+++.+ +++++.|+++||||||+|+++++||||. ++||++|++||++||+|
T Consensus 320 ~l~~~a~~l~~~~~~~~~~~~ia~~ie~~~~~--~~~~~~r~l~pNvD~~s~~l~~~lG~p~-~~~t~lFa~~R~~Gw~A 396 (419)
T PRK05614 320 IMRETCHEVLKELGLNDPLLEVAMELEEIALN--DEYFIERKLYPNVDFYSGIILKALGIPT-SMFTVIFALARTVGWIA 396 (419)
T ss_pred HHHHHHHHHHHHcCCCcHHHHHHHHHHHHHhh--hhhhccCCCCcChHHHHHHHHHHcCcCh-hhhcchHHhHhHHHHHH
Confidence 999999864 33 78999999999998765 5678889999999999999999999996 99999999999999999
Q ss_pred HHHHHHHc-CCCccCCCccchhH
Q 012107 441 QLIWDRAL-GLPLERPKSVTLDW 462 (471)
Q Consensus 441 H~ieq~~~-~~pI~RP~s~~~~~ 462 (471)
|++||+.. +.+|+||+++|+|.
T Consensus 397 H~~Eq~~~~~~~iiRPr~~Y~G~ 419 (419)
T PRK05614 397 HWNEMHSDPEQKIGRPRQLYTGY 419 (419)
T ss_pred HHHHHHhccCCcccCCCccccCC
Confidence 99999987 34799999999974
No 17
>PRK14036 citrate synthase; Provisional
Probab=100.00 E-value=1.3e-95 Score=754.03 Aligned_cols=360 Identities=27% Similarity=0.412 Sum_probs=331.1
Q ss_pred cccccccccccccccceecCCCCe-eecCCCHHHHhhhCCCCCCCCCCCHHHHHHHHHhCCCCCHHHHHHHHHHHHhhCC
Q 012107 75 VIGGMRGMTGLLWETSLLDPDEGI-RFRGLSIPECQKLLPAAKPDGEPLPEGLLWLLLTGKVPSKEQVDGLSKELRDRAT 153 (471)
Q Consensus 75 ~~~Glrgv~~~~t~iS~lD~~~Gi-~yRGy~I~eL~~~~p~~~~~~~~~~Eev~~LLl~G~lPt~~ql~~f~~~l~~~~~ 153 (471)
+..||+|+.+++|+||+||+++|+ +||||+|+||++++ +||||+||||+|++||++|++.|+.+|.+++.
T Consensus 4 ~~~Gl~gv~~~~t~Is~idg~~G~L~yRGy~i~dL~~~~---------~Feev~~LLl~G~lP~~~el~~f~~~L~~~~~ 74 (377)
T PRK14036 4 YRPGLEGVPATQSSISYVDGQKGILEYRGYPIEELAEKS---------SFLETAYLLIWGELPTAEELEEFEQEVRMHRR 74 (377)
T ss_pred CCCccCCCeeeeeeceEEECCCCEEEECCccHHHHHccC---------CHHHHHHHHHcCCCCCHHHHHHHHHHHHHccC
Confidence 346999999999999999999996 89999999999986 49999999999999999999999999999999
Q ss_pred CcHHHHHHHHcCCCCCChHHHHHHHHHHhcccchhHHHhhhccCCCCCCcchHHHHHHHHhhhhHHHHHHHHHHhcCCcc
Q 012107 154 VPDYVYKAIDALPVTAHPMTQFASGVMALQVQSEFQEAYEKGIHKSKYWEPTYEDSLNLIARVPVVAAYVYQRIYKDGKI 233 (471)
Q Consensus 154 lp~~v~~~i~~lP~~~hPM~~l~~avsal~~~s~f~~~y~~~~~k~~~~e~~~e~al~LiA~~p~i~a~iyr~~~~~~~~ 233 (471)
+|+.|.++++++|+++|||++|+++|++|+.+++.. .....+..++++++|+|++|+|+|++||.+.+ .++
T Consensus 75 lp~~v~~~i~~~p~~~hpm~~L~~~vs~l~~~~~~~--------~~~~~~~~~~~~~rliA~~p~i~a~~~r~~~g-~~~ 145 (377)
T PRK14036 75 VKYRIRDMMKCFPETGHPMDALQASAAALGLFYSRR--------ALDDPEYIRDAVVRLIAKIPTMVAAFQLIRKG-NDP 145 (377)
T ss_pred CCHHHHHHHHhCCCCCCHHHHHHHHHHHhhhcCccc--------ccCCHHHHHHHHHHHHHHHHHHHHHHHHHHCC-CCC
Confidence 999999999999999999999999999998754321 11224678899999999999999999887654 458
Q ss_pred cCCCCCCCHHHHHHhhhcC--CchHHHHHHHHHHHHhccCCCCCCchhHHHHhhccCCChHHHHHHHHhcccccccccch
Q 012107 234 IPKDDSLDYGGNFSHMLGF--DDPKMLELMRLYVTIHSDHEGGNVSAHTGHLVASALSDPYLSFAAALNGLAGPLHGLAN 311 (471)
Q Consensus 234 ~~p~~~l~~~~n~~~ml~~--~~~~~~~~l~~~LvL~aDHeg~n~St~aarvvaSt~sd~y~avaAgl~aL~GplHGgA~ 311 (471)
++||+++||++||++||++ |++.+.++||++|||||||| +|+||||+|+++||++|+|+|++||+++|+||+|||||
T Consensus 146 ~~p~~~l~~a~nfl~ml~g~~p~~~~~~~l~~~Lil~ADHg-~naST~aaRv~aSt~ad~ys~v~agi~aL~GplHGGA~ 224 (377)
T PRK14036 146 IQPRDDLDYAANFLYMLTEREPDPLAARIFDRCLILHAEHT-INASTFSARVTASTLTDPYAVIASAVGTLAGPLHGGAN 224 (377)
T ss_pred CCCCCCCCHHHHHHHHhcCCCCCHHHHHHHHHHHhhhccCC-CCchHHHHHHHHhcCCcHHHHHHHHHHHccCccccChH
Confidence 8999999999999999987 78999999999999999998 99999999999999999999999999999999999999
Q ss_pred HHHHHHHHHHHHhcCCCCChhhHHHHHHHHHhCCCcccccCCCCCCCCCchHHHHHHHHHhh---CCCChHHHHHHHHHH
Q 012107 312 QEVLLWIKSVVDECGENVTTEQLKDYVWKTLNSGKVVPGFGHGVLRKTDPRYTCQREFALKH---LPDDPLFQLVSKLFE 388 (471)
Q Consensus 312 e~v~~~l~~i~~~ig~~~~~~~i~~~v~~~l~~g~~IpGfGH~vyk~~DPRa~~l~~~a~~~---~~~~~~~~la~~le~ 388 (471)
|+|++||.++ + +++++++||++.+++|++||||||||||..|||+++|+++++++ .++++++++++++++
T Consensus 225 e~v~~ml~~i----~---~~~~~~~~v~~~~~~~~~i~GFGHrvyk~~DPRa~~L~~~~~~l~~~~~~~~~~~~a~~~e~ 297 (377)
T PRK14036 225 EDVLAMLEEI----G---SVENVRPYLDERLANKQKIMGFGHREYKVKDPRATILQKLAEELFARFGHDEYYEIALELER 297 (377)
T ss_pred HHHHHHHHHh----C---ChhhHHHHHHHHHHCCCceecCCCCCCCCCCccHHHHHHHHHHHHHhcCCcHHHHHHHHHHH
Confidence 9999999886 5 57899999999999999999999999999999999999999886 357899999999999
Q ss_pred hhhhhHHhcCCCCCCCCchhhHHHHHHhccCCCccccchhhhhhhhhhhHHHHHHHHHHcCCCccCCCccchhHHHHH
Q 012107 389 VVPPILTKLGKVKNPWPNVDAHSGVLLNHFGLAEARYYTVLFGVSRSLGICSQLIWDRALGLPLERPKSVTLDWIEKN 466 (471)
Q Consensus 389 ~~~~~l~~~~k~k~l~pNVD~~sg~l~~~lGlp~~~~~t~lF~vsR~~GwlAH~ieq~~~~~pI~RP~s~~~~~~~~~ 466 (471)
++.+.+ +.|+++||||||+|+++++||||+ ++||++|++||++||+||++||...+ +|+||++.|+|...+.
T Consensus 298 ~~~~~~----~~k~l~pNvD~~sa~l~~~lGip~-~~~t~lf~~sR~~Gw~AH~~Eq~~~~-~l~RP~~~Y~G~~~~~ 369 (377)
T PRK14036 298 VAEERL----GPKGIYPNVDFYSGLVYRKLGIPR-DLFTPIFAIARVAGWLAHWREQLGAN-RIFRPTQIYTGSHNRR 369 (377)
T ss_pred HHHHHh----ccCCCCcChHHHHHHHHHHcCCCh-hhhhhHHHHHhHHHHHHHHHHHHhcC-cccCCCceecCCCCCC
Confidence 997644 468999999999999999999996 99999999999999999999999987 6999999999975543
No 18
>cd06108 Ec2MCS_like Escherichia coli (Ec) 2-methylcitrate synthase (2MCS)_like. 2MCS catalyzes the condensation of propionyl-coenzyme A (PrCoA) and oxalacetate (OAA) to form 2-methylcitrate and coenzyme A (CoA) during propionate metabolism. Citrate synthase (CS) catalyzes the condensation of acetyl coenzyme A (AcCoA) and OAA to form citrate and coenzyme A (CoA), the first step in the citric acid cycle (TCA or Krebs cycle). This group contains proteins similar to the E. coli 2MCS, EcPrpC. EcPrpC is one of two CS isozymes in the gram-negative E. coli. EcPrpC is a dimeric (type I ) CS; it is induced during growth on propionate and prefers PrCoA as a substrate though it has partial CS activity with AcCoA. This group also includes Salmonella typhimurium PrpC and Ralstonia eutropha (Re) 2-MCS1 which are also induced during growth on propionate and prefer PrCoA as substrate, but can also use AcCoA. Re 2-MCS1 can use butyryl-CoA and valeryl-CoA at a lower rate. A second Ralstonia eutropha 2MC
Probab=100.00 E-value=2.4e-95 Score=748.28 Aligned_cols=351 Identities=26% Similarity=0.402 Sum_probs=322.1
Q ss_pred cccccccccccccceecCCCC-eeecCCCHHHHhhhCCCCCCCCCCCHHHHHHHHHhCCCCCHHHHHHHHHHHHhhCCCc
Q 012107 77 GGMRGMTGLLWETSLLDPDEG-IRFRGLSIPECQKLLPAAKPDGEPLPEGLLWLLLTGKVPSKEQVDGLSKELRDRATVP 155 (471)
Q Consensus 77 ~Glrgv~~~~t~iS~lD~~~G-i~yRGy~I~eL~~~~p~~~~~~~~~~Eev~~LLl~G~lPt~~ql~~f~~~l~~~~~lp 155 (471)
.||+||.+++|+||+||+++| |+||||+|+||+++. +||||+||||+|+|||++|+++|+++|.+++.+|
T Consensus 1 ~GL~gv~~~~t~is~id~~~g~L~yRGy~i~dLa~~~---------sfeeva~LLl~G~lPt~~el~~f~~~L~~~~~lp 71 (363)
T cd06108 1 GGLAGVVAGQTAISTVGKGGKGLTYRGYDIEDLAENA---------TFEEVAYLLLYGKLPTRKQLDAYKTKLVALRRLP 71 (363)
T ss_pred CCCCCCeeeeeeCceEeCCCCEEEECCccHHHHHhcC---------CHHHHHHHHHcCCCCCHHHHHHHHHHHHHhcCCC
Confidence 499999999999999999997 699999999999975 5999999999999999999999999999999999
Q ss_pred HHHHHHHHcCCCCCChHHHHHHHHHHhcccchhHHHhhhccCCCCCCcchHHHHHHHHhhhhHHHHHHHHHHhcCCcccC
Q 012107 156 DYVYKAIDALPVTAHPMTQFASGVMALQVQSEFQEAYEKGIHKSKYWEPTYEDSLNLIARVPVVAAYVYQRIYKDGKIIP 235 (471)
Q Consensus 156 ~~v~~~i~~lP~~~hPM~~l~~avsal~~~s~f~~~y~~~~~k~~~~e~~~e~al~LiA~~p~i~a~iyr~~~~~~~~~~ 235 (471)
+.|.+++++||+++|||++|+++|++|++.++... -+..++++++|||++|+|+|++||.++++..+.+
T Consensus 72 ~~v~~~i~~~p~~~hpm~~L~~~vs~l~~~d~~~~-----------~~~~~~~a~rlia~~p~i~a~~~r~~~~~~~~~p 140 (363)
T cd06108 72 AALKTVLELIPKDSHPMDVMRTGCSMLGCLEPENE-----------FSQQYEIAIRLLAIFPSILLYWYHYSHSGKRIET 140 (363)
T ss_pred HHHHHHHHhCCCCCChHHHHHHHHHhhhhcCCccc-----------cHHHHHHHHHHHHHHHHHHHHHHHHHcCCCccCC
Confidence 99999999999999999999999999987543210 0345689999999999999999998865433345
Q ss_pred CCCCCCHHHHHHhhhcC--CchHHHHHHHHHHHHhccCCCCCCchhHHHHhhccCCChHHHHHHHHhcccccccccchHH
Q 012107 236 KDDSLDYGGNFSHMLGF--DDPKMLELMRLYVTIHSDHEGGNVSAHTGHLVASALSDPYLSFAAALNGLAGPLHGLANQE 313 (471)
Q Consensus 236 p~~~l~~~~n~~~ml~~--~~~~~~~~l~~~LvL~aDHeg~n~St~aarvvaSt~sd~y~avaAgl~aL~GplHGgA~e~ 313 (471)
|++++||++||++||++ |++...++||++|||||||| +|+||||+|+++||++|+|+|++||+++|+||+|||||++
T Consensus 141 ~~~~~s~a~nfl~ml~g~~p~~~~~~~l~~~LvL~ADH~-~n~St~aaRv~aSt~ad~~sav~agi~al~GplHGGA~e~ 219 (363)
T cd06108 141 ETDEDSIAGHFLHLLHGKKPGELEIKAMDVSLILYAEHE-FNASTFAARVTASTLSDFYSAITGAIGTLRGPLHGGANEA 219 (363)
T ss_pred CCCCCCHHHHHHHHhcCCCCCHHHHHHHHHHhhhhccCC-CcchHHHHHHHhccCCCHHHHHHHHHHhccCCcccchHHH
Confidence 58889999999999987 78899999999999999998 9999999999999999999999999999999999999999
Q ss_pred HHHHHHHHHHhcCCCCChhhHHHHHHHHHhCCCcccccCCCCCCCCCchHHHHHHHHHhh---CCCChHHHHHHHHHHhh
Q 012107 314 VLLWIKSVVDECGENVTTEQLKDYVWKTLNSGKVVPGFGHGVLRKTDPRYTCQREFALKH---LPDDPLFQLVSKLFEVV 390 (471)
Q Consensus 314 v~~~l~~i~~~ig~~~~~~~i~~~v~~~l~~g~~IpGfGH~vyk~~DPRa~~l~~~a~~~---~~~~~~~~la~~le~~~ 390 (471)
|++||+++ + +++++++||++.+++|++||||||||||..|||+++|+++++++ .+++++++++.++++++
T Consensus 220 v~~~l~~i----~---~~~~~~~~v~~~l~~~~~i~GFGHrvyk~~DPRa~~L~~~a~~l~~~~~~~~~~~~a~~ie~~~ 292 (363)
T cd06108 220 AMELIERF----K---SPEEAEQGLLEKLERKELIMGFGHRVYKEGDPRSDIIKKWSKKLSEEGGDPLLYQISERIEEVM 292 (363)
T ss_pred HHHHHHHh----C---CHHHHHHHHHHHHhcCCeecCCCCCCCCCCCccHHHHHHHHHHHHHhcCCCHHHHHHHHHHHHH
Confidence 99999987 4 56899999999999999999999999999999999999999986 35689999999999987
Q ss_pred hhhHHhcCCCCCCCCchhhHHHHHHhccCCCccccchhhhhhhhhhhHHHHHHHHHHcCCCccCCCccchhHHH
Q 012107 391 PPILTKLGKVKNPWPNVDAHSGVLLNHFGLAEARYYTVLFGVSRSLGICSQLIWDRALGLPLERPKSVTLDWIE 464 (471)
Q Consensus 391 ~~~l~~~~k~k~l~pNVD~~sg~l~~~lGlp~~~~~t~lF~vsR~~GwlAH~ieq~~~~~pI~RP~s~~~~~~~ 464 (471)
.+ .|+++||||||+|+++++||||. +++|++|++||++||+||++||+..+ +|+||+++|+|...
T Consensus 293 ~~-------~~~l~pNvD~~sa~l~~~lG~p~-~~~t~iF~i~R~~Gw~AH~~Eq~~~~-~~iRP~~~Y~G~~~ 357 (363)
T cd06108 293 WE-------EKKLFPNLDFYSASAYHFCGIPT-ELFTPIFVMSRVTGWAAHIMEQRANN-RLIRPSADYIGPEP 357 (363)
T ss_pred HH-------hcCCCcChHHHHHHHHHHcCCCh-hhhhhHHHHHHHHHHHHHHHHHHhcC-CCcCccceecCCCC
Confidence 43 48999999999999999999996 99999999999999999999999887 58899999998643
No 19
>PRK14032 citrate synthase; Provisional
Probab=100.00 E-value=4.7e-95 Score=762.52 Aligned_cols=395 Identities=28% Similarity=0.402 Sum_probs=346.1
Q ss_pred hHCHHHHHHHH-HHHHhhCCCcccceeecccccccc-----cccccccccceecCC----------CC-eeecCCCHHHH
Q 012107 46 EMIPEQQERLK-KVKSELGKAQLGNITVDMVIGGMR-----GMTGLLWETSLLDPD----------EG-IRFRGLSIPEC 108 (471)
Q Consensus 46 ~~ip~~~~~~~-~l~~~~g~~~~g~~t~~~~~~Glr-----gv~~~~t~iS~lD~~----------~G-i~yRGy~I~eL 108 (471)
+.+|+++|.+. ++.++|- + ..||+ ||.+.+|+||+||++ +| |+||||+|+||
T Consensus 10 ~~~~~~~~~~~~~~~~~~~--------~---~~GL~~~~~~gv~~~~t~is~v~~~~~~dg~~~~~~G~L~YRGy~I~dL 78 (447)
T PRK14032 10 SELCEKNNKIDPELYDKYD--------V---KRGLRNEDGTGVLVGLTNIGDVHGYEIDDGEKIPDEGKLYYRGYDIKDL 78 (447)
T ss_pred HHHHHHcCCcCHHHHHHhC--------C---CcccccCCCCCeEEeeeEEeeeeceeecCCcccCCCCceeECCccHHHH
Confidence 45666666643 2334433 2 36999 999999999999994 47 79999999999
Q ss_pred hhhCCCCCCCCCCCHHHHHHHHHhCCCCCHHHHHHHHHHHHhhCCCcHH-HHHHHHcCCCCCChHHHHHHHHHHhcccch
Q 012107 109 QKLLPAAKPDGEPLPEGLLWLLLTGKVPSKEQVDGLSKELRDRATVPDY-VYKAIDALPVTAHPMTQFASGVMALQVQSE 187 (471)
Q Consensus 109 ~~~~p~~~~~~~~~~Eev~~LLl~G~lPt~~ql~~f~~~l~~~~~lp~~-v~~~i~~lP~~~hPM~~l~~avsal~~~s~ 187 (471)
++++||+ ++.+||||+||||+|+|||++|+++|+++|.+++.+|+. +.++++++| ++|||++|+++|++|+++++
T Consensus 79 a~~~~~~---~~~~FeEv~~LLl~G~LPt~~el~~f~~~L~~~~~lp~~~v~~~i~~~p-~~hPM~~L~a~vsaL~~~~~ 154 (447)
T PRK14032 79 VNGFLKE---KRFGFEEVAYLLLFGELPTKEELAEFTELLGDYRELPDGFTRDMILKAP-SKDIMNSLARSVLALYSYDD 154 (447)
T ss_pred Hhhcccc---cCCCHHHHHHHHHcCCCCCHHHHHHHHHHHHHhcCCCHHHHHHHHHhCC-CcCHHHHHHHHHHhhhhcCC
Confidence 9999875 355799999999999999999999999999999999999 899999999 79999999999999997654
Q ss_pred hHHHhhhccCCCCCCcchHHHHHHHHhhhhHHHHHHHHHH--hc-CCc--ccCCCCCCCHHHHHHhhhcC---CchHHHH
Q 012107 188 FQEAYEKGIHKSKYWEPTYEDSLNLIARVPVVAAYVYQRI--YK-DGK--IIPKDDSLDYGGNFSHMLGF---DDPKMLE 259 (471)
Q Consensus 188 f~~~y~~~~~k~~~~e~~~e~al~LiA~~p~i~a~iyr~~--~~-~~~--~~~p~~~l~~~~n~~~ml~~---~~~~~~~ 259 (471)
.. .+.+|++.++++++|||++|+|+|++||.. +. ++. +++|++++||++||++||++ +++..++
T Consensus 155 ~~--------~~~~~~~~~~~a~rLiA~~p~i~A~~yr~~~~~~~g~~~~~~~p~~~ls~a~nfl~ml~g~~~p~~~~~~ 226 (447)
T PRK14032 155 NP--------DDTSIDNVLRQSISLIARFPTLAVYAYQAYRHYHDGKSLYIHPPKPELSTAENILYMLRPDNKYTELEAR 226 (447)
T ss_pred Cc--------ccCCHHHHHHHHHHHHHHHHHHHHHHHHHHhhhhcCCCccccCCCCCCCHHHHHHHHhccCCCCCHHHHH
Confidence 31 124689999999999999999999999942 22 333 45799999999999999975 5678899
Q ss_pred HHHHHHHHhccCCCCCCchhHHHHhhccCCChHHHHHHHHhcccccccccchHHHHHHHHHHHHhcCCCCChhhHHHHHH
Q 012107 260 LMRLYVTIHSDHEGGNVSAHTGHLVASALSDPYLSFAAALNGLAGPLHGLANQEVLLWIKSVVDECGENVTTEQLKDYVW 339 (471)
Q Consensus 260 ~l~~~LvL~aDHeg~n~St~aarvvaSt~sd~y~avaAgl~aL~GplHGgA~e~v~~~l~~i~~~ig~~~~~~~i~~~v~ 339 (471)
+||++||||||||++|+||||+|++|||++|+|+|++|||++|+||+|||||++|++||.++.+..++..+++++++||+
T Consensus 227 ~ld~~LiL~ADHg~~naSTfaaRv~aSt~ad~ysavaagi~aL~GplHGGA~e~v~~~l~ei~~~~~~~~s~~~v~~~v~ 306 (447)
T PRK14032 227 LLDLALVLHAEHGGGNNSTFTTRVVSSSGTDTYSAIAAAIGSLKGPKHGGANIKVMEMFEDIKENVKDWEDEDEIADYLT 306 (447)
T ss_pred HHHHHHHHHhccCCCchhHHHHHHHHccCCcHHHHHHHHHHhccCccccCHHHHHHHHHHHHHhhccCCCCHHHHHHHHH
Confidence 99999999999997899999999999999999999999999999999999999999999999765555557889999999
Q ss_pred HHHh-----CCCcccccCCCCCCCCCchHHHHHHHHHhhC---CCChHHHHHHHHHHhhhhhHHh-cCCCCCCCCchhhH
Q 012107 340 KTLN-----SGKVVPGFGHGVLRKTDPRYTCQREFALKHL---PDDPLFQLVSKLFEVVPPILTK-LGKVKNPWPNVDAH 410 (471)
Q Consensus 340 ~~l~-----~g~~IpGfGH~vyk~~DPRa~~l~~~a~~~~---~~~~~~~la~~le~~~~~~l~~-~~k~k~l~pNVD~~ 410 (471)
+.++ +|++||||||||||..|||+++|+++++++. +.++++++++++|+++.+++.+ +++.|+++||||||
T Consensus 307 ~~l~~~~~~~~~ri~GFGHrvyk~~DPRa~~L~~~~~~l~~~~g~~~~~~~~~~~e~~~~~~~~~~~~~~k~l~pNVDfy 386 (447)
T PRK14032 307 KILNKEAFDKSGLIYGMGHAVYTISDPRAVILKKFAEKLAKEKGREEEFNLYEKIEKLAPELIAEERGIYKGVSANVDFY 386 (447)
T ss_pred HHHhccccccCCcccCCCCCCCCCCCccHHHHHHHHHHHHHHcCCchHHHHHHHHHHHHHHHHHHhhccCCCCCcChhhH
Confidence 9987 5699999999999999999999999999874 4567899999999988765543 46789999999999
Q ss_pred HHHHHhccCCCccccchhhhhhhhhhhHHHHHHHHHHcCCCccCCCccchhHHHH
Q 012107 411 SGVLLNHFGLAEARYYTVLFGVSRSLGICSQLIWDRALGLPLERPKSVTLDWIEK 465 (471)
Q Consensus 411 sg~l~~~lGlp~~~~~t~lF~vsR~~GwlAH~ieq~~~~~pI~RP~s~~~~~~~~ 465 (471)
+|++++.||||+ ++||++|++||++||+||++||+..+.+|+||+++|+|. .+
T Consensus 387 sa~i~~~lGip~-~~~t~lFaisR~~Gw~AH~~Eq~~~~~~i~RP~~~YvG~-~~ 439 (447)
T PRK14032 387 SGFVYDMLGIPE-ELYTPLFAIARIVGWSAHRIEELVNGGKIIRPAYKSVLE-RR 439 (447)
T ss_pred HHHHHHHcCCCh-hhhhhhHHHHhHHHHHHHHHHHHhcCCceecccceeeCC-CC
Confidence 999999999996 999999999999999999999996555799999999998 44
No 20
>cd06112 citrate_synt_like_1_1 Citrate synthase (CS) catalyzes the condensation of acetyl coenzyme A (AcCoA) and oxalacetate (OAA) to form citrate and coenzyme A (CoA), the first step in the oxidative citric acid cycle (TCA or Krebs cycle). Peroxisomal CS is involved in the glyoxylate cycle. This group also includes CS proteins which functions as a 2-methylcitrate synthase (2MCS). 2MCS catalyzes the condensation of propionyl-CoA (PrCoA) and OAA to form 2-methylcitrate and CoA during propionate metabolism. This group contains proteins which functions exclusively as either a CS or a 2MCS, as well as those with relaxed specificity which have dual functions as both a CS and a 2MCS. The overall CS reaction is thought to proceed through three partial reactions and involves both closed and open conformational forms of the enzyme: a) the carbanion or equivalent is generated from AcCoA by base abstraction of a proton, b) the nucleophilic attack of this carbanion on OAA to generate citryl-CoA, an
Probab=100.00 E-value=6.7e-95 Score=748.71 Aligned_cols=360 Identities=28% Similarity=0.436 Sum_probs=332.6
Q ss_pred ccccccccccccccceecCCCCe-eecCCCHHHHhhhCCCCCCCCCCCHHHHHHHHHhCCCCCHHHHHHHHHHHHhhCCC
Q 012107 76 IGGMRGMTGLLWETSLLDPDEGI-RFRGLSIPECQKLLPAAKPDGEPLPEGLLWLLLTGKVPSKEQVDGLSKELRDRATV 154 (471)
Q Consensus 76 ~~Glrgv~~~~t~iS~lD~~~Gi-~yRGy~I~eL~~~~p~~~~~~~~~~Eev~~LLl~G~lPt~~ql~~f~~~l~~~~~l 154 (471)
..||+||.+++|+||+||+++|+ +||||+|+||+++. +||||+||||+|++||++|+++|+++|.+++.+
T Consensus 2 ~~Gl~gv~~~~t~is~id~~~G~L~yRGy~i~dL~~~~---------~Feev~~LLl~G~lP~~~el~~~~~~L~~~~~l 72 (373)
T cd06112 2 IPGLAGVPAAESSISYIDGKNGILEYRGYDIEELAEYS---------SFEEVALLLLDGDLPTAAELEEFDKELRQHRRV 72 (373)
T ss_pred CCccCCCeeeeeeceEEeCCCCEEEECCccHHHHhcCC---------CHHHHHHHHHcCCCCCHHHHHHHHHHHHHhcCC
Confidence 36999999999999999999995 99999999999985 599999999999999999999999999999999
Q ss_pred cHHHHHHHHcCCCCCChHHHHHHHHHHhcccchhHHHhhhccCCCCCCcchHHHHHHHHhhhhHHHHHHHHHHhcCCccc
Q 012107 155 PDYVYKAIDALPVTAHPMTQFASGVMALQVQSEFQEAYEKGIHKSKYWEPTYEDSLNLIARVPVVAAYVYQRIYKDGKII 234 (471)
Q Consensus 155 p~~v~~~i~~lP~~~hPM~~l~~avsal~~~s~f~~~y~~~~~k~~~~e~~~e~al~LiA~~p~i~a~iyr~~~~~~~~~ 234 (471)
|++|.++++++|+++|||++|+++|++|++++++... .+ ++|++.++++++|+|++|+|+|++||++.+. +++
T Consensus 73 p~~v~~~i~~~p~~~hpm~~L~~~vs~l~~~~~~~~~-----~~-~~~~~~~~~a~~liA~~p~i~a~~~r~~~g~-~~~ 145 (373)
T cd06112 73 KYNIRDMMKCFPETGHPMDMLQATVAALGMFYPKPEV-----LK-PNPDYIDAATVKLIAKMPTLVAMWARIRNGD-DPI 145 (373)
T ss_pred CHHHHHHHHhCCCCCCHHHHHHHHHHhhhccCccccc-----cc-CCHHHHHHHHHHHHHHHHHHHHHHHHHHCCC-CCc
Confidence 9999999999999999999999999999987765321 11 4688999999999999999999999876553 588
Q ss_pred CCCCCCCHHHHHHhhhcC--CchHHHHHHHHHHHHhccCCCCCCchhHHHHhhccCCChHHHHHHHHhcccccccccchH
Q 012107 235 PKDDSLDYGGNFSHMLGF--DDPKMLELMRLYVTIHSDHEGGNVSAHTGHLVASALSDPYLSFAAALNGLAGPLHGLANQ 312 (471)
Q Consensus 235 ~p~~~l~~~~n~~~ml~~--~~~~~~~~l~~~LvL~aDHeg~n~St~aarvvaSt~sd~y~avaAgl~aL~GplHGgA~e 312 (471)
.|++++||++||++||++ |++..+++||++|||||||| +|+||||+|+++||++|+|+|++||+++|+||+|||||+
T Consensus 146 ~p~~~ls~~~nfl~ml~g~~p~~~~~~~l~~~Lil~aDHg-~n~STfaaRvvaSt~ad~~s~~~aai~al~GplHGGA~e 224 (373)
T cd06112 146 EPRPDLDYAENFLYMLFGEEPDPATAKILDACLILHAEHT-MNASTFSALVTGSTLADPYAVISSAIGTLSGPLHGGANE 224 (373)
T ss_pred CCCCCCCHHHHHHHHHhCCCCCHHHHHHHHHHHhhcccCC-CCchHHHHHHHHhcCCcHHHHHHHHHHhccCccccchHH
Confidence 999999999999999987 78899999999999999998 999999999999999999999999999999999999999
Q ss_pred HHHHHHHHHHHhcCCCCChhhHHHHHHHHHhCCCcccccCCCCCCCCCchHHHHHHHHHhhCC----CChHHHHHHHHHH
Q 012107 313 EVLLWIKSVVDECGENVTTEQLKDYVWKTLNSGKVVPGFGHGVLRKTDPRYTCQREFALKHLP----DDPLFQLVSKLFE 388 (471)
Q Consensus 313 ~v~~~l~~i~~~ig~~~~~~~i~~~v~~~l~~g~~IpGfGH~vyk~~DPRa~~l~~~a~~~~~----~~~~~~la~~le~ 388 (471)
+|++||.++ + +++++++||++.+++|++||||||+|||..|||+++|+++++++.. .++++++++++|+
T Consensus 225 ~~~~~l~~i----~---~~~~~~~~v~~~l~~~~~i~GfGH~vyk~~DPRa~~L~~~~~~l~~~~~~~~~~~~i~~~~e~ 297 (373)
T cd06112 225 DVLEMLEEI----G---SPENVKAYLDKKLANKQKIWGFGHRVYKTKDPRATILQKLAEDLFAKMGELSKLYEIALEVER 297 (373)
T ss_pred HHHHHHHHh----C---CHHHHHHHHHHHHhcCCeeeCCCCccCCCCCcHHHHHHHHHHHHHhhcCCccHHHHHHHHHHH
Confidence 999999886 5 5789999999999999999999999999999999999999999853 5789999999999
Q ss_pred hhhhhHHhcCCCCCCCCchhhHHHHHHhccCCCccccchhhhhhhhhhhHHHHHHHHHHcCCCccCCCccchhHHHH
Q 012107 389 VVPPILTKLGKVKNPWPNVDAHSGVLLNHFGLAEARYYTVLFGVSRSLGICSQLIWDRALGLPLERPKSVTLDWIEK 465 (471)
Q Consensus 389 ~~~~~l~~~~k~k~l~pNVD~~sg~l~~~lGlp~~~~~t~lF~vsR~~GwlAH~ieq~~~~~pI~RP~s~~~~~~~~ 465 (471)
++.+ +++.|+++||||||+|+++++||||. ++||++|++||++||+||++||+.++ +|+||++.|+|...+
T Consensus 298 ~~~~----~~~~k~l~pNvd~~s~~l~~~lG~p~-~~~t~lF~isR~~Gw~AH~~Eq~~~~-~l~RP~~~YvG~~~~ 368 (373)
T cd06112 298 LCEE----LLGHKGVYPNVDFYSGIVYKELGIPA-DLFTPIFAVARVAGWLAHWKEQLGDN-RIFRPTQIYIGEIDR 368 (373)
T ss_pred HHHH----HhCcCCCCcChHHHHHHHHHHhCcCh-HhhchHHHHHhHHHHHHHHHHHHhcc-CccCCCceecCCCCC
Confidence 8865 34568999999999999999999996 99999999999999999999999976 699999999997544
No 21
>PRK14035 citrate synthase; Provisional
Probab=100.00 E-value=2.2e-94 Score=742.99 Aligned_cols=356 Identities=25% Similarity=0.358 Sum_probs=328.4
Q ss_pred cccccccccccccccceecCCCCeeecCCCHHHHhhhCCCCCCCCCCCHHHHHHHHHhCCCCCHHHHHHHHHHHHhhCCC
Q 012107 75 VIGGMRGMTGLLWETSLLDPDEGIRFRGLSIPECQKLLPAAKPDGEPLPEGLLWLLLTGKVPSKEQVDGLSKELRDRATV 154 (471)
Q Consensus 75 ~~~Glrgv~~~~t~iS~lD~~~Gi~yRGy~I~eL~~~~p~~~~~~~~~~Eev~~LLl~G~lPt~~ql~~f~~~l~~~~~l 154 (471)
+..||+||.+++|+||+||++ +++||||+|+||+++. +||||+||||+|+|||++|+++|+.+|.+++.+
T Consensus 3 ~~~Gl~~v~~~~s~Is~id~~-~L~YRGy~i~dLa~~~---------~Feeva~LLl~G~lP~~~el~~f~~~L~~~~~l 72 (371)
T PRK14035 3 LQRGLEGVIAAETKISSIIDS-QLTYAGYDIDDLAENA---------SFEEVIFLLWNYRLPTEEELAHLKGKLRKYMTL 72 (371)
T ss_pred CCCCCCCceEeeeeeeEecCC-EeEECCccHHHHHhcC---------CHHHHHHHHHCCcCCCHHHHHHHHHHHHHcCCC
Confidence 457999999999999999986 5999999999999985 599999999999999999999999999999999
Q ss_pred cHHHHHHHHcCC-CCCChHHHHHHHHHHhcccchhHHHhhhccCCCCCCcchHHHHHHHHhhhhHHHHHHHHHHhcCCcc
Q 012107 155 PDYVYKAIDALP-VTAHPMTQFASGVMALQVQSEFQEAYEKGIHKSKYWEPTYEDSLNLIARVPVVAAYVYQRIYKDGKI 233 (471)
Q Consensus 155 p~~v~~~i~~lP-~~~hPM~~l~~avsal~~~s~f~~~y~~~~~k~~~~e~~~e~al~LiA~~p~i~a~iyr~~~~~~~~ 233 (471)
|+.|.+++.++| +++|||++|+++|++|++++++. .+..|+..++++++|+|++|+|+|++||++.+ .++
T Consensus 73 p~~v~~~i~~~~~~~~hpm~~l~~~vs~l~~~~~~~--------~~~~~~~~~~~a~rliA~~p~i~A~~~r~~~g-~~~ 143 (371)
T PRK14035 73 NDRVYQHFEEYSTDHVHPMTALRTSVSYLAHFDPDA--------EEESDEARYERAIRIQAKVASLVTAFARVRQG-KEP 143 (371)
T ss_pred CHHHHHHHHhcCCcCCCHHHHHHHHHHHHhccCccc--------ccCCHHHHHHHHHHHHHHHHHHHHHHHHHhCC-CCC
Confidence 999999999975 69999999999999999876542 12457889999999999999999999998644 358
Q ss_pred cCCCCCCCHHHHHHhhhcC--CchHHHHHHHHHHHHhccCCCCCCchhHHHHhhccCCChHHHHHHHHhcccccccccch
Q 012107 234 IPKDDSLDYGGNFSHMLGF--DDPKMLELMRLYVTIHSDHEGGNVSAHTGHLVASALSDPYLSFAAALNGLAGPLHGLAN 311 (471)
Q Consensus 234 ~~p~~~l~~~~n~~~ml~~--~~~~~~~~l~~~LvL~aDHeg~n~St~aarvvaSt~sd~y~avaAgl~aL~GplHGgA~ 311 (471)
++|++++||++||++||++ |++..+++||++|||||||| +|+||||+|+++||++|+|+|++||+++|+||+|||||
T Consensus 144 ~~p~~~ls~~~nfl~ml~g~~p~~~~~~~l~~~LvL~ADHg-~naST~aaRv~aSt~ad~~sav~Agi~al~GplHGGA~ 222 (371)
T PRK14035 144 LKPRPDLSYAANFLYMLRGELPTDIEVEAFNKALVLHADHE-LNASTFTARCAVSSLSDMYSGVVAAVGSLKGPLHGGAN 222 (371)
T ss_pred CCCCCCCCHHHHHHHHhccCCCCHHHHHHHHHHHHHhccCC-CCchHHHHHHHHhcCCcHHHHHHHHHHhccCccccChH
Confidence 8999999999999999986 78889999999999999998 99999999999999999999999999999999999999
Q ss_pred HHHHHHHHHHHHhcCCCCChhhHHHHHHHHHhCCCcccccCCCCCCCCCchHHHHHHHHHhhC---CCChHHHHHHHHHH
Q 012107 312 QEVLLWIKSVVDECGENVTTEQLKDYVWKTLNSGKVVPGFGHGVLRKTDPRYTCQREFALKHL---PDDPLFQLVSKLFE 388 (471)
Q Consensus 312 e~v~~~l~~i~~~ig~~~~~~~i~~~v~~~l~~g~~IpGfGH~vyk~~DPRa~~l~~~a~~~~---~~~~~~~la~~le~ 388 (471)
++|++||.++ + +++++++||++.+++|++||||||||||..|||+++|+++++++. +.++++++++++++
T Consensus 223 e~v~~~l~~i----~---~~~~~~~~v~~~~~~~~~l~GFGHrvyk~~DPRa~~L~~~~~~l~~~~~~~~~~~~a~~ie~ 295 (371)
T PRK14035 223 ERVMDMLSEI----R---SIGDVDAYLDEKFANKEKIMGFGHRVYKDGDPRAKYLREMSRKITKGTGREELFEMSVKIEK 295 (371)
T ss_pred HHHHHHHHHh----C---ChHHHHHHHHHHHhcCCcccCCCCCCCCCCCccHHHHHHHHHHHHhhcCCCHHHHHHHHHHH
Confidence 9999999987 4 468999999999999999999999999999999999999999874 56799999999999
Q ss_pred hhhhhHHhcCCCCCCCCchhhHHHHHHhccCCCccccchhhhhhhhhhhHHHHHHHHHHcCCCccCCCccchhHHHHH
Q 012107 389 VVPPILTKLGKVKNPWPNVDAHSGVLLNHFGLAEARYYTVLFGVSRSLGICSQLIWDRALGLPLERPKSVTLDWIEKN 466 (471)
Q Consensus 389 ~~~~~l~~~~k~k~l~pNVD~~sg~l~~~lGlp~~~~~t~lF~vsR~~GwlAH~ieq~~~~~pI~RP~s~~~~~~~~~ 466 (471)
++.+ .||++||||||+|+++++||||+ ++||++|++||++||+||++||+..+ +|+||+++|+|...+.
T Consensus 296 ~~~~-------~k~l~pNvD~~s~~l~~~lG~p~-~~~t~lf~i~R~~Gw~AH~~Eq~~~~-~l~RP~~~Y~G~~~~~ 364 (371)
T PRK14035 296 RMKE-------EKGLIPNVDFYSATVYHVMGIPH-DLFTPIFAVSRVAGWIAHILEQYKDN-RIMRPRAKYIGETNRK 364 (371)
T ss_pred HHHH-------hcCCCCChHHHHHHHHHHcCCCh-HhhhhHHHHHhHHHHHHHHHHHHhcC-CccCCCccccCCCCCC
Confidence 8744 47899999999999999999996 99999999999999999999999876 6999999999976543
No 22
>cd06113 citrate_synt_like_1_2 Citrate synthase (CS) catalyzes the condensation of acetyl coenzyme A (AcCoA) and oxalacetate (OAA) to form citrate and coenzyme A (CoA), the first step in the oxidative citric acid cycle (TCA or Krebs cycle). Peroxisomal CS is involved in the glyoxylate cycle. This group also includes CS proteins which functions as a 2-methylcitrate synthase (2MCS). 2MCS catalyzes the condensation of propionyl-CoA (PrCoA) and OAA to form 2-methylcitrate and CoA during propionate metabolism. This group contains proteins which functions exclusively as either a CS or a 2MCS, as well as those with relaxed specificity which have dual functions as both a CS and a 2MCS. The overall CS reaction is thought to proceed through three partial reactions and involves both closed and open conformational forms of the enzyme: a) a carbanion or equivalent is generated from AcCoA by base abstraction of a proton, b) nucleophilic attack of this carbanion on OAA to generate citryl-CoA, and c) h
Probab=100.00 E-value=8.8e-94 Score=746.69 Aligned_cols=368 Identities=27% Similarity=0.406 Sum_probs=332.2
Q ss_pred ccccccccccee------cCC----CC-eeecCCCHHHHhhhCCCCCCCCCCCHHHHHHHHHhCCCCCHHHHHHHHHHHH
Q 012107 81 GMTGLLWETSLL------DPD----EG-IRFRGLSIPECQKLLPAAKPDGEPLPEGLLWLLLTGKVPSKEQVDGLSKELR 149 (471)
Q Consensus 81 gv~~~~t~iS~l------D~~----~G-i~yRGy~I~eL~~~~p~~~~~~~~~~Eev~~LLl~G~lPt~~ql~~f~~~l~ 149 (471)
||.+.+|.||+| |++ +| |+||||+|+||++++||+ ++++||||+||||+|+|||++|+++|+++|.
T Consensus 10 gv~~~~t~is~i~~~~~idg~~~~~~G~L~yRGy~I~dLa~~~p~~---~~~sFEev~yLLl~G~LPt~~el~~f~~~L~ 86 (406)
T cd06113 10 GVLAGLTNISDVVGYKIIDGEKVPCPGKLYYRGYDVEDLVNGAQKE---NRFGFEETAYLLLFGYLPNKEELEEFCEILS 86 (406)
T ss_pred ceEeecceeeeeeeeeecCCcccCCCCeeeECCCcHHHHHhhcccc---cCCCHHHHHHHHHcCCCCCHHHHHHHHHHHH
Confidence 788999999999 899 88 599999999999999875 3568999999999999999999999999999
Q ss_pred hhCCCcHHH-HHHHHcCCCCCChHHHHHHHHHHhcccchhHHHhhhccCCCCCCcchHHHHHHHHhhhhHHHHHHHHHHh
Q 012107 150 DRATVPDYV-YKAIDALPVTAHPMTQFASGVMALQVQSEFQEAYEKGIHKSKYWEPTYEDSLNLIARVPVVAAYVYQRIY 228 (471)
Q Consensus 150 ~~~~lp~~v-~~~i~~lP~~~hPM~~l~~avsal~~~s~f~~~y~~~~~k~~~~e~~~e~al~LiA~~p~i~a~iyr~~~ 228 (471)
+++.+|+.+ .++++++|. .|||++|+++|++|+.+++. .++.+|+..++++++|||++|+|+|++||.+.
T Consensus 87 ~~~~lp~~~~~~~i~~~p~-~hpM~~L~a~v~~l~~~~~~--------~~~~~~~~~~~~a~rLiA~~p~i~A~~yr~~~ 157 (406)
T cd06113 87 SYRTLPDNFVEDVILKAPS-KDIMNKLQRSVLALYSYDDK--------PDDISLENVLRQSIQLIARLPTIAVYAYQAKR 157 (406)
T ss_pred HhcCCCHHHHHHHHHhCCC-cCHHHHHHHHHHhccccCCC--------cccCCHHHHHHHHHHHHHHHHHHHHHHHHHHh
Confidence 999999985 669999995 99999999999999976432 23457999999999999999999999999643
Q ss_pred --cCCc---ccCCCCCCCHHHHHHhhhcC---CchHHHHHHHHHHHHhccCCCCCCchhHHHHhhccCCChHHHHHHHHh
Q 012107 229 --KDGK---IIPKDDSLDYGGNFSHMLGF---DDPKMLELMRLYVTIHSDHEGGNVSAHTGHLVASALSDPYLSFAAALN 300 (471)
Q Consensus 229 --~~~~---~~~p~~~l~~~~n~~~ml~~---~~~~~~~~l~~~LvL~aDHeg~n~St~aarvvaSt~sd~y~avaAgl~ 300 (471)
.+++ +++|++++||++||++||++ +++..+++||++||||||||++|+||||+|+++||++|+|+|++|||+
T Consensus 158 ~~~~~~~~~~~~p~~~ls~a~nfl~ml~g~~~p~~~~~~~l~~~Lvl~ADHg~~naST~aaRv~aSt~ad~~~avaagi~ 237 (406)
T cd06113 158 HYYDGESLYIHHPQPELSTAENILSMLRPDKKYTELEAKLLDLCLVLHAEHGGGNNSTFTTRVVSSSGTDTYSAIAAAIG 237 (406)
T ss_pred hhccCCCccccCCCCCCCHHHHHHHHhccCCCCCHHHHHHHHHHHhhhhccCCCcchHHHHHHHHccCCCHHHHHHHHHH
Confidence 1222 55799999999999999975 577889999999999999997899999999999999999999999999
Q ss_pred cccccccccchHHHHHHHHHHHHhcCCCCChhhHHHHHHHHHhCC-----CcccccCCCCCCCCCchHHHHHHHHHhhC-
Q 012107 301 GLAGPLHGLANQEVLLWIKSVVDECGENVTTEQLKDYVWKTLNSG-----KVVPGFGHGVLRKTDPRYTCQREFALKHL- 374 (471)
Q Consensus 301 aL~GplHGgA~e~v~~~l~~i~~~ig~~~~~~~i~~~v~~~l~~g-----~~IpGfGH~vyk~~DPRa~~l~~~a~~~~- 374 (471)
+|+||+|||||++|++||.++.+..++..+++++++||++.++++ ++||||||||||..|||+++|+++++++.
T Consensus 238 al~GplHGGA~e~v~~~l~~i~~~~~~~~~~~~v~~~v~~~l~~~~~~~~~~l~GFGHrvyk~~DPRa~~L~~~~~~l~~ 317 (406)
T cd06113 238 SLKGPRHGGANIKVMEMLEDIKENVKDWTDEDEVRAYLRKILNKEAFDKSGLIYGMGHAVYTLSDPRAVVLKKYARSLAK 317 (406)
T ss_pred HccCccccChHHHHHHHHHHHHhhccCCCCHHHHHHHHHHHHhccccccCceeecCCCCCCCCCCccHHHHHHHHHHHHH
Confidence 999999999999999999999765566567899999999999876 59999999999999999999999999874
Q ss_pred --CCChHHHHHHHHHHhhhhhHHh-cCCCCCCCCchhhHHHHHHhccCCCccccchhhhhhhhhhhHHHHHHHHHHcCCC
Q 012107 375 --PDDPLFQLVSKLFEVVPPILTK-LGKVKNPWPNVDAHSGVLLNHFGLAEARYYTVLFGVSRSLGICSQLIWDRALGLP 451 (471)
Q Consensus 375 --~~~~~~~la~~le~~~~~~l~~-~~k~k~l~pNVD~~sg~l~~~lGlp~~~~~t~lF~vsR~~GwlAH~ieq~~~~~p 451 (471)
+.++++++++++|+++.+++.+ +++.|+++||||||+|+++++||||+ ++||++|++||++||+||++||+.++.+
T Consensus 318 ~~~~~~~~~~~~~ie~~~~~~~~~~~~~~r~l~pNvD~~sa~l~~~lG~p~-~~~t~lF~isR~~Gw~AH~~Eq~~~~~~ 396 (406)
T cd06113 318 EKGREEEFALYERIERLAPEVIAEERGIGKTVCANVDFYSGFVYKMLGIPQ-ELYTPLFAVARIVGWCAHRIEELLNSGR 396 (406)
T ss_pred hcCcchHHHHHHHHHHHHHHHHHHhhccCCCCCCChHHHHHHHHHHcCCCh-hhhhhHHHHHhHHHHHHHHHHHHhcCCc
Confidence 4567999999999999877654 47889999999999999999999996 9999999999999999999999876557
Q ss_pred ccCCCccchh
Q 012107 452 LERPKSVTLD 461 (471)
Q Consensus 452 I~RP~s~~~~ 461 (471)
|+||++.|+|
T Consensus 397 l~RP~~~Y~G 406 (406)
T cd06113 397 IIRPAYKYVG 406 (406)
T ss_pred eeccccccCC
Confidence 9999999985
No 23
>PRK14034 citrate synthase; Provisional
Probab=100.00 E-value=1.6e-93 Score=736.81 Aligned_cols=353 Identities=26% Similarity=0.399 Sum_probs=324.5
Q ss_pred ccccccccccccccceecCCCCeeecCCCHHHHhhhCCCCCCCCCCCHHHHHHHHHhCCCCCHHHHHHHHHHHHhhCCCc
Q 012107 76 IGGMRGMTGLLWETSLLDPDEGIRFRGLSIPECQKLLPAAKPDGEPLPEGLLWLLLTGKVPSKEQVDGLSKELRDRATVP 155 (471)
Q Consensus 76 ~~Glrgv~~~~t~iS~lD~~~Gi~yRGy~I~eL~~~~p~~~~~~~~~~Eev~~LLl~G~lPt~~ql~~f~~~l~~~~~lp 155 (471)
..||+||.+.+|.||+||++ +|+||||+|+||+++. +||||+||||+|+|||++|+++|+++|..++.+|
T Consensus 4 ~~GL~gv~~~~s~is~i~~~-~L~YRGy~i~dLa~~~---------~fEeva~LLl~G~lPt~~el~~f~~~L~~~~~lp 73 (372)
T PRK14034 4 TRGLEGVVATTSSVSSIIDD-TLTYVGYNIDDLAENA---------SFEEVVYLLWHRKLPNKQELAEFKEQLSENAKVP 73 (372)
T ss_pred CCCCCCceEeeeEeeccCCC-eEEECCccHHHHhccC---------CHHHHHHHHHCCCCCCHHHHHHHHHHHHHhcCCC
Confidence 46999999999999999964 6999999999999875 5999999999999999999999999999999999
Q ss_pred HHHHHHHHcCCC-CCChHHHHHHHHHHhcccchhHHHhhhccCCCCCCcchHHHHHHHHhhhhHHHHHHHHHHhcCCccc
Q 012107 156 DYVYKAIDALPV-TAHPMTQFASGVMALQVQSEFQEAYEKGIHKSKYWEPTYEDSLNLIARVPVVAAYVYQRIYKDGKII 234 (471)
Q Consensus 156 ~~v~~~i~~lP~-~~hPM~~l~~avsal~~~s~f~~~y~~~~~k~~~~e~~~e~al~LiA~~p~i~a~iyr~~~~~~~~~ 234 (471)
+.+.++++++|+ ++|||++|+++|++|+.++++.. +...+..++++++|+|++|+|+|++||+..+ .+++
T Consensus 74 ~~v~~~l~~~p~~~~hpm~~l~~~vs~l~~~~~~~~--------~~~~~~~~~~a~~liA~~p~i~a~~~r~~~g-~~~~ 144 (372)
T PRK14034 74 GEIIEHLKQYDLKKVHPMSVLRTAISMLGLYDEEAE--------IMDEEANYRKAVRLQAKVPTIVAAFSRIRKG-LDPV 144 (372)
T ss_pred HHHHHHHHhCCCcCcCHHHHHHHHHHhhcccCcccc--------cCCHHHHHHHHHHHHHHHHHHHHHHHHHHCC-CCCC
Confidence 999999999997 59999999999999998765431 1224677899999999999999999987544 4588
Q ss_pred CCCCCCCHHHHHHhhhcC--CchHHHHHHHHHHHHhccCCCCCCchhHHHHhhccCCChHHHHHHHHhcccccccccchH
Q 012107 235 PKDDSLDYGGNFSHMLGF--DDPKMLELMRLYVTIHSDHEGGNVSAHTGHLVASALSDPYLSFAAALNGLAGPLHGLANQ 312 (471)
Q Consensus 235 ~p~~~l~~~~n~~~ml~~--~~~~~~~~l~~~LvL~aDHeg~n~St~aarvvaSt~sd~y~avaAgl~aL~GplHGgA~e 312 (471)
+|++++||++||++|+++ |++.++++||++|||||||| +|+||||+|+++||++|+|+|++||+++|+||+|||||+
T Consensus 145 ~p~~~ls~a~nfl~ml~g~~p~~~~~~~l~~~Lvl~aDHg-~n~ST~aaRv~aSt~~d~ysav~agi~al~GplHGGA~e 223 (372)
T PRK14034 145 EPRKDLSLAANFLYMLNGEEPDEVEVEAFNKALVLHADHE-LNASTFTARVCVATLSDVYSGITAAIGALKGPLHGGANE 223 (372)
T ss_pred CCCCCCCHHHHHHHHhcCCCCCHHHHHHHHHHHhHhccCC-CCccHHHHHHHhccCCcHHHHHHHHhcccCCCccCCHHH
Confidence 999999999999999986 78889999999999999998 999999999999999999999999999999999999999
Q ss_pred HHHHHHHHHHHhcCCCCChhhHHHHHHHHHhCCCcccccCCCCCCCCCchHHHHHHHHHhhC---CCChHHHHHHHHHHh
Q 012107 313 EVLLWIKSVVDECGENVTTEQLKDYVWKTLNSGKVVPGFGHGVLRKTDPRYTCQREFALKHL---PDDPLFQLVSKLFEV 389 (471)
Q Consensus 313 ~v~~~l~~i~~~ig~~~~~~~i~~~v~~~l~~g~~IpGfGH~vyk~~DPRa~~l~~~a~~~~---~~~~~~~la~~le~~ 389 (471)
+|++||+++ + +++++++||++.+++|++||||||||||..|||+++|+++++++. +++++++++++++++
T Consensus 224 ~~~~~l~~i----~---~~~~~~~~v~~~~~~~~~l~GFGHrvyk~~DPRa~~L~~~~~~~~~~~~~~~~~~~a~~~e~~ 296 (372)
T PRK14034 224 NVMKMLTEI----G---EEENVESYIHNKLQNKEKIMGFGHRVYRQGDPRAKHLREMSKRLTVLLGEEKWYNMSIKIEEI 296 (372)
T ss_pred HHHHHHHHh----C---CHHHHHHHHHHHHhCCCCcccCCCCCCCCCCcCHHHHHHHHHHHHHhcCCCHHHHHHHHHHHH
Confidence 999999887 5 568999999999999999999999999999999999999999874 567999999999998
Q ss_pred hhhhHHhcCCCCCCCCchhhHHHHHHhccCCCccccchhhhhhhhhhhHHHHHHHHHHcCCCccCCCccchhHHH
Q 012107 390 VPPILTKLGKVKNPWPNVDAHSGVLLNHFGLAEARYYTVLFGVSRSLGICSQLIWDRALGLPLERPKSVTLDWIE 464 (471)
Q Consensus 390 ~~~~l~~~~k~k~l~pNVD~~sg~l~~~lGlp~~~~~t~lF~vsR~~GwlAH~ieq~~~~~pI~RP~s~~~~~~~ 464 (471)
+.+ .|+++||||||+|+++++||||+ ++||++|++||++||+||++||+.++ +|+||+++|+|.-.
T Consensus 297 ~~~-------~k~l~pNvD~~~a~l~~~lG~p~-~~~t~lf~i~R~~Gw~AH~~Eq~~~~-~l~Rp~~~Y~G~~~ 362 (372)
T PRK14034 297 VTK-------EKGLPPNVDFYSASVYHCLGIDH-DLFTPIFAISRMSGWLAHILEQYENN-RLIRPRADYVGPTH 362 (372)
T ss_pred HHH-------cCCCCCChHHHHHHHHHHcCCCh-HhccchhHHHhHHHHHHHHHHHHhcC-CccCCCceecCCCC
Confidence 743 47899999999999999999996 99999999999999999999999876 79999999999643
No 24
>PRK14037 citrate synthase; Provisional
Probab=100.00 E-value=3.9e-93 Score=735.58 Aligned_cols=357 Identities=26% Similarity=0.386 Sum_probs=324.9
Q ss_pred cccccccccccccccceecCCCCe-eecCCCHHHHhhhCCCCCCCCCCCHHHHHHHHHhCCCCCHHHHHHHHHHHHhhCC
Q 012107 75 VIGGMRGMTGLLWETSLLDPDEGI-RFRGLSIPECQKLLPAAKPDGEPLPEGLLWLLLTGKVPSKEQVDGLSKELRDRAT 153 (471)
Q Consensus 75 ~~~Glrgv~~~~t~iS~lD~~~Gi-~yRGy~I~eL~~~~p~~~~~~~~~~Eev~~LLl~G~lPt~~ql~~f~~~l~~~~~ 153 (471)
+..||+||++++|+||+||+++|+ +||||+|+||+++. +||||+||||+|+|||++|+++|+++|..++.
T Consensus 4 ~~~GL~gv~~~~t~is~id~~~g~L~yRGy~i~dL~~~~---------~Feev~~LLl~G~lP~~~e~~~f~~~L~~~~~ 74 (377)
T PRK14037 4 ISKGLENVIIKVTNLTFIDGEKGILRYRGYNIEDLVNYG---------SYEETIYLMLYGELPTKKELNDLKEKLNEEYE 74 (377)
T ss_pred CCCCCCCCeeeeeeceEEeCCCCEEEECCccHHHHHccC---------CHHHHHHHHHcCCCCCHHHHHHHHHHHHHhcC
Confidence 457999999999999999999995 99999999999985 49999999999999999999999999999999
Q ss_pred CcHHHHHHHHcCCCCCChHHHHHHHHHHhcccchhHHHhhhccCCCCCC-cchHHHHHHHHhhhhHHHHHHHHHHhcCCc
Q 012107 154 VPDYVYKAIDALPVTAHPMTQFASGVMALQVQSEFQEAYEKGIHKSKYW-EPTYEDSLNLIARVPVVAAYVYQRIYKDGK 232 (471)
Q Consensus 154 lp~~v~~~i~~lP~~~hPM~~l~~avsal~~~s~f~~~y~~~~~k~~~~-e~~~e~al~LiA~~p~i~a~iyr~~~~~~~ 232 (471)
+|+.+.+++++||+++|||++|+++|++|+++++. .+| +..++++++|||++|+|+|++||++.+. +
T Consensus 75 lp~~v~~~~~~~p~~~hpm~~l~~~vs~l~~~~~~-----------~~~~~~~~~~a~~liA~~p~i~a~~yr~~~g~-~ 142 (377)
T PRK14037 75 VPQEVIDSIYLMPRDSDAIGLMEAAFAALASIDKN-----------FKWKENDKEKAISIIAKMATIVANVYRRKEGN-K 142 (377)
T ss_pred CCHHHHHHHHhCCccCCcHHHHHHHHHhhhccCCc-----------ccccHHHHHHHHHHHHHHHHHHHHHHHHHcCC-C
Confidence 99999999999999999999999999999975311 123 3457899999999999999999987654 5
Q ss_pred ccCCCCCCCHHHHHHhhhcC--CchHHHHHHHHHHHHhccCCCCCCchhHHHHhhccCCChHHHHHHHHhcccccccccc
Q 012107 233 IIPKDDSLDYGGNFSHMLGF--DDPKMLELMRLYVTIHSDHEGGNVSAHTGHLVASALSDPYLSFAAALNGLAGPLHGLA 310 (471)
Q Consensus 233 ~~~p~~~l~~~~n~~~ml~~--~~~~~~~~l~~~LvL~aDHeg~n~St~aarvvaSt~sd~y~avaAgl~aL~GplHGgA 310 (471)
++.|++++||++||++||.+ |++.++++||++|||||||| +|+||||+|+++||++|+|+|++|||++|+||+||||
T Consensus 143 ~~~p~~~~s~a~nfl~ml~G~~p~~~~~~~l~~~Lil~ADHg-~naST~aarv~aSt~ad~ysav~agi~al~GplHGGA 221 (377)
T PRK14037 143 PRIPEPSDSFAESFLLASFAREPTAEEIKAMDAALILYTDHE-VPASTTAALVAASTLSDMYSCITAALAALKGPLHGGA 221 (377)
T ss_pred CCCCCCCCCHHHHHHHHHhccCCcHHHHHHHHHHHhHhcccC-CchHhHHHHHhhccCCCHHHHHHHHHHhccCcccCCh
Confidence 78899999999999999976 88999999999999999999 8999999999999999999999999999999999999
Q ss_pred hHHHHHHHHHHHHhcCCCCChhhHHHHHHHHH-hCCCcccccCCCCCCCCCchHHHHHHHHHhhC---C-CChHHHHHHH
Q 012107 311 NQEVLLWIKSVVDECGENVTTEQLKDYVWKTL-NSGKVVPGFGHGVLRKTDPRYTCQREFALKHL---P-DDPLFQLVSK 385 (471)
Q Consensus 311 ~e~v~~~l~~i~~~ig~~~~~~~i~~~v~~~l-~~g~~IpGfGH~vyk~~DPRa~~l~~~a~~~~---~-~~~~~~la~~ 385 (471)
|++|++||+++ + +++++++|+++.+ ++|++||||||+|||..|||+++|+++++++. + .+++++++.+
T Consensus 222 ~e~v~~~l~ei----~---~~~~~~~~~~~~~~~~~~~i~GFGHrvyk~~DPRa~~L~~~~~~~~~~~~~~~~~~~ia~~ 294 (377)
T PRK14037 222 AEEAFKQFVEI----G---DPNNVEMWFNDKIINGKKRLMGFGHRVYKTYDPRAKIFKELAETLIERNSEAKKYFEIAQK 294 (377)
T ss_pred HHHHHHHHHHh----c---ChhhHHHHHHHHHhcCCCeecCCCCCCCCCCCccHHHHHHHHHHHHHhcCCccHHHHHHHH
Confidence 99999999886 5 4689999998765 45589999999999999999999999999874 3 4789999999
Q ss_pred HHHhhhhhHHhcCCCCCCCCchhhHHHHHHhccCCCccccchhhhhhhhhhhHHHHHHHHHHcCCCccCCCccchhHHHH
Q 012107 386 LFEVVPPILTKLGKVKNPWPNVDAHSGVLLNHFGLAEARYYTVLFGVSRSLGICSQLIWDRALGLPLERPKSVTLDWIEK 465 (471)
Q Consensus 386 le~~~~~~l~~~~k~k~l~pNVD~~sg~l~~~lGlp~~~~~t~lF~vsR~~GwlAH~ieq~~~~~pI~RP~s~~~~~~~~ 465 (471)
+|+++.+ +++.|+++||||||+|++++.||||+ ++||++|++||++||+||++||+..+.+|+||+++|+|...+
T Consensus 295 ~e~~~~~----~~~~k~l~pNvD~~sa~l~~~lG~p~-~~~t~lf~isR~~Gw~AH~~Eq~~~~~~~~RP~~~Y~G~~~~ 369 (377)
T PRK14037 295 LEELGIK----QFGSKGIYPNTDFYSGIVFYALGFPV-YMFTALFALSRTLGWLAHIIEYVEEQHRLIRPRALYVGPEHR 369 (377)
T ss_pred HHHHHHH----HhhccCCCCChHHHHHHHHHHcCCCh-hhcchhHHhhhhhHHHHHHHHHHhcCCccccCcceecCCCCC
Confidence 9998754 33568999999999999999999996 999999999999999999999998766899999999996543
No 25
>cd06114 EcCS_like Escherichia coli (Ec) citrate synthase (CS) GltA_like. CS catalyzes the condensation of acetyl coenzyme A (AcCoA) and oxalacetate (OAA) to form citrate and coenzyme A (CoA), the first step in the citric acid cycle (TCA or Krebs cycle). The overall CS reaction is thought to proceed through three partial reactions and involves both closed and open conformational forms of the enzyme: a) the carbanion or equivalent is generated from AcCoA by base abstraction of a proton, b) the nucleophilic attack of this carbanion on OAA to generate citryl-CoA, and c) the hydrolysis of citryl-CoA to produce citrate and CoA. There are two types of CSs: type I CS and type II CSs. Type I CSs are found in eukarya, gram-positive bacteria, archaea, and in some gram-negative bacteria and are homodimers with both subunits participating in the active site. Type II CSs are unique to gram-negative bacteria and are homohexamers of identical subunits (approximated as a trimer of dimers). Some typ
Probab=100.00 E-value=5.7e-93 Score=739.35 Aligned_cols=359 Identities=28% Similarity=0.423 Sum_probs=327.4
Q ss_pred cccccccccccccccceecCCCCe-eecCCCHHHHhhhCCCCCCCCCCCHHHHHHHHHhCCCCCHHHHHHHHHHHHhhCC
Q 012107 75 VIGGMRGMTGLLWETSLLDPDEGI-RFRGLSIPECQKLLPAAKPDGEPLPEGLLWLLLTGKVPSKEQVDGLSKELRDRAT 153 (471)
Q Consensus 75 ~~~Glrgv~~~~t~iS~lD~~~Gi-~yRGy~I~eL~~~~p~~~~~~~~~~Eev~~LLl~G~lPt~~ql~~f~~~l~~~~~ 153 (471)
+..||+||.+++|+||+||+++|+ +||||+|+||+++. +||||+||||+|+|||++|+++|+.+|.+++.
T Consensus 27 ~~~GL~gv~v~~S~Is~idg~~G~L~YRGy~i~dLa~~~---------sfEEva~LL~~G~lP~~~el~~f~~~L~~~~~ 97 (400)
T cd06114 27 YDPGFMNTASCESAITYIDGEKGILRYRGYPIEQLAEKS---------SFLEVCYLLLYGELPTAEQLQEFREEITRHTL 97 (400)
T ss_pred CCCCCCCceeEeeeCeEEeCCCCEEEECCccHHHHHhcC---------CHHHHHHHHHcCcCCCHHHHHHHHHHHHHccC
Confidence 346999999999999999999995 99999999999985 49999999999999999999999999999999
Q ss_pred CcHHHHHHHHcCCCCCChHHHHHHHHHHhcccchhHHHhhhccCCCCCCcchHHHHHHHHhhhhHHHHHHHHHHhcCCcc
Q 012107 154 VPDYVYKAIDALPVTAHPMTQFASGVMALQVQSEFQEAYEKGIHKSKYWEPTYEDSLNLIARVPVVAAYVYQRIYKDGKI 233 (471)
Q Consensus 154 lp~~v~~~i~~lP~~~hPM~~l~~avsal~~~s~f~~~y~~~~~k~~~~e~~~e~al~LiA~~p~i~a~iyr~~~~~~~~ 233 (471)
+|+.+.++|+++|+++|||++|+++|++|+.+++. ...+ ..|+..++++++|||++|+|+|++||++.+. ++
T Consensus 98 lp~~v~~~i~~~p~~~~pm~~l~~~vs~l~~~d~~------~~~~-~~~~~~~~~a~~lia~~p~i~a~~~r~~~g~-~~ 169 (400)
T cd06114 98 VHEQMKRFFNGFPRDAHPMAILSAMVNALSAFYPD------SLDV-NDPEQRELAAIRLIAKVPTIAAMAYRYSIGQ-PF 169 (400)
T ss_pred CCHHHHHHHHhcccCCCHHHHHHHHHHHHhhcCcc------cccc-CCHHHHHHHHHHHHHHHHHHHHHHHHHHcCC-CC
Confidence 99999999999999999999999999999975422 1111 3478888999999999999999999987653 47
Q ss_pred cCCCCCCCHHHHHHhhhcC-------CchHHHHHHHHHHHHhccCCCCCCchhHHHHhhccCCChHHHHHHHHhcccccc
Q 012107 234 IPKDDSLDYGGNFSHMLGF-------DDPKMLELMRLYVTIHSDHEGGNVSAHTGHLVASALSDPYLSFAAALNGLAGPL 306 (471)
Q Consensus 234 ~~p~~~l~~~~n~~~ml~~-------~~~~~~~~l~~~LvL~aDHeg~n~St~aarvvaSt~sd~y~avaAgl~aL~Gpl 306 (471)
++|++++||++||++|+++ +++...++||++|||||||| +|+||||+|+++||++|+|+|++|||++|+||+
T Consensus 170 ~~p~~~ls~a~nfl~ml~g~~~~~~~p~~~~~~~l~~~LvL~aDH~-~n~STfaaRv~aSt~adl~sav~agl~al~Gpl 248 (400)
T cd06114 170 IYPDNDLSYVENFLHMMFAVPYEPYEVDPVVVKALDTILILHADHE-QNASTSTVRMVGSSGANLFASISAGIAALWGPL 248 (400)
T ss_pred CCCCCCcCHHHHHHHHhcCCCCccCCCCHHHHHHHHHHHeeeccCC-CcchHHHHHHHhccCCcHHHHHHHHHHhccCCc
Confidence 8899999999999999974 46789999999999999998 999999999999999999999999999999999
Q ss_pred cccchHHHHHHHHHHHHhcCCCCChhhHHHHHHHHHhCC--CcccccCCCCCCCCCchHHHHHHHHHhh---C-CCChHH
Q 012107 307 HGLANQEVLLWIKSVVDECGENVTTEQLKDYVWKTLNSG--KVVPGFGHGVLRKTDPRYTCQREFALKH---L-PDDPLF 380 (471)
Q Consensus 307 HGgA~e~v~~~l~~i~~~ig~~~~~~~i~~~v~~~l~~g--~~IpGfGH~vyk~~DPRa~~l~~~a~~~---~-~~~~~~ 380 (471)
||||+++|++||.++ + +++++++||++.+++| ++||||||+|||..|||+++|+++++++ . .+++++
T Consensus 249 HGGA~~~v~~~l~~i----~---~~~~~~~~v~~~l~~~~~~~ipGfGH~vyk~~DPRa~~L~~~~~~l~~~~~~~~~~~ 321 (400)
T cd06114 249 HGGANEAVLEMLEEI----G---SVGNVDKYIAKAKDKNDPFRLMGFGHRVYKNYDPRAKILKKTCDEVLAELGKDDPLL 321 (400)
T ss_pred ccChHHHHHHHHHHh----c---CcccHHHHHHHHHhcCCCccccCCCCCCCCCCCccHHHHHHHHHHHHHHhCCCcHHH
Confidence 999999999999887 4 3578999999999987 5999999999999999999999999875 2 357899
Q ss_pred HHHHHHHHhhhhhHHhcCCCCCCCCchhhHHHHHHhccCCCccccchhhhhhhhhhhHHHHHHHHHHcC-CCccCCCccc
Q 012107 381 QLVSKLFEVVPPILTKLGKVKNPWPNVDAHSGVLLNHFGLAEARYYTVLFGVSRSLGICSQLIWDRALG-LPLERPKSVT 459 (471)
Q Consensus 381 ~la~~le~~~~~~l~~~~k~k~l~pNVD~~sg~l~~~lGlp~~~~~t~lF~vsR~~GwlAH~ieq~~~~-~pI~RP~s~~ 459 (471)
++++++|+++.+ .++++.|+++||||||+|+++++||||+ +++|++|++||++||+||++||+..+ .+|+||++.|
T Consensus 322 ~~~~~ie~~~~~--~~~~~~~~l~pNvD~~~a~l~~~lG~p~-~~~~~lFa~sR~~Gw~AH~~Eq~~~~~~~liRP~~~Y 398 (400)
T cd06114 322 EIAMELEEIALK--DDYFIERKLYPNVDFYSGIILRALGIPT-EMFTVLFALGRTPGWIAQWREMHEDPELKIGRPRQLY 398 (400)
T ss_pred HHHHHHHHHHHH--hhhhcccCCCCChHHHHHHHHHHcCCCh-HhhhhhHHHHhHHHHHHHHHHHHhCCCCceeCccccc
Confidence 999999998765 5567789999999999999999999996 99999999999999999999999974 5799999999
Q ss_pred hh
Q 012107 460 LD 461 (471)
Q Consensus 460 ~~ 461 (471)
+|
T Consensus 399 vG 400 (400)
T cd06114 399 TG 400 (400)
T ss_pred CC
Confidence 86
No 26
>cd06111 DsCS_like Cold-active citrate synthase (CS) from an Antarctic bacterial strain DS2-3R (Ds)-like. CS catalyzes the condensation of acetyl coenzyme A (AcCoA) and oxalacetate (OAA) to form citrate and coenzyme A (CoA), the first step in the citric acid cycle (TCA or Krebs cycle). 2-methylcitrate synthase (2MCS) catalyzes the condensation of propionyl-coenzyme A (PrCoA) and OAA to form 2-methylcitrate and coenzyme A (CoA) during propionate metabolism. The overall CS reaction is thought to proceed through three partial reactions: a) the carbanion or equivalent is generated from AcCoA by base abstraction of a proton, b) the nucleophilic attack of this carbanion on OAA to generate citryl-CoA, and c) the hydrolysis of citryl-CoA to produce citrate and CoA. DsCS, compared with CS from the hyperthermophile Pyrococcus furiosus (not included in this group), has an increase in the size of surface loops, a higher proline content in the loop regions, a more accessible active site, and a highe
Probab=100.00 E-value=3.1e-90 Score=711.54 Aligned_cols=352 Identities=24% Similarity=0.350 Sum_probs=325.6
Q ss_pred cccccccccccccceecCCCC-eeecCCCHHHHhhhCCCCCCCCCCCHHHHHHHHHhCCCCCHHHHHHHHHHHHhhCCCc
Q 012107 77 GGMRGMTGLLWETSLLDPDEG-IRFRGLSIPECQKLLPAAKPDGEPLPEGLLWLLLTGKVPSKEQVDGLSKELRDRATVP 155 (471)
Q Consensus 77 ~Glrgv~~~~t~iS~lD~~~G-i~yRGy~I~eL~~~~p~~~~~~~~~~Eev~~LLl~G~lPt~~ql~~f~~~l~~~~~lp 155 (471)
.||+||++.+|+||++|+++| ++||||+|+||+++. +||||+||||+|++|+++|++.|+.+|.+++.+|
T Consensus 1 ~Gl~gv~~~~s~Is~i~~~~g~L~yRG~di~dLa~~~---------~feeva~LL~~G~lP~~~e~~~f~~~l~~~~~lp 71 (362)
T cd06111 1 KGLAGVVADTTAISKVMPETNSLTYRGYPVQDLAENC---------SFEEVAYLLWNGELPNAAQLAEFSQRERSYRRLD 71 (362)
T ss_pred CCCCCceEecccceEEECCCCeEEECCccHHHHHccC---------CHHHHHHHHHCCCCCCHHHHHHHHHHHHHccCCC
Confidence 499999999999999999987 799999999999986 4999999999999999999999999999999999
Q ss_pred HHHHHHHHcCCCCCChHHHHHHHHHHhcccchhHHHhhhccCCCCCCcchHHHHHHHHhhhhHHHHHHHHHHhcCCcccC
Q 012107 156 DYVYKAIDALPVTAHPMTQFASGVMALQVQSEFQEAYEKGIHKSKYWEPTYEDSLNLIARVPVVAAYVYQRIYKDGKIIP 235 (471)
Q Consensus 156 ~~v~~~i~~lP~~~hPM~~l~~avsal~~~s~f~~~y~~~~~k~~~~e~~~e~al~LiA~~p~i~a~iyr~~~~~~~~~~ 235 (471)
+.+.++++.+|+++|||++|+++|++++.++++. .+..|+..++++++|+|++|+|+|++||+..+. .+++
T Consensus 72 ~~~~~~~~~~p~~~~pm~~l~~~vs~l~~~d~~~--------~~~~~~~~~~~a~~lia~~~~i~a~~~~~~~g~-~~~~ 142 (362)
T cd06111 72 RNLLSLIASLPKNCHPMDVLRTAVSVLGAEDSET--------DDSSPDANLAKAIRLLAQLPTVVAADIRRRKGL-DPIP 142 (362)
T ss_pred HHHHHHHHhCCCCCChHHHHHHHHHHhhccCccc--------ccCCHHHHHHHHHHHHHHHHHHHHHHHHHcCCC-CCcC
Confidence 9999999999999999999999999999876542 224578889999999999999999999987543 5788
Q ss_pred CCCCCCHHHHHHhhhcC--CchHHHHHHHHHHHHhccCCCCCCchhHHHHhhccCCChHHHHHHHHhcccccccccchHH
Q 012107 236 KDDSLDYGGNFSHMLGF--DDPKMLELMRLYVTIHSDHEGGNVSAHTGHLVASALSDPYLSFAAALNGLAGPLHGLANQE 313 (471)
Q Consensus 236 p~~~l~~~~n~~~ml~~--~~~~~~~~l~~~LvL~aDHeg~n~St~aarvvaSt~sd~y~avaAgl~aL~GplHGgA~e~ 313 (471)
|+++++|++||++|+++ |++...++||++|||||||| +|+||||+|+++||++|+|+|++|||++|+||+||||++.
T Consensus 143 p~~~ls~a~nfl~m~~g~~p~~~~~~~l~~~Lvl~ADHg-~n~St~aaR~~aSt~ad~~~av~agl~aL~GplHGGA~~~ 221 (362)
T cd06111 143 PDSDLGIAENFLHMCFGEVPSPEVVRAFDVSLILYAEHS-FNASTFTARVITSTLSDIYSAITGAIGALKGPLHGGANEA 221 (362)
T ss_pred CCCCcCHHHHHHHHhhCCCCCHHHHHHHHHHHHHHhccC-CchhHHHHHHHHccCCCHHHHHHHHHhhccCccccchHHH
Confidence 99999999999999965 68889999999999999998 9999999999999999999999999999999999999999
Q ss_pred HHHHHHHHHHhcCCCCChhhHHHHHHHHHhCCCcccccCCCCCCCCCchHHHHHHHHHhhC---CCChHHHHHHHHHHhh
Q 012107 314 VLLWIKSVVDECGENVTTEQLKDYVWKTLNSGKVVPGFGHGVLRKTDPRYTCQREFALKHL---PDDPLFQLVSKLFEVV 390 (471)
Q Consensus 314 v~~~l~~i~~~ig~~~~~~~i~~~v~~~l~~g~~IpGfGH~vyk~~DPRa~~l~~~a~~~~---~~~~~~~la~~le~~~ 390 (471)
|++||.++ + +++++++||++.+++|++||||||+|||..|||+++|++.++++. +.++++++++++++++
T Consensus 222 ~~~~l~ei----~---~~~~~~~~v~~~~~~~~~l~GFGH~vyk~~DPRa~~L~~~l~~l~~~~~~~~~~~~~~~i~~~~ 294 (362)
T cd06111 222 VMHMMLEI----D---DPEKAAQWMLDALARKEKVMGFGHRVYKSGDSRVPTMEKALRRVAAVHDGQKWLAMYDALEDAM 294 (362)
T ss_pred HHHHHHHh----C---ChhhHHHHHHHHHhcCCceecCCCCCCCCCCchHHHHHHHHHHHHhhcCccHHHHHHHHHHHHH
Confidence 99999886 5 468999999999999999999999999999999999999988763 3568999999999977
Q ss_pred hhhHHhcCCCCCCCCchhhHHHHHHhccCCCccccchhhhhhhhhhhHHHHHHHHHHcCCCccCCCccchhHH
Q 012107 391 PPILTKLGKVKNPWPNVDAHSGVLLNHFGLAEARYYTVLFGVSRSLGICSQLIWDRALGLPLERPKSVTLDWI 463 (471)
Q Consensus 391 ~~~l~~~~k~k~l~pNVD~~sg~l~~~lGlp~~~~~t~lF~vsR~~GwlAH~ieq~~~~~pI~RP~s~~~~~~ 463 (471)
.+ .||++||||||+|++++.||||+ +++|++|++||++||+||++||+.++ +|+||++.|+|.-
T Consensus 295 ~~-------~~~l~pNvD~~~a~l~~~lG~p~-~~~~~lf~~~R~~Gw~AH~~Eq~~~~-~l~Rp~~~Y~G~~ 358 (362)
T cd06111 295 VA-------AKGIKPNLDFPAGPAYYLMGFDI-DFFTPIFVMARITGWTAHIMEQRADN-ALIRPLSEYNGPE 358 (362)
T ss_pred HH-------hcCCCCChHHHHHHHHHHcCcCh-hhhhhHHHHHHHHHHHHHHHHHHHcC-CcccCCceeeCCC
Confidence 43 36899999999999999999996 99999999999999999999999987 6999999999864
No 27
>PF00285 Citrate_synt: Citrate synthase; InterPro: IPR002020 Citrate synthase 2.3.3.1 from EC is a member of a small family of enzymes that can directly form a carbon-carbon bond without the presence of metal ion cofactors. It catalyses the first reaction in the Krebs' cycle, namely the conversion of oxaloacetate and acetyl-coenzyme A into citrate and coenzyme A. This reaction is important for energy generation and for carbon assimilation. The reaction proceeds via a non-covalently bound citryl-coenzyme A intermediate in a 2-step process (aldol-Claisen condensation followed by the hydrolysis of citryl-CoA). Citrate synthase enzymes are found in two distinct structural types: type I enzymes (found in eukaryotes, Gram-positive bacteria and archaea) form homodimers and have shorter sequences than type II enzymes, which are found in Gram-negative bacteria and are hexameric in structure. In both types, the monomer is composed of two domains: a large alpha-helical domain consisting of two structural repeats, where the second repeat is interrupted by a small alpha-helical domain. The cleft between these domains forms the active site, where both citrate and acetyl-coenzyme A bind. The enzyme undergoes a conformational change upon binding of the oxaloacetate ligand, whereby the active site cleft closes over in order to form the acetyl-CoA binding site []. The energy required for domain closure comes from the interaction of the enzyme with the substrate. Type II enzymes possess an extra N-terminal beta-sheet domain, and some type II enzymes are allosterically inhibited by NADH []. This entry represents types I and II citrate synthase enzymes, as well as the related enzymes 2-methylcitrate synthase and ATP citrate synthase. 2-methylcitrate (2.3.3.5 from EC) synthase catalyses the conversion of oxaloacetate and propanoyl-CoA into (2R,3S)-2-hydroxybutane-1,2,3-tricarboxylate and coenzyme A. This enzyme is induced during bacterial growth on propionate, while type II hexameric citrate synthase is constitutive []. ATP citrate synthase (2.3.3.8 from EC) (also known as ATP citrate lyase) catalyses the MgATP-dependent, CoA-dependent cleavage of citrate into oxaloacetate and acetyl-CoA, a key step in the reductive tricarboxylic acid pathway of CO2 assimilation used by a variety of autotrophic bacteria and archaea to fix carbon dioxide []. ATP citrate synthase is composed of two distinct subunits. In eukaryotes, ATP citrate synthase is a homotetramer of a single large polypeptide, and is used to produce cytosolic acetyl-CoA from mitochondrial produced citrate [].; GO: 0046912 transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer, 0044262 cellular carbohydrate metabolic process; PDB: 2C6X_D 3L96_B 1OWB_B 1NXG_A 1K3P_A 1OWC_B 3L97_B 1NXE_A 3L98_A 3L99_A ....
Probab=100.00 E-value=6e-91 Score=717.15 Aligned_cols=348 Identities=33% Similarity=0.540 Sum_probs=300.8
Q ss_pred ccccccccccccceecCCCC-eeecCCCHHHHhhhCCCCCCCCCCCHHHHHHHHHhCCCCCHHHHHHHHHHHHhhCCCcH
Q 012107 78 GMRGMTGLLWETSLLDPDEG-IRFRGLSIPECQKLLPAAKPDGEPLPEGLLWLLLTGKVPSKEQVDGLSKELRDRATVPD 156 (471)
Q Consensus 78 Glrgv~~~~t~iS~lD~~~G-i~yRGy~I~eL~~~~p~~~~~~~~~~Eev~~LLl~G~lPt~~ql~~f~~~l~~~~~lp~ 156 (471)
||+|+++++|+||+||+++| ++||||+|.||+++. +||||+||||+|++||++|+++|+++|.+++.+|+
T Consensus 1 Gl~gv~v~~T~Is~id~~~G~L~YRGy~i~dL~~~~---------sfeeva~LL~~g~lP~~~el~~f~~~l~~~~~lpe 71 (356)
T PF00285_consen 1 GLRGVPVCETSISFIDGEKGILRYRGYDIEDLAENA---------SFEEVAYLLWYGELPTAEELEEFSAELKERRALPE 71 (356)
T ss_dssp GGTTEEEEEESSEEEETTTTEEEETTEEHHHHHHHS---------BHHHHHHHHHHSS--BHHHHHHHHHHHHCTTS--H
T ss_pred CCCCCeEeeeeCeEEeCCCCEEEEcCeEHHHHHhcC---------CHHHHHHHHHhccCCChhhhccchhHHHhhcchhH
Confidence 89999999999999999999 799999999999975 59999999999999999999999999999999999
Q ss_pred HHHHHHHcCCCCCChHHHHHHHHHHhcccchhHHHhhhccCCCCCCcchHHHHHHHHhhhhHHHHHHHHHHhcCCcccCC
Q 012107 157 YVYKAIDALPVTAHPMTQFASGVMALQVQSEFQEAYEKGIHKSKYWEPTYEDSLNLIARVPVVAAYVYQRIYKDGKIIPK 236 (471)
Q Consensus 157 ~v~~~i~~lP~~~hPM~~l~~avsal~~~s~f~~~y~~~~~k~~~~e~~~e~al~LiA~~p~i~a~iyr~~~~~~~~~~p 236 (471)
+|.+++.++|+++|||++|+++|++|+.++++ .....+|+..++++++++|++|+|+|++|++..+ .++++|
T Consensus 72 ~v~~~i~~lp~~~~pm~~L~~~vs~l~~~~~~-------~~~~~~~~~~~~~~~~liA~~p~i~a~~~~~~~g-~~~~~p 143 (356)
T PF00285_consen 72 EVIEVIEALPRDAHPMDVLRAAVSALSAFDPD-------PLYDNSPEDVLEDAIRLIAKIPTIVAAIYRHRRG-QPPIPP 143 (356)
T ss_dssp HHHHHHHCSTTTS-HHHHHHHHHHHHHHHSTT-------GTCTTSHHHHHHHHHHHHHHHHHHHHHHHHHHTT-S-----
T ss_pred HHHHHHhhcCCCCCchHHHHHHHhhhhhhhhc-------cccccchhHHHHHHHHHhhcchHHHHHHHHHhCC-CCcccc
Confidence 99999999999999999999999999986554 1244678999999999999999999999998744 357889
Q ss_pred CCCCCHHHHHHhhhc--C--CchHHHHHHHHHHHHhccCCCCCCchhHHHHhhccCCChHHHHHHHHhcccccccccchH
Q 012107 237 DDSLDYGGNFSHMLG--F--DDPKMLELMRLYVTIHSDHEGGNVSAHTGHLVASALSDPYLSFAAALNGLAGPLHGLANQ 312 (471)
Q Consensus 237 ~~~l~~~~n~~~ml~--~--~~~~~~~~l~~~LvL~aDHeg~n~St~aarvvaSt~sd~y~avaAgl~aL~GplHGgA~e 312 (471)
+++++|++||++|++ + +++...++||++|||||||| +|||||++|+++||++|+|+|++||+++++||+||||++
T Consensus 144 ~~~~~~~~n~l~~l~~~g~~p~~~~~~~l~~~lvl~aDH~-~~~St~aaR~~aSt~~~~~~av~agl~al~G~~hgga~~ 222 (356)
T PF00285_consen 144 DPDLSYAENFLYMLGVTGREPDPEEARALDAALVLHADHG-LNPSTFAARVAASTGADLYSAVAAGLAALSGPLHGGANE 222 (356)
T ss_dssp -TTSSHHHHHHHHHH-HSSB--HHHHHHHHHHHHHHS--S-SSHHHHHHHHHHTTT--HHHHHHHHHHHHCSTTTTTHHH
T ss_pred ccchHHHHHHHHHhhccccCCChHHHHHHHHHHHhhcCCC-CCccchhhhhhhccCcchhHHHHhhhhhccCcccccccH
Confidence 999999999999993 3 68999999999999999997 999999999999999999999999999999999999999
Q ss_pred HHHHHHHHHHHhcCCCCChhhHHHHHHHHHhCCCcccccCCCCCCCCCchHHHHHHHHHhhC---CCChHHHHHHHHHHh
Q 012107 313 EVLLWIKSVVDECGENVTTEQLKDYVWKTLNSGKVVPGFGHGVLRKTDPRYTCQREFALKHL---PDDPLFQLVSKLFEV 389 (471)
Q Consensus 313 ~v~~~l~~i~~~ig~~~~~~~i~~~v~~~l~~g~~IpGfGH~vyk~~DPRa~~l~~~a~~~~---~~~~~~~la~~le~~ 389 (471)
+|++||+++ + +++++++||++.+++|++||||||+|||..|||+++|+++++++. ..++++++++++|++
T Consensus 223 ~~~~~l~~i----~---~~~~~~~~v~~~l~~~~~i~GfGH~vy~~~DPRa~~l~~~~~~~~~~~~~~~~~~~~~~ie~~ 295 (356)
T PF00285_consen 223 AAMRMLQEI----G---SPENVEEYVEERLAKGERIPGFGHRVYKNGDPRAEALLALARELGEEFPDGPLVELAEAIEEA 295 (356)
T ss_dssp HHHHHHHHH----S---SGGGHHHHHHHHHHTTSTTTTBCESSSSS--HHHHHHHHHHHHHHHHHTTHHHHHHHHHHHHH
T ss_pred HHHHHHHHH----H---hhHHHHHHHHHHHhccccccccCCCcCCCCCCChHHHHHHHHHhhhccCCCHHHHHHHHHHHH
Confidence 999999987 5 578999999999999999999999999999999999999999987 789999999999999
Q ss_pred hhhhHHhcCCCCCCCCchhhHHHHHHhccCCCccccchhhhhhhhhhhHHHHHHHHHHcCCCccCC
Q 012107 390 VPPILTKLGKVKNPWPNVDAHSGVLLNHFGLAEARYYTVLFGVSRSLGICSQLIWDRALGLPLERP 455 (471)
Q Consensus 390 ~~~~l~~~~k~k~l~pNVD~~sg~l~~~lGlp~~~~~t~lF~vsR~~GwlAH~ieq~~~~~pI~RP 455 (471)
+.+.+. .|+++||||||+|++++.||||+ +++|++|++||++||+||++||+..+.+|+||
T Consensus 296 ~~~~~~----~~~l~pNvd~~~a~l~~~lG~p~-~~~~~if~~~R~~Gw~AH~~Eq~~~~~~i~RP 356 (356)
T PF00285_consen 296 APEDFK----ERKLYPNVDFYSAALLRALGFPP-ELFTAIFALSRTAGWIAHILEQRQLNNKIIRP 356 (356)
T ss_dssp HHHHHH----HHTESB-THHHHHHHHHHTT--G-GGHHHHHHHHHHHHHHHHHHHHHHCT------
T ss_pred HHHHHh----hccccCchhhHHHHHHHHHhcch-hhchHHHHHHHHHHHHHHHHHHHhcCCCCCCc
Confidence 988663 45799999999999999999996 99999999999999999999999955689999
No 28
>PRK12349 citrate synthase 3; Provisional
Probab=100.00 E-value=4.4e-90 Score=711.98 Aligned_cols=352 Identities=27% Similarity=0.395 Sum_probs=322.7
Q ss_pred cccccccccccccceecCCCC-eeecCCCHHHHhhhCCCCCCCCCCCHHHHHHHHHhCCCCCHHHHHHHHHHHHhhCCCc
Q 012107 77 GGMRGMTGLLWETSLLDPDEG-IRFRGLSIPECQKLLPAAKPDGEPLPEGLLWLLLTGKVPSKEQVDGLSKELRDRATVP 155 (471)
Q Consensus 77 ~Glrgv~~~~t~iS~lD~~~G-i~yRGy~I~eL~~~~p~~~~~~~~~~Eev~~LLl~G~lPt~~ql~~f~~~l~~~~~lp 155 (471)
.||+|+.+++|+||+||+++| ++||||+|+||+++. +||||+||||+|+|||++|++.|+++|.+++.+|
T Consensus 7 ~Gl~g~~~~~S~IS~id~~~g~L~YRGydi~dLa~~~---------sFeeva~LL~~G~LP~~~e~~~f~~~L~~~~~~p 77 (369)
T PRK12349 7 PGLDGVIAAETKISFLDTVKGEIVIQGYDLIELSKTK---------EYLDIVHLLLEEHLPNEDEKATLEKKLKEEYAVP 77 (369)
T ss_pred CccCCCeeeeeeceeEeCCCCEEEECCccHHHHHccC---------CHHHHHHHHHCCCCCCHHHHHHHHHHHHhccCCC
Confidence 599999999999999999888 699999999999985 4999999999999999999999999999999999
Q ss_pred HHHHHHHHcCCCCCChHHHHHHHHHHhcccchhHHHhhhccCCCCCCcchHHHHHHHHhhhhHHHHHHHHHHhcCCcccC
Q 012107 156 DYVYKAIDALPVTAHPMTQFASGVMALQVQSEFQEAYEKGIHKSKYWEPTYEDSLNLIARVPVVAAYVYQRIYKDGKIIP 235 (471)
Q Consensus 156 ~~v~~~i~~lP~~~hPM~~l~~avsal~~~s~f~~~y~~~~~k~~~~e~~~e~al~LiA~~p~i~a~iyr~~~~~~~~~~ 235 (471)
+.|.++++.+|++.|||++|+++|++++.++++. + +..++...+++++|||++|+|+|++||+..+ .+++.
T Consensus 78 ~~v~~~l~~~p~~~~pm~~l~~~vs~l~~~d~~~--~------~~~~~~~~~~a~~lia~~p~i~a~~~r~~~g-~~~~~ 148 (369)
T PRK12349 78 EGVFNILKALPKETHPMDGLRTGVSALAGYDNDI--E------DRSLEVNKSRAYKLLSKVPNIVANSYHILNN-EEPIE 148 (369)
T ss_pred HHHHHHHHhCCCCCCHHHHHHHHHHHhcccCccc--c------ccCcHHHHHHHHHHHHHHHHHHHHHHHHhcC-CCCCC
Confidence 9999999999999999999999999999876542 1 2235677889999999999999999998654 35789
Q ss_pred CCCCCCHHHHHHhhhcC--CchHHHHHHHHHHHHhccCCCCCCchhHHHHhhccCCChHHHHHHHHhcccccccccchHH
Q 012107 236 KDDSLDYGGNFSHMLGF--DDPKMLELMRLYVTIHSDHEGGNVSAHTGHLVASALSDPYLSFAAALNGLAGPLHGLANQE 313 (471)
Q Consensus 236 p~~~l~~~~n~~~ml~~--~~~~~~~~l~~~LvL~aDHeg~n~St~aarvvaSt~sd~y~avaAgl~aL~GplHGgA~e~ 313 (471)
|+++++|++||++|+++ |++...++||++|||||||| +|+||||+|+++||++|+|+|++|||++|+||+||||+++
T Consensus 149 p~~~l~~a~nfl~ml~g~~p~~~~~~~~~~~Lvl~ADH~-lnaStfa~Rv~aSt~ad~~~av~agl~al~GplHGGA~e~ 227 (369)
T PRK12349 149 PLKELSYSANFLYMLTGKKPTELEEKIFDRSLVLYSEHE-MPNSTFTARVIASTQSDLYGALTGAVASLKGSLHGGANEA 227 (369)
T ss_pred CCcCCCHHHHHHHHHhCCCCCHHHHHHHHHHHHHHhCcC-ccHHHHHHHHHHccCccHHHHHHHHHHhccCccccChHHH
Confidence 99999999999999976 68889999999999999998 8999999999999999999999999999999999999999
Q ss_pred HHHHHHHHHHhcCCCCChhhHHHHHHHHHhCCCcccccCCCCC-CCCCchHHHHHHHHHhhC---CCChHHHHHHHHHHh
Q 012107 314 VLLWIKSVVDECGENVTTEQLKDYVWKTLNSGKVVPGFGHGVL-RKTDPRYTCQREFALKHL---PDDPLFQLVSKLFEV 389 (471)
Q Consensus 314 v~~~l~~i~~~ig~~~~~~~i~~~v~~~l~~g~~IpGfGH~vy-k~~DPRa~~l~~~a~~~~---~~~~~~~la~~le~~ 389 (471)
|++||.++ + +++++++||++.+++|++||||||+|| +..|||+++|++.++++. +..++++++++++++
T Consensus 228 ~~~~l~~i----~---~~~~~~~~v~~~l~~~~~i~GFGH~vy~~~~DPRa~~l~~~~~~l~~~~~~~~~~~~~~~~e~~ 300 (369)
T PRK12349 228 VMYMLLEA----G---TVEKFEELLQKKLYNKEKIMGFGHRVYMKKMDPRALMMKEALKQLCDVKGDYTLYEMCEAGEKI 300 (369)
T ss_pred HHHHHHHc----C---CHHHHHHHHHHHHhcCCcccCCCCCCCCCCCCCcHHHHHHHHHHHHHHcCchHHHHHHHHHHHH
Confidence 99999886 4 568999999999999999999999999 667999999999998763 345788888888887
Q ss_pred hhhhHHhcCCCCCCCCchhhHHHHHHhccCCCccccchhhhhhhhhhhHHHHHHHHHHcCCCccCCCccchhHH
Q 012107 390 VPPILTKLGKVKNPWPNVDAHSGVLLNHFGLAEARYYTVLFGVSRSLGICSQLIWDRALGLPLERPKSVTLDWI 463 (471)
Q Consensus 390 ~~~~l~~~~k~k~l~pNVD~~sg~l~~~lGlp~~~~~t~lF~vsR~~GwlAH~ieq~~~~~pI~RP~s~~~~~~ 463 (471)
+.+ .|+++||||||+|++++.||||+ +++|++|++||++||+||++||+..+ +|+||++.|+|..
T Consensus 301 ~~~-------~~gl~pNvD~~~a~l~~~lG~p~-~~~~~lf~i~R~~Gw~AH~~Eq~~~~-~l~RP~~~Y~G~~ 365 (369)
T PRK12349 301 MEK-------EKGLYPNLDYYAAPVYWMLGIPI-QLYTPIFFSSRTVGLCAHVIEQHANN-RLFRPRVNYIGER 365 (369)
T ss_pred HHH-------hcCCCCCcHHHHHHHHHHcCCCh-hhhhHHHHHHHHHHHHHHHHHHHhcC-CCccccceeeCCC
Confidence 743 47899999999999999999996 99999999999999999999999987 6889999999864
No 29
>cd06118 citrate_synt_like_1 Citrate synthase (CS) catalyzes the condensation of acetyl coenzyme A (AcCoA) and oxalacetate (OAA) to form citrate and coenzyme A (CoA), the first step in the oxidative citric acid cycle (TCA or Krebs cycle). Peroxisomal CS is involved in the glyoxylate cycle. This group also includes CS proteins which functions as a 2-methylcitrate synthase (2MCS). 2MCS catalyzes the condensation of propionyl-CoA (PrCoA) and OAA to form 2-methylcitrate and CoA during propionate metabolism. This group contains proteins which functions exclusively as either a CS or a 2MCS, as well as those with relaxed specificity which have dual functions as both a CS and a 2MCS. The overall CS reaction is thought to proceed through three partial reactions and involves both closed and open conformational forms of the enzyme: a) the carbanion or equivalent is generated from AcCoA by base abstraction of a proton, b) the nucleophilic attack of this carbanion on OAA to generate citryl-CoA, and
Probab=100.00 E-value=8.9e-90 Score=708.61 Aligned_cols=352 Identities=38% Similarity=0.587 Sum_probs=327.5
Q ss_pred cccccccccccccceecCCCC-eeecCCCHHHHhhhCCCCCCCCCCCHHHHHHHHHhCCCCCHHHHHHHHHHHHhhCCCc
Q 012107 77 GGMRGMTGLLWETSLLDPDEG-IRFRGLSIPECQKLLPAAKPDGEPLPEGLLWLLLTGKVPSKEQVDGLSKELRDRATVP 155 (471)
Q Consensus 77 ~Glrgv~~~~t~iS~lD~~~G-i~yRGy~I~eL~~~~p~~~~~~~~~~Eev~~LLl~G~lPt~~ql~~f~~~l~~~~~lp 155 (471)
.||+|+++++|+||+||+++| ++||||+|+||+++. +||||+||||+|+|||++|+++|+.+|..++.+|
T Consensus 1 ~Gl~g~~v~~s~is~id~~~g~l~YRG~~i~dL~~~~---------~feeva~LL~~G~lP~~~el~~f~~~L~~~~~~p 71 (358)
T cd06118 1 PGLEGVKAKETSISYIDGDEGILRYRGYDIEELAEKS---------SFEEVAYLLLYGKLPTKEELAEFKKKLASHRALP 71 (358)
T ss_pred CCCCCceeeeeeeeEEeCCCCeEEECCccHHHHHhcC---------CHHHHHHHHHcCCCCCHHHHHHHHHHHHHccCCC
Confidence 499999999999999999987 799999999999985 5999999999999999999999999999999999
Q ss_pred HHHHHHHHcCCCCCChHHHHHHHHHHhcccchhHHHhhhccCCCCCCcchHHHHHHHHhhhhHHHHHHHHHHhcCCcccC
Q 012107 156 DYVYKAIDALPVTAHPMTQFASGVMALQVQSEFQEAYEKGIHKSKYWEPTYEDSLNLIARVPVVAAYVYQRIYKDGKIIP 235 (471)
Q Consensus 156 ~~v~~~i~~lP~~~hPM~~l~~avsal~~~s~f~~~y~~~~~k~~~~e~~~e~al~LiA~~p~i~a~iyr~~~~~~~~~~ 235 (471)
+.+.++++.+|++.|||++|+++|++++.++++. .+.+|+...+++++|||++|+|++++|++..+. .++.
T Consensus 72 ~~v~~~~~~~p~~~~pm~~l~~~~~~l~~~~~~~--------~~~~~~~~~~~a~~lia~~~~i~a~~~~~~~g~-~~~~ 142 (358)
T cd06118 72 EHVVEILDLLPKNAHPMDVLRTAVSALGSFDPFA--------RDKSPEARYEKAIRLIAKLPTIAANIYRNREGL-EIIA 142 (358)
T ss_pred HHHHHHHHhcCCCCChHHHHHHHHHhhhccCCcc--------ccCCHHHHHHHHHHHHHHHHHHHHHHHHHhCCC-CCCC
Confidence 9999999999999999999999999999876542 234578889999999999999999999986443 4778
Q ss_pred CCCCCCHHHHHHhhhcC--CchHHHHHHHHHHHHhccCCCCCCchhHHHHhhccCCChHHHHHHHHhcccccccccchHH
Q 012107 236 KDDSLDYGGNFSHMLGF--DDPKMLELMRLYVTIHSDHEGGNVSAHTGHLVASALSDPYLSFAAALNGLAGPLHGLANQE 313 (471)
Q Consensus 236 p~~~l~~~~n~~~ml~~--~~~~~~~~l~~~LvL~aDHeg~n~St~aarvvaSt~sd~y~avaAgl~aL~GplHGgA~e~ 313 (471)
|++++||++||++|+++ +++..+++||++|||||||| +|+||||+|+++||++|+|+|++||+++|+||+||||++.
T Consensus 143 p~~~~~~~~~~~~~~~g~~p~~~~~~~l~~~Lvl~aDH~-~n~Stfa~R~~aSt~ad~~~av~agl~al~GplHGGA~~~ 221 (358)
T cd06118 143 PDPDLSYAENFLYMLFGEEPDPEEAKAMDLALILHADHE-GNASTFTARVVASTLSDMYSAIAAAIAALKGPLHGGANEA 221 (358)
T ss_pred CCCcccHHHHHHHHhcCCCCCHHHHHHHHHHHhhhcCCC-CChHHHHHHHHHccCCCHHHHHHHHHHHccCccccChHHH
Confidence 99999999999999988 89999999999999999999 7999999999999999999999999999999999999999
Q ss_pred HHHHHHHHHHhcCCCCChhhHHHHHHHHHhCCCcccccCCCCCCCCCchHHHHHHHHHhhCC---CChHHHHHHHHHHhh
Q 012107 314 VLLWIKSVVDECGENVTTEQLKDYVWKTLNSGKVVPGFGHGVLRKTDPRYTCQREFALKHLP---DDPLFQLVSKLFEVV 390 (471)
Q Consensus 314 v~~~l~~i~~~ig~~~~~~~i~~~v~~~l~~g~~IpGfGH~vyk~~DPRa~~l~~~a~~~~~---~~~~~~la~~le~~~ 390 (471)
|++||+++ + +++++++||++.+++|++||||||+|||..|||+.+|+++++++.. +++++++++++++++
T Consensus 222 ~~~~l~~~----~---~~~~~~~~i~~~l~~~~~i~GfGH~vyk~~DPRa~~L~~~~~~~~~~~~~~~~~~~~~~~e~~~ 294 (358)
T cd06118 222 VLKMLLEI----G---TPENVEAYIWKKLANKRRIMGFGHRVYKTYDPRAKILKELAEELAEEKGDDKLFEIAEELEEIA 294 (358)
T ss_pred HHHHHHHh----C---CchHHHHHHHHHHhcCCeecCCCCCCCCCCCCchHHHHHHHHHHHHhcCCCHHHHHHHHHHHHH
Confidence 99999987 4 3578999999999999999999999999999999999999998854 589999999999998
Q ss_pred hhhHHhcCCCCCCCCchhhHHHHHHhccCCCccccchhhhhhhhhhhHHHHHHHHHHcCCCccCCCccc
Q 012107 391 PPILTKLGKVKNPWPNVDAHSGVLLNHFGLAEARYYTVLFGVSRSLGICSQLIWDRALGLPLERPKSVT 459 (471)
Q Consensus 391 ~~~l~~~~k~k~l~pNVD~~sg~l~~~lGlp~~~~~t~lF~vsR~~GwlAH~ieq~~~~~pI~RP~s~~ 459 (471)
.+.. ..|+++||||||+|+++++||||+ +++|++|++||++||+||++||+.++.+|+||+++|
T Consensus 295 ~~~~----~~r~l~pNvd~~~~~l~~~lg~p~-~~~~~lf~i~R~~Gw~AH~~Eq~~~~~~iiRP~~~Y 358 (358)
T cd06118 295 LEVL----GEKGIYPNVDFYSGVVYKALGFPT-ELFTPLFAVSRAVGWLAHIIEYRENNQRLIRPRAEY 358 (358)
T ss_pred HHhh----cCCCCCcChHHHHHHHHHHcCcCH-HHHhHHHHHHHHhHHHHHHHHHHhCCCCccCCcccC
Confidence 7632 227999999999999999999996 999999999999999999999999987799999987
No 30
>cd06110 BSuCS-II_like Bacillus subtilis (Bs) citrate synthase (CS)-II_like. CS catalyzes the condensation of acetyl coenzyme A (AcCoA) and oxalacetate (OAA) to form citrate and coenzyme A (CoA), the first step in the citric acid cycle (TCA or Krebs cycle). 2MCS catalyzes the condensation of propionyl-coenzyme A (PrCoA) and OAA to form 2-methylcitrate and CoA during propionate metabolism. The overall CS reaction is thought to proceed through three partial reactions: a) the carbanion or equivalent is generated from AcCoA by base abstraction of a proton, b) the nucleophilic attack of this carbanion on OAA to generate citryl-CoA, and c) the hydrolysis of citryl-CoA to produce citrate and CoA. This group contains proteins similar to BsCS-II, the major CS of the gram-positive bacterium Bacillus subtilis. A mutation in the gene which encodes BsCS-II (citZ gene) has been described which resulted in a significant loss of CS activity, partial glutamate auxotrophy, and a sporulation deficiency, a
Probab=100.00 E-value=5e-89 Score=702.32 Aligned_cols=350 Identities=27% Similarity=0.417 Sum_probs=324.7
Q ss_pred cccccccccccccceecCCCC-eeecCCCHHHHhhhCCCCCCCCCCCHHHHHHHHHhCCCCCHHHHHHHHHHHHhhCCCc
Q 012107 77 GGMRGMTGLLWETSLLDPDEG-IRFRGLSIPECQKLLPAAKPDGEPLPEGLLWLLLTGKVPSKEQVDGLSKELRDRATVP 155 (471)
Q Consensus 77 ~Glrgv~~~~t~iS~lD~~~G-i~yRGy~I~eL~~~~p~~~~~~~~~~Eev~~LLl~G~lPt~~ql~~f~~~l~~~~~lp 155 (471)
.||+|+++++|+||++|+++| ++||||+|+||+++. +||||+||||+|++|+++|++.|+.+|..++.+|
T Consensus 1 ~Gl~g~~~~~T~IS~id~~~g~L~yRG~di~dL~~~~---------~feeva~LL~~G~lP~~~e~~~f~~~l~~~~~~p 71 (356)
T cd06110 1 KGLEGVIAADSKISYIDGDAGILIYRGYDIHDLAENS---------TFEEVAYLLWNGELPTAEELDAFKAQLAAERELP 71 (356)
T ss_pred CCCCCCeeeeeeceEEECCCCeEEECCeeHHHHHhcC---------CHHHHHHHHHcCcCCCHHHHHHHHHhhhhccCCC
Confidence 499999999999999999999 599999999999875 5999999999999999999999999999999999
Q ss_pred HHHHHHHHcCCCCCChHHHHHHHHHHhcccchhHHHhhhccCCCCCCcchHHHHHHHHhhhhHHHHHHHHHHhcCCcccC
Q 012107 156 DYVYKAIDALPVTAHPMTQFASGVMALQVQSEFQEAYEKGIHKSKYWEPTYEDSLNLIARVPVVAAYVYQRIYKDGKIIP 235 (471)
Q Consensus 156 ~~v~~~i~~lP~~~hPM~~l~~avsal~~~s~f~~~y~~~~~k~~~~e~~~e~al~LiA~~p~i~a~iyr~~~~~~~~~~ 235 (471)
+.+.++++++|++.|||++|+++|++++.+++.. .+..|+..++++++|+|++|+|+|++|+...+ .+++.
T Consensus 72 ~~v~~~~~~~p~~~~pm~~l~~~v~~l~~~~~~~--------~~~~~~~~~~~a~~lla~~p~i~a~~~~~~~~-~~~~~ 142 (356)
T cd06110 72 AEIIDLLKLLPKDAHPMDVLRTAVSALALYDPEA--------DDMSREANLRKAIRLIAKMPTIVAAFHRIRNG-LEPVA 142 (356)
T ss_pred HHHHHHHHhCCCCCCchHHHHHHHHhhhhcCCCc--------ccCCHHHHHHHHHHHHHHHHHHHHHHHHHhCC-CCCCC
Confidence 9999999999999999999999999998754321 23458889999999999999999999987544 45789
Q ss_pred CCCCCCHHHHHHhhhcC--CchHHHHHHHHHHHHhccCCCCCCchhHHHHhhccCCChHHHHHHHHhcccccccccchHH
Q 012107 236 KDDSLDYGGNFSHMLGF--DDPKMLELMRLYVTIHSDHEGGNVSAHTGHLVASALSDPYLSFAAALNGLAGPLHGLANQE 313 (471)
Q Consensus 236 p~~~l~~~~n~~~ml~~--~~~~~~~~l~~~LvL~aDHeg~n~St~aarvvaSt~sd~y~avaAgl~aL~GplHGgA~e~ 313 (471)
|+++++|++||++|+++ +++...++||++|||||||| +|+||||+|+++||++|+|+|++|||++|+||+||||++.
T Consensus 143 p~~~~~~a~~~l~~l~g~~p~~~~~~~l~~~Lvl~aDHg-~n~Stfa~Rv~aSt~ad~~~av~agl~al~GplHGgA~~~ 221 (356)
T cd06110 143 PDPDLSHAANFLYMLTGEKPSEEAARAFDVALILHADHE-LNASTFAARVVASTLSDMYSAVTAAIGALKGPLHGGANER 221 (356)
T ss_pred CCCCCCHHHHHHHHhcCCCCCHHHHHHHHHHHHHhccCC-CchhHHHHHHHHhcCCCHHHHHHHHHhhcCCCcccCcHHH
Confidence 99999999999999976 78889999999999999998 9999999999999999999999999999999999999999
Q ss_pred HHHHHHHHHHhcCCCCChhhHHHHHHHHHhCCCcccccCCCCCCCCCchHHHHHHHHHhhC---CCChHHHHHHHHHHhh
Q 012107 314 VLLWIKSVVDECGENVTTEQLKDYVWKTLNSGKVVPGFGHGVLRKTDPRYTCQREFALKHL---PDDPLFQLVSKLFEVV 390 (471)
Q Consensus 314 v~~~l~~i~~~ig~~~~~~~i~~~v~~~l~~g~~IpGfGH~vyk~~DPRa~~l~~~a~~~~---~~~~~~~la~~le~~~ 390 (471)
|++||+++ + +.+++++||++.+++|++||||||+|||..|||+++|+++++++. ++++++++++++++++
T Consensus 222 ~~~~l~~~----~---~~~~~~~~v~~~~~~~~~i~GfGH~vy~~~DPRa~~L~~~~~~~~~~~~~~~~~~~~~~ie~~~ 294 (356)
T cd06110 222 VMKMLLEI----G---SVDNVAAYVKDKLANKEKIMGFGHRVYKTGDPRAKHLREMSRRLGKETGEPKWYEMSEAIEQAM 294 (356)
T ss_pred HHHHHHHh----C---CHHHHHHHHHHHHhcCCeecCCCCccCCCCCChHHHHHHHHHHHHHHcCCCHHHHHHHHHHHHH
Confidence 99999987 4 568899999999999999999999999999999999999999974 5679999999999988
Q ss_pred hhhHHhcCCCCCCCCchhhHHHHHHhccCCCccccchhhhhhhhhhhHHHHHHHHHHcCCCccCCCccchh
Q 012107 391 PPILTKLGKVKNPWPNVDAHSGVLLNHFGLAEARYYTVLFGVSRSLGICSQLIWDRALGLPLERPKSVTLD 461 (471)
Q Consensus 391 ~~~l~~~~k~k~l~pNVD~~sg~l~~~lGlp~~~~~t~lF~vsR~~GwlAH~ieq~~~~~pI~RP~s~~~~ 461 (471)
.+ .||++||||+|+|++++.||||+ +++|++|++||++||+||++||+.++ +|+||+++|+|
T Consensus 295 ~~-------~~~l~pNvd~~~a~l~~~lg~p~-~~~~~lf~i~R~~Gw~AH~~Eq~~~~-~iiRP~~~Y~G 356 (356)
T cd06110 295 RD-------EKGLNPNVDFYSASVYYMLGIPV-DLFTPIFAISRVSGWCAHILEQYFNN-RLIRPRAEYVG 356 (356)
T ss_pred HH-------ccCCCcChHHHHHHHHHHcCcCh-hhhhHHHHHHHHHHHHHHHHHHHHcC-CccCCccccCC
Confidence 55 37999999999999999999996 99999999999999999999999986 69999999986
No 31
>TIGR01800 cit_synth_II 2-methylcitrate synthase/citrate synthase II. Members of this family are dimeric enzymes with activity as 2-methylcitrate synthase, citrate synthase, or both. Many Gram-negative species have a hexameric citrate synthase, termed citrate synthase I (TIGR01798). Members of this family (TIGR01800) appear as a second citrate synthase isozyme but typically are associated with propionate metabolism and synthesize 2-methylcitrate from propionyl-CoA; citrate synthase activity may be incidental. A number of species, including Thermoplasma acidophilum, Pyrococcus furiosus, and the Antarctic bacterium DS2-3R have a bifunctional member of this family as the only citrate synthase isozyme.
Probab=100.00 E-value=8.9e-89 Score=702.70 Aligned_cols=355 Identities=28% Similarity=0.442 Sum_probs=327.3
Q ss_pred cccccccccccccceecCCCC-eeecCCCHHHHhhhCCCCCCCCCCCHHHHHHHHHhCCCCCHHHHHHHHHHHHhhCCCc
Q 012107 77 GGMRGMTGLLWETSLLDPDEG-IRFRGLSIPECQKLLPAAKPDGEPLPEGLLWLLLTGKVPSKEQVDGLSKELRDRATVP 155 (471)
Q Consensus 77 ~Glrgv~~~~t~iS~lD~~~G-i~yRGy~I~eL~~~~p~~~~~~~~~~Eev~~LLl~G~lPt~~ql~~f~~~l~~~~~lp 155 (471)
.||+|+++++|+||++|+++| |+||||+|.||+++. +||||+||||+|++|+++|++.|..+|..++.+|
T Consensus 1 ~Gl~g~~~~~t~Is~id~~~g~l~yRG~~i~dL~~~~---------~feeva~LL~~G~lP~~~e~~~f~~~l~~~~~~p 71 (368)
T TIGR01800 1 KGLEGVIADETALSTIDGSEGILTYRGYDIEDLAEHA---------SFEEVAYLLLHGKLPTRSELRKFKTELAKLRGLP 71 (368)
T ss_pred CCCCCCeeeeeeceEEECCcceEEECCeeHHHHHhcC---------CHHHHHHHHHcCCCCCHHHHHHHHHHHHhhcCCC
Confidence 499999999999999999999 699999999999985 5999999999999999999999999999999999
Q ss_pred HHHHHHHHcCCCCCChHHHHHHHHHHhcccchhHHHhhhccCCCCCCcchHHHHHHHHhhhhHHHHHHHHHHhcCCcccC
Q 012107 156 DYVYKAIDALPVTAHPMTQFASGVMALQVQSEFQEAYEKGIHKSKYWEPTYEDSLNLIARVPVVAAYVYQRIYKDGKIIP 235 (471)
Q Consensus 156 ~~v~~~i~~lP~~~hPM~~l~~avsal~~~s~f~~~y~~~~~k~~~~e~~~e~al~LiA~~p~i~a~iyr~~~~~~~~~~ 235 (471)
+.+.++++++|++.|||++|+++|++++.+++.. + +..++...+++++|||++|+|+|++||++.+ .+++.
T Consensus 72 ~~~~~~~~~~p~~~~pm~~l~~~ls~l~~~d~~~--~------~~~~~~~~~~a~~lia~~p~i~a~~~~~~~g-~~~~~ 142 (368)
T TIGR01800 72 DEVIELIEALPAESHPMDALRTAVSYLGALDPEA--F------GHTPEEARDIAIRLIAKLPTIVAYWYRIRNG-LEIVA 142 (368)
T ss_pred HHHHHHHHhCCCCCCcHHHHHHHHHHhhccCccc--c------cCCHHHHHHHHHHHHHHHHHHHHHHHHHhcC-CCCcC
Confidence 9999999999999999999999999999876542 1 1224677889999999999999999998754 45789
Q ss_pred CCCCCCHHHHHHhhhcC--CchHHHHHHHHHHHHhccCCCCCCchhHHHHhhccCCChHHHHHHHHhcccccccccchHH
Q 012107 236 KDDSLDYGGNFSHMLGF--DDPKMLELMRLYVTIHSDHEGGNVSAHTGHLVASALSDPYLSFAAALNGLAGPLHGLANQE 313 (471)
Q Consensus 236 p~~~l~~~~n~~~ml~~--~~~~~~~~l~~~LvL~aDHeg~n~St~aarvvaSt~sd~y~avaAgl~aL~GplHGgA~e~ 313 (471)
|+++++|++||++|+++ +++..+++||++|||||||| +|+||||+|+++||++|+|+|++|||++|+||+||||++.
T Consensus 143 p~~~~~~~~n~l~ml~g~~p~~~~~~~l~~~Lvl~ADHg-~n~St~aaRv~aSt~adl~~av~agl~al~Gp~HGGA~~~ 221 (368)
T TIGR01800 143 PKEDDSHAANFLYMLHGEEPSKEEEKAMDIALILYAEHE-FNASTFAARVAASTLSDMYSAITAAIGALKGPLHGGANEA 221 (368)
T ss_pred CCCCccHHHHHHHHhcCCCCCHHHHHHHHHHHhHhccCC-CchHHHHHHHHhccCCCHHHHHHHHHhhcCCccccCHHHH
Confidence 99999999999999986 68889999999999999998 9999999999999999999999999999999999999999
Q ss_pred HHHHHHHHHHhcCCCCChhhHHHHHHHHHhCCCcccccCCCCCCCCCchHHHHHHHHHhhC---CCChHHHHHHHHHHhh
Q 012107 314 VLLWIKSVVDECGENVTTEQLKDYVWKTLNSGKVVPGFGHGVLRKTDPRYTCQREFALKHL---PDDPLFQLVSKLFEVV 390 (471)
Q Consensus 314 v~~~l~~i~~~ig~~~~~~~i~~~v~~~l~~g~~IpGfGH~vyk~~DPRa~~l~~~a~~~~---~~~~~~~la~~le~~~ 390 (471)
|++||.++ + +.+++++||++.+++|++||||||+|||..|||+++|+++++++. +++++++++.++++++
T Consensus 222 ~~~~l~~i----~---~~~~~~~~v~~~l~~~~~i~GfGH~vy~~~DPRa~~L~~~~~~~~~~~~~~~~~~~~~~i~~~~ 294 (368)
T TIGR01800 222 VMAMLDEI----G---DPDKAEAWIRKALENKERIMGFGHRVYKTYDPRAKILKEYAKKLSAKEGDSKWYEIAERLEDVM 294 (368)
T ss_pred HHHHHHHh----c---ChHHHHHHHHHHHHCCCccCCCCCCCCCCCCchHHHHHHHHHHHHHhhCCCHHHHHHHHHHHHH
Confidence 99999886 4 467899999999999999999999999999999999999999874 5688999999999988
Q ss_pred hhhHHhcCCCCCCCCchhhHHHHHHhccCCCccccchhhhhhhhhhhHHHHHHHHHHcCCCccCCCccchhHHHHH
Q 012107 391 PPILTKLGKVKNPWPNVDAHSGVLLNHFGLAEARYYTVLFGVSRSLGICSQLIWDRALGLPLERPKSVTLDWIEKN 466 (471)
Q Consensus 391 ~~~l~~~~k~k~l~pNVD~~sg~l~~~lGlp~~~~~t~lF~vsR~~GwlAH~ieq~~~~~pI~RP~s~~~~~~~~~ 466 (471)
.+ .||++||||||+|++++.||||+ +++|++|++||++||+||++||+..+ +|+||++.|+|...+.
T Consensus 295 ~~-------~~~l~pNvD~~~a~l~~~lg~p~-~~~~~lf~~~R~~Gw~AH~~Eq~~~~-~l~Rp~~~Y~G~~~~~ 361 (368)
T TIGR01800 295 EK-------EKGIYPNVDFYSGSVYYSMGIPT-DLFTPIFAMSRVSGWTAHIIEQVENN-RLIRPRADYVGPEERK 361 (368)
T ss_pred HH-------hcCCCCChHHHHHHHHHHcCcCH-HHhhhHHHHHHHHHHHHHHHHHHhcC-CccCccccccCCCCCC
Confidence 54 37899999999999999999996 99999999999999999999999877 6999999999975443
No 32
>PRK14033 citrate synthase; Provisional
Probab=100.00 E-value=2.1e-88 Score=700.46 Aligned_cols=356 Identities=24% Similarity=0.343 Sum_probs=328.0
Q ss_pred cccccccccccccccceecCCCC-eeecCCCHHHHhhhCCCCCCCCCCCHHHHHHHHHhCCCCCHHHHHHHHHHHHhhCC
Q 012107 75 VIGGMRGMTGLLWETSLLDPDEG-IRFRGLSIPECQKLLPAAKPDGEPLPEGLLWLLLTGKVPSKEQVDGLSKELRDRAT 153 (471)
Q Consensus 75 ~~~Glrgv~~~~t~iS~lD~~~G-i~yRGy~I~eL~~~~p~~~~~~~~~~Eev~~LLl~G~lPt~~ql~~f~~~l~~~~~ 153 (471)
+..||+||.+++|+||++|+++| ++||||+|+||+++. +||||+||||+|++||++|++.|+.+|.+++.
T Consensus 9 ~~~GL~gv~v~~S~Is~id~~~g~L~yRG~di~dLa~~~---------sfeeva~LL~~G~lP~~~el~~f~~~l~~~~~ 79 (375)
T PRK14033 9 IKKGLAGVVVDTTAISKVVPETNSLTYRGYPVQDLAARC---------SFEEVAYLLWNGELPTDAELALFSQRERAYRR 79 (375)
T ss_pred CCCCCCCceEeeccCeEEECCCCeEEECCccHHHHHhcC---------CHHHHHHHHHcCCCCCHHHHHHHHHHHHHccC
Confidence 56899999999999999999987 699999999999986 59999999999999999999999999999999
Q ss_pred CcHHHHHHHHcCCCCCChHHHHHHHHHHhcccchhHHHhhhccCCCCCCcchHHHHHHHHhhhhHHHHHHHHHHhcCCcc
Q 012107 154 VPDYVYKAIDALPVTAHPMTQFASGVMALQVQSEFQEAYEKGIHKSKYWEPTYEDSLNLIARVPVVAAYVYQRIYKDGKI 233 (471)
Q Consensus 154 lp~~v~~~i~~lP~~~hPM~~l~~avsal~~~s~f~~~y~~~~~k~~~~e~~~e~al~LiA~~p~i~a~iyr~~~~~~~~ 233 (471)
+|+++.++++.+|++.|||++|+++|++++.++++. .+..|+...+++++|+|++|+|+|++|+++.+ .++
T Consensus 80 ~p~~v~~~~~~~p~~~~pm~~l~~~vs~l~~~d~~~--------~~~~~~~~~~~a~~lia~~~~i~a~~~~~~~g-~~~ 150 (375)
T PRK14033 80 LDRSVLSLIDKLPTTCHPMDVVRTAVSYLGAEDPEA--------DDSSPEANLAKALRLFAVLPTIVAADQRRRRG-LDP 150 (375)
T ss_pred CCHHHHHHHHhCCCCCCHHHHHHHHHHHhccCCccc--------ccCCHHHHHHHHHHHHHHHHHHHHHHHHhcCC-CCc
Confidence 999999999999999999999999999999876542 12346788899999999999999999998754 357
Q ss_pred cCCCCCCCHHHHHHhhhcC--CchHHHHHHHHHHHHhccCCCCCCchhHHHHhhccCCChHHHHHHHHhcccccccccch
Q 012107 234 IPKDDSLDYGGNFSHMLGF--DDPKMLELMRLYVTIHSDHEGGNVSAHTGHLVASALSDPYLSFAAALNGLAGPLHGLAN 311 (471)
Q Consensus 234 ~~p~~~l~~~~n~~~ml~~--~~~~~~~~l~~~LvL~aDHeg~n~St~aarvvaSt~sd~y~avaAgl~aL~GplHGgA~ 311 (471)
++|+++++|++||++|+++ |++...++||++|||||||| +|+||||+|+++||++|+|+|++|||++|+||+||||+
T Consensus 151 ~~p~~~~s~a~nfl~ml~g~~p~~~~~~~l~~~Lvl~ADHg-ln~StfaaRv~aSt~adl~~av~agl~al~GplHGGA~ 229 (375)
T PRK14033 151 IAPRSDLGYAENFLHMCFGEVPEPEVVRAFEVSLILYAEHS-FNASTFTARVITSTLSDIYSAVTGAIGALKGPLHGGAN 229 (375)
T ss_pred cCCCCCCCHHHHHHHHHhCCCCCHHHHHHHHHHHHHHhccC-CCcHHHHHHHHhccCCCHHHHHHHHHhhccCccccChH
Confidence 8999999999999999965 68889999999999999998 99999999999999999999999999999999999999
Q ss_pred HHHHHHHHHHHHhcCCCCChhhHHHHHHHHHhCCCcccccCCCCCCCCCchHHHHHHHHHhhC---CCChHHHHHHHHHH
Q 012107 312 QEVLLWIKSVVDECGENVTTEQLKDYVWKTLNSGKVVPGFGHGVLRKTDPRYTCQREFALKHL---PDDPLFQLVSKLFE 388 (471)
Q Consensus 312 e~v~~~l~~i~~~ig~~~~~~~i~~~v~~~l~~g~~IpGfGH~vyk~~DPRa~~l~~~a~~~~---~~~~~~~la~~le~ 388 (471)
+.|++||.++ + +++++++||++.+++|++||||||++||..|||+++|++.++++. +.++++++++++++
T Consensus 230 e~~~~~l~ei----~---~~~~~~~~v~~~~~~~~~l~GFGH~vyk~~DPRa~~L~~~l~~l~~~~~~~~~~~~~~~i~~ 302 (375)
T PRK14033 230 EAVMHTMLEI----G---DPARAAEWLRDALARKEKVMGFGHRVYKHGDSRVPTMKAALRRVAAVRDGQRWLDIYEALEK 302 (375)
T ss_pred HHHHHHHHHh----C---ChhHHHHHHHHHHhCCCceecCCCCCCCCCCchHHHHHHHHHHHHHhcCccHHHHHHHHHHH
Confidence 9999999886 5 578999999999999999999999999999999999999988763 45789999999999
Q ss_pred hhhhhHHhcCCCCCCCCchhhHHHHHHhccCCCccccchhhhhhhhhhhHHHHHHHHHHcCCCccCCCccchhHHHH
Q 012107 389 VVPPILTKLGKVKNPWPNVDAHSGVLLNHFGLAEARYYTVLFGVSRSLGICSQLIWDRALGLPLERPKSVTLDWIEK 465 (471)
Q Consensus 389 ~~~~~l~~~~k~k~l~pNVD~~sg~l~~~lGlp~~~~~t~lF~vsR~~GwlAH~ieq~~~~~pI~RP~s~~~~~~~~ 465 (471)
++.+ .+|++||||||+|++++.||||+ +++|++|++||++||+||++||+.++ +|+||++.|+|...+
T Consensus 303 ~~~~-------~~gl~pNvD~~~a~l~~~lGip~-~~~~~lf~~~R~~Gw~AH~~Eq~~~~-~l~RP~~~YvG~~~~ 370 (375)
T PRK14033 303 AMAE-------ATGIKPNLDFPAGPAYYLMGFDI-DFFTPIFVMSRITGWTAHIMEQRASN-ALIRPLSEYNGPEQR 370 (375)
T ss_pred HHHH-------HhCCCCCcHHHHHHHHHHcCcCc-hhhhHHHHHHHHHHHHHHHHHHHhcC-CccccCceecCCCCC
Confidence 8854 37899999999999999999996 99999999999999999999999987 699999999997543
No 33
>PRK12350 citrate synthase 2; Provisional
Probab=100.00 E-value=1.3e-88 Score=694.58 Aligned_cols=337 Identities=23% Similarity=0.297 Sum_probs=296.4
Q ss_pred cccccccccccccceecCCCCe-eecCCCHHHHhhhCCCCCCCCCCCHHHHHHHHHhCCCCCHHHHH---HHHHHHHhhC
Q 012107 77 GGMRGMTGLLWETSLLDPDEGI-RFRGLSIPECQKLLPAAKPDGEPLPEGLLWLLLTGKVPSKEQVD---GLSKELRDRA 152 (471)
Q Consensus 77 ~Glrgv~~~~t~iS~lD~~~Gi-~yRGy~I~eL~~~~p~~~~~~~~~~Eev~~LLl~G~lPt~~ql~---~f~~~l~~~~ 152 (471)
.||+||.+++|+||+||+++|+ +||||+|+||++++ +||||+||||+|+|||+.+.+ .++..+.
T Consensus 3 ~GL~~v~~~~s~Is~idg~~G~L~YRGy~i~dLa~~~---------sFeEva~LL~~G~LP~~~~~~~~~~~~~~~~--- 70 (353)
T PRK12350 3 PGLEGVVAFETEIAEPDGDGGALRYRGVDIEDLVGRV---------TFEDVWALLVDGRFGPGLPPAEPFPLPVHLG--- 70 (353)
T ss_pred CCCCCceeEeeeCcceeCCCCEEEECCccHHHHhccC---------CHHHHHHHHHCCCCCCcchhhhccchHHHhh---
Confidence 5999999999999999999995 99999999999986 599999999999999987544 3333322
Q ss_pred CCcHHHHHHHHcCCCCCChHHHHHHHHHHhcccchhHHHhhhccCCCCCCcchHHHHHHHHhhhhHHHHHHHHHHhcCCc
Q 012107 153 TVPDYVYKAIDALPVTAHPMTQFASGVMALQVQSEFQEAYEKGIHKSKYWEPTYEDSLNLIARVPVVAAYVYQRIYKDGK 232 (471)
Q Consensus 153 ~lp~~v~~~i~~lP~~~hPM~~l~~avsal~~~s~f~~~y~~~~~k~~~~e~~~e~al~LiA~~p~i~a~iyr~~~~~~~ 232 (471)
..+..+.+.+.. .|||+.|++++ + . ...+++++|+|++|+|+|++||++.++.+
T Consensus 71 ~~~~~~~~~~~~----~~~~~~l~~~~------~-----------~-----~~~~~~~rliA~~pti~a~~~r~~~g~~~ 124 (353)
T PRK12350 71 DARVDVQAALAM----LAPVWGFRPLL------D-----------I-----DDLTARLDLARASVMALSAVAQSARGIGQ 124 (353)
T ss_pred ccchhhhhhHHH----hhHHHHHHhhc------C-----------C-----CCHHHHHHHHHHHHHHHHHHHHHHcCCCC
Confidence 233334333333 45777776643 0 0 11357799999999999999998876346
Q ss_pred ccCCCCCCCHHHHHHhhhcC-----CchHHHHHHHHHHHHhccCCCCCCchhHHHHhhccCCChHHHHHHHHhccccccc
Q 012107 233 IIPKDDSLDYGGNFSHMLGF-----DDPKMLELMRLYVTIHSDHEGGNVSAHTGHLVASALSDPYLSFAAALNGLAGPLH 307 (471)
Q Consensus 233 ~~~p~~~l~~~~n~~~ml~~-----~~~~~~~~l~~~LvL~aDHeg~n~St~aarvvaSt~sd~y~avaAgl~aL~GplH 307 (471)
+++|++++||++||++||.+ |++..+++||++|||||||| +|+||||+|+++||++|+|+|++||+++|+||+|
T Consensus 125 ~i~p~~~ls~a~nfl~ml~g~~~~~p~~~~~~~ld~~LiL~ADHg-~naSTfaaRv~aSt~adlysav~agi~aL~GplH 203 (353)
T PRK12350 125 PAVPQREIDHAATILERFMGRWRGEPDPAHVAALDAYWVSAAEHG-MNASTFTARVIASTGADVAAALSGAIGALSGPLH 203 (353)
T ss_pred CcCCCCCCCHHHHHHHHhccCccCCCCHHHHHHHHHHHHHhccCC-CCcchHHHHHHhccCCcHHHHHHHHHhhcCCCcc
Confidence 88999999999999999965 47888999999999999998 9999999999999999999999999999999999
Q ss_pred ccchHHHHHHHHHHHHhcCCCCChhhHHHHHHHHHhCCCcccccCCCCCCCCCchHHHHHHHHHhhCCCChHHHHHHHHH
Q 012107 308 GLANQEVLLWIKSVVDECGENVTTEQLKDYVWKTLNSGKVVPGFGHGVLRKTDPRYTCQREFALKHLPDDPLFQLVSKLF 387 (471)
Q Consensus 308 GgA~e~v~~~l~~i~~~ig~~~~~~~i~~~v~~~l~~g~~IpGfGH~vyk~~DPRa~~l~~~a~~~~~~~~~~~la~~le 387 (471)
|||||.|++||.++ + +++++++||++.+++|++||||||||||..|||+++|+++++++. ++++++++++|
T Consensus 204 GGA~e~v~~ml~ei----~---~~~~~~~~v~~~l~~~~ri~GFGHrvYk~~DPRa~~L~~~~~~l~--~~~~~ia~~le 274 (353)
T PRK12350 204 GGAPARVLPMLDAV----E---RTGDARGWVKGALDRGERLMGFGHRVYRAEDPRARVLRATAKRLG--APRYEVAEAVE 274 (353)
T ss_pred cChHHHHHHHHHHh----C---ChhhHHHHHHHHHHCCCccccCCCCCCCCCCCCHHHHHHHHHHhC--ChHHHHHHHHH
Confidence 99999999999887 5 568999999999999999999999999999999999999999985 68999999999
Q ss_pred HhhhhhHHhcCCCCCCCCchhhHHHHHHhccCCCccccchhhhhhhhhhhHHHHHHHHHHcCCCccCCCccchhHH
Q 012107 388 EVVPPILTKLGKVKNPWPNVDAHSGVLLNHFGLAEARYYTVLFGVSRSLGICSQLIWDRALGLPLERPKSVTLDWI 463 (471)
Q Consensus 388 ~~~~~~l~~~~k~k~l~pNVD~~sg~l~~~lGlp~~~~~t~lF~vsR~~GwlAH~ieq~~~~~pI~RP~s~~~~~~ 463 (471)
+++.+.+++++..|+++||||||+|++++.||||. ++||++|++||++||+||++||+.+| +|+||++.|+|..
T Consensus 275 ~~~~~~~~~~~~~r~l~pNVDfysa~v~~~lGip~-~~ft~lFai~R~~Gw~AH~~Eq~~~~-~i~RP~~~Y~G~~ 348 (353)
T PRK12350 275 QAALAELRERRPDRPLETNVEFWAAVLLDFAGVPA-HMFTAMFTCGRTAGWSAHILEQKRTG-RLVRPSARYVGPA 348 (353)
T ss_pred HHHHHHHHHhcCCCCCCcChHHHHHHHHHHcCcCh-hhhcchHHhhhHHHHHHHHHHHHhcC-CCcCCCcceeCCC
Confidence 99988766777789999999999999999999996 99999999999999999999999987 6999999999864
No 34
>cd06101 citrate_synt Citrate synthase (CS) catalyzes the condensation of acetyl coenzyme A (AcCoA) and oxalacetate (OAA) to form citrate and coenzyme A (CoA), the first step in the oxidative citric acid cycle (TCA or Krebs cycle). Peroxisomal CS is involved in the glyoxylate cycle. This group also includes CS proteins which functions as a 2-methylcitrate synthase (2MCS). 2MCS catalyzes the condensation of propionyl-CoA (PrCoA) and OAA to form 2-methylcitrate and CoA during propionate metabolism. This group contains proteins which functions exclusively as either a CS or a 2MCS, as well as those with relaxed specificity which have dual functions as both a CS and a 2MCS. The overall CS reaction is thought to proceed through three partial reactions and involves both closed and open conformational forms of the enzyme: a) the carbanion or equivalent is generated from AcCoA by base abstraction of a proton, b) the nucleophilic attack of this carbanion on OAA to generate citryl-CoA, and c) the
Probab=100.00 E-value=7.3e-73 Score=560.87 Aligned_cols=259 Identities=43% Similarity=0.673 Sum_probs=241.0
Q ss_pred cccccccccccccceecCCCC-eeecCCCHHHHhhhCCCCCCCCCCCHHHHHHHHHhCCCCCHHHHHHHHHHHHhhCCCc
Q 012107 77 GGMRGMTGLLWETSLLDPDEG-IRFRGLSIPECQKLLPAAKPDGEPLPEGLLWLLLTGKVPSKEQVDGLSKELRDRATVP 155 (471)
Q Consensus 77 ~Glrgv~~~~t~iS~lD~~~G-i~yRGy~I~eL~~~~p~~~~~~~~~~Eev~~LLl~G~lPt~~ql~~f~~~l~~~~~lp 155 (471)
+||+|+++++|+||.+|+++| ++||||+|.||+++. +||||+||||+|+||
T Consensus 1 ~gl~~~~~~~t~is~id~~~g~l~yRGy~i~dL~~~~---------~f~ev~~LL~~G~lP------------------- 52 (265)
T cd06101 1 PGLRGVAALESEISVIDGDEGGLRYRGYPIEELAENS---------SFEEVAYLLLTGELP------------------- 52 (265)
T ss_pred CCCCCcceeeeEEEEEeCCCCEEEECCeeHHHHHhcC---------CHHHHHHHHHcCCCC-------------------
Confidence 499999999999999999998 699999999999986 599999999999999
Q ss_pred HHHHHHHHcCCCCCChHHHHHHHHHHhcccchhHHHhhhccCCCCCCcchHHHHHHHHhhhhHHHHHHHHHHhcCCcccC
Q 012107 156 DYVYKAIDALPVTAHPMTQFASGVMALQVQSEFQEAYEKGIHKSKYWEPTYEDSLNLIARVPVVAAYVYQRIYKDGKIIP 235 (471)
Q Consensus 156 ~~v~~~i~~lP~~~hPM~~l~~avsal~~~s~f~~~y~~~~~k~~~~e~~~e~al~LiA~~p~i~a~iyr~~~~~~~~~~ 235 (471)
T Consensus 53 -------------------------------------------------------------------------------- 52 (265)
T cd06101 53 -------------------------------------------------------------------------------- 52 (265)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCCCCCHHHHHHhhhcC--CchHHHHHHHHHHHHhccCCCCCCchhHHHHhhccCCChHHHHHHHHhcccccccccchHH
Q 012107 236 KDDSLDYGGNFSHMLGF--DDPKMLELMRLYVTIHSDHEGGNVSAHTGHLVASALSDPYLSFAAALNGLAGPLHGLANQE 313 (471)
Q Consensus 236 p~~~l~~~~n~~~ml~~--~~~~~~~~l~~~LvL~aDHeg~n~St~aarvvaSt~sd~y~avaAgl~aL~GplHGgA~e~ 313 (471)
+|++||++|+++ +++.++++||.+||+||||| +|+||||+|+++||++|+|+|++|||++|+||+||||++.
T Consensus 53 -----~~~~nfl~m~~g~~p~~~~~~~l~~~Lvl~aDHg-~naST~aaRv~aSt~ad~~~av~agl~al~Gp~HGGA~e~ 126 (265)
T cd06101 53 -----SYAENFLYMLGGEEPDPEFAKAMDLALILHADHE-GNASTFTARVVGSTLSDPYSAIAAAIAALKGPLHGGANEA 126 (265)
T ss_pred -----cHHHHHHHHhcCCCCCHHHHHHHHHHHhhhcCCC-CchHHHHHHHHHccCCcHHHHHHHHHHhCCCCCcCCHHHH
Confidence 799999999987 78999999999999999999 8999999999999999999999999999999999999999
Q ss_pred HHHHHHHHHHhcCCCCChhhHHHHHHHHHhCCCcccccCCCCCCCCCchHHHHHHHHHhhCC---CChHHHHHHHHHHhh
Q 012107 314 VLLWIKSVVDECGENVTTEQLKDYVWKTLNSGKVVPGFGHGVLRKTDPRYTCQREFALKHLP---DDPLFQLVSKLFEVV 390 (471)
Q Consensus 314 v~~~l~~i~~~ig~~~~~~~i~~~v~~~l~~g~~IpGfGH~vyk~~DPRa~~l~~~a~~~~~---~~~~~~la~~le~~~ 390 (471)
|++||.++.+ . ..++++++|++.+++|++||||||||||+.|||+++|+++++++.. +++++++++++++++
T Consensus 127 ~~~~l~~i~~----~-~~~~~~~~v~~~~~~~~~i~GFGH~vy~~~DPRa~~L~~~~~~l~~~~~~~~~~~~a~~~e~~~ 201 (265)
T cd06101 127 VLKMLEEIGT----P-KNEPAEAYIRKKLNSKRVLMGFGHRVYKKYDPRATVLKKFAEKLLKEKGLDPMFELAAELEKIA 201 (265)
T ss_pred HHHHHHHhCc----c-ccccHHHHHHHHHhcCCCccCCCCCCCCCCCCChHHHHHHHHHHHHhhCCCHHHHHHHHHHHHH
Confidence 9999998732 1 2368899999999999999999999999999999999999999754 589999999999988
Q ss_pred hhhHHhcCCCCCCCCchhhHHHHHHhccCCCccccchhhhhhhhhhhHHHHHHHHHHcCCCccCCCccc
Q 012107 391 PPILTKLGKVKNPWPNVDAHSGVLLNHFGLAEARYYTVLFGVSRSLGICSQLIWDRALGLPLERPKSVT 459 (471)
Q Consensus 391 ~~~l~~~~k~k~l~pNVD~~sg~l~~~lGlp~~~~~t~lF~vsR~~GwlAH~ieq~~~~~pI~RP~s~~ 459 (471)
.+.. ..|+++||||||+|+++++||||+ +++|++|++||++||+||++||+.++.+|+||+++|
T Consensus 202 ~~~~----~~k~l~pNvd~~~a~v~~~lG~p~-~~~~~lf~i~R~~Gw~AH~~Eq~~~~~~i~RP~~~Y 265 (265)
T cd06101 202 PEVL----YEKKLYPNVDFYSGVLYKAMGFPT-ELFTPLFAVSRAVGWLAHLIEQREDGQRIIRPRAEY 265 (265)
T ss_pred HHHh----hccCCCCChHHHHHHHHHHhCCCh-HhhhhHHHHHhHhHHHHHHHHHHhcCCCccCCCccC
Confidence 7632 237999999999999999999996 999999999999999999999999986799999987
No 35
>cd06102 citrate_synt_like_2 Citrate synthase (CS) catalyzes the condensation of acetyl coenzyme A (AcCoA) and oxalacetate (OAA) to form citrate and coenzyme A (CoA), the first step in the oxidative citric acid cycle (TCA or Krebs cycle). Peroxisomal CS is involved in the glyoxylate cycle. This group also includes CS proteins which functions as a 2-methylcitrate synthase (2MCS). 2MCS catalyzes the condensation of propionyl-CoA (PrCoA) and OAA to form 2-methylcitrate and CoA during propionate metabolism. This group contains proteins which functions exclusively as either a CS or a 2MCS, as well as those with relaxed specificity which have dual functions as both a CS and a 2MCS. The overall CS reaction is thought to proceed through three partial reactions and involves both closed and open conformational forms of the enzyme: a) the carbanion or equivalent is generated from AcCoA by base abstraction of a proton, b) the nucleophilic attack of this carbanion on OAA to generate citryl-CoA, and
Probab=100.00 E-value=6.2e-65 Score=506.53 Aligned_cols=266 Identities=26% Similarity=0.333 Sum_probs=234.4
Q ss_pred cccccccccceecCCCCeeecCCCHHHHhhhCCCCCCCCCCCHHHHHHHHHhCCCCCHHHHHHHHHHHHhhCCCcHHHHH
Q 012107 81 GMTGLLWETSLLDPDEGIRFRGLSIPECQKLLPAAKPDGEPLPEGLLWLLLTGKVPSKEQVDGLSKELRDRATVPDYVYK 160 (471)
Q Consensus 81 gv~~~~t~iS~lD~~~Gi~yRGy~I~eL~~~~p~~~~~~~~~~Eev~~LLl~G~lPt~~ql~~f~~~l~~~~~lp~~v~~ 160 (471)
|.++++|.||.++++ +++||||++.||+++. +||||+||||+|++|
T Consensus 17 g~~~~~t~It~i~~~-~~~yRG~da~~L~~~~---------~~e~va~LLw~g~~~------------------------ 62 (282)
T cd06102 17 GEPVLESAITLITEG-RLFYRGRDAVELAETA---------TLEEVAALLWDGDEA------------------------ 62 (282)
T ss_pred CCceEEeeeEEEeCC-eeEEcCccHHHHHhcC---------CHHHHHHHHHcCCch------------------------
Confidence 567899999999864 4999999999999986 599999999999999
Q ss_pred HHHcCCCCCChHHHHHHHHHHhcccchhHHHhhhccCCCCCCcchHHHHHHHHhhhhHHHHHHHHHHhcCCcccCCCCCC
Q 012107 161 AIDALPVTAHPMTQFASGVMALQVQSEFQEAYEKGIHKSKYWEPTYEDSLNLIARVPVVAAYVYQRIYKDGKIIPKDDSL 240 (471)
Q Consensus 161 ~i~~lP~~~hPM~~l~~avsal~~~s~f~~~y~~~~~k~~~~e~~~e~al~LiA~~p~i~a~iyr~~~~~~~~~~p~~~l 240 (471)
.. .++.++ +.. .+ .+.++.
T Consensus 63 ---------------~~-------------------------------~l~~~~------~~~------~~---~~~~~~ 81 (282)
T cd06102 63 ---------------AR-------------------------------LLRLLA------AAL------LG---AAPSDA 81 (282)
T ss_pred ---------------HH-------------------------------HHHHHH------HHh------cc---CCCCcc
Confidence 00 111111 110 00 223467
Q ss_pred CHHHHHHhhhcCCchHHHHHHHHHHHHhccCCCCCCchhHHHHhhccCCChHHHHHHHHhcccccccccchHHHHHHHHH
Q 012107 241 DYGGNFSHMLGFDDPKMLELMRLYVTIHSDHEGGNVSAHTGHLVASALSDPYLSFAAALNGLAGPLHGLANQEVLLWIKS 320 (471)
Q Consensus 241 ~~~~n~~~ml~~~~~~~~~~l~~~LvL~aDHeg~n~St~aarvvaSt~sd~y~avaAgl~aL~GplHGgA~e~v~~~l~~ 320 (471)
++++||++|++++ +...++||++|||+|||| +|||||++|+++||++|+|+|++|||++|+||+||||++.|++||++
T Consensus 82 ~~~~~~~~~~~~~-~~~~~~l~~~LVL~ADHg-ln~St~aaRv~AStgadl~~avaagl~al~Gp~HGGA~~~a~~~l~e 159 (282)
T cd06102 82 PVHRRLARAWGLD-PAAADLLRRALVLLADHE-LNASTFAARVAASTGASLYAAVLAGLAALSGPRHGGATARVEALLDE 159 (282)
T ss_pred cHHHHHHHHhcCC-HHHHHHHHHHHHHHhccC-CCcHHHHHHHHhccCCcHHHHHHHHHHhCCCCCccCHHHHHHHHHHH
Confidence 8999999999874 468899999999999998 99999999999999999999999999999999999999999999998
Q ss_pred HHHhcCCCCChhhHHHHHHHHHhCCCcccccCCCCCCCCCchHHHHHHHHHhhCCCChHHHHHHHHHHhhhhhHHhcCCC
Q 012107 321 VVDECGENVTTEQLKDYVWKTLNSGKVVPGFGHGVLRKTDPRYTCQREFALKHLPDDPLFQLVSKLFEVVPPILTKLGKV 400 (471)
Q Consensus 321 i~~~ig~~~~~~~i~~~v~~~l~~g~~IpGfGH~vyk~~DPRa~~l~~~a~~~~~~~~~~~la~~le~~~~~~l~~~~k~ 400 (471)
+ + +.+++++||++.+++|++||||||++||..|||+++|+++++++.. +++++++++++++.+ .
T Consensus 160 ~----~---~~~~~~~~v~~~l~~g~~ipGFGH~vy~~~DPRa~~L~~~~~~~~~--~~~~~a~~ve~~~~~-------~ 223 (282)
T cd06102 160 A----L---RAGDAEAAVRERLRRGEALPGFGHPLYPDGDPRAAALLAALRPLGP--AAPPAARALIEAARA-------L 223 (282)
T ss_pred h----c---CCccHHHHHHHHHHcCCcccCCCCCCCCCCCccHHHHHHHHHHHhh--HHHHHHHHHHHHHHH-------H
Confidence 7 3 3468899999999999999999999999999999999999999866 999999999999865 2
Q ss_pred CCCCCchhhHHHHHHhccCCCccccchhhhhhhhhhhHHHHHHHHHHcCCCccCCCccchh
Q 012107 401 KNPWPNVDAHSGVLLNHFGLAEARYYTVLFGVSRSLGICSQLIWDRALGLPLERPKSVTLD 461 (471)
Q Consensus 401 k~l~pNVD~~sg~l~~~lGlp~~~~~t~lF~vsR~~GwlAH~ieq~~~~~pI~RP~s~~~~ 461 (471)
++++||||||++++++.||||+ ++++++|++||++||+||++||+.++ +++||++.|+|
T Consensus 224 ~gl~pNvD~a~a~l~~~lG~p~-~~~~~lF~~~R~~GwiAH~~Eq~~~~-~liRP~~~Y~G 282 (282)
T cd06102 224 TGARPNIDFALAALTRALGLPA-GAAFALFALGRSAGWIAHALEQRAQG-KLIRPRARYVG 282 (282)
T ss_pred HCCCCChHHHHHHHHHHcCCCh-hhcchHHHHHHHHHHHHHHHHHHhcC-CCcCCCcccCC
Confidence 5799999999999999999996 89999999999999999999999997 69999999985
No 36
>cd06099 CS_ACL-C_CCL Citrate synthase (CS), citryl-CoA lyase (CCL), the C-terminal portion of the single-subunit type ATP-citrate lyase (ACL) and the C-terminal portion of the large subunit of the two-subunit type ACL. CS catalyzes the condensation of acetyl coenzyme A (AcCoA) and oxalacetate (OAA) from citrate and coenzyme A (CoA), the first step in the oxidative citric acid cycle (TCA or Krebs cycle). Peroxisomal CS is involved in the glyoxylate cycle. Some CS proteins function as a 2-methylcitrate synthase (2MCS). 2MCS catalyzes the condensation of propionyl-CoA (PrCoA) and OAA to form 2-methylcitrate and CoA during propionate metabolism. CCL cleaves citryl-CoA (CiCoA) to AcCoA and OAA. ACLs catalyze an ATP- and a CoA- dependant cleavage of citrate to form AcCoA and OAA; they do this in a multistep reaction, the final step of which is likely to involve the cleavage of CiCoA to generate AcCoA and OAA. The overall CS reaction is thought to proceed through three partial reactions and i
Probab=100.00 E-value=7e-59 Score=447.67 Aligned_cols=208 Identities=41% Similarity=0.650 Sum_probs=192.2
Q ss_pred CHHHHHHhhhcC--CchHHHHHHHHHHHHhccCCCCCCchhHHHHhhccCCChHHHHHHHHhcccccccccchHHHHHHH
Q 012107 241 DYGGNFSHMLGF--DDPKMLELMRLYVTIHSDHEGGNVSAHTGHLVASALSDPYLSFAAALNGLAGPLHGLANQEVLLWI 318 (471)
Q Consensus 241 ~~~~n~~~ml~~--~~~~~~~~l~~~LvL~aDHeg~n~St~aarvvaSt~sd~y~avaAgl~aL~GplHGgA~e~v~~~l 318 (471)
||++||++|+++ |+++++++||++||+|+||| +|+||||+|+++||++|+|+|++|||++++||+||||++.|++||
T Consensus 1 ~~~~~fl~ml~g~~p~~~~~~~l~~~lvl~aDHg-~~~St~aar~~aSt~ad~~~av~Agl~al~Gp~hGGa~~~a~~~l 79 (213)
T cd06099 1 SYAENFLYMLGGEEPDPEFARAMDLALILHADHE-GNASTFTARVVGSTGSDPYSAIAAAIGALKGPLHGGANEAVLKML 79 (213)
T ss_pred CHHHHHHHHhcCCCCCHHHHHHHHHHHHHhcCCC-CchhhHHHHHHhccCCCHHHHHHHHHHHcCCCCcCCHHHHHHHHH
Confidence 699999999987 89999999999999999999 799999999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCChhhHHHHHHHHHhCCCcccccCCCCCCCCCchHHHHHHHHHhhCC---CChHHHHHHHHHHhhhhhHH
Q 012107 319 KSVVDECGENVTTEQLKDYVWKTLNSGKVVPGFGHGVLRKTDPRYTCQREFALKHLP---DDPLFQLVSKLFEVVPPILT 395 (471)
Q Consensus 319 ~~i~~~ig~~~~~~~i~~~v~~~l~~g~~IpGfGH~vyk~~DPRa~~l~~~a~~~~~---~~~~~~la~~le~~~~~~l~ 395 (471)
+++ +.. ..++++++|++.+++|++|||||||+||..|||+++|+++++++.. .++++++++++|+++.+..
T Consensus 80 ~e~----~~~-~~~~~~~~v~~~~~~~~~ipGFGH~vy~~~DPRa~~L~~~~~~l~~~~~~~~~~~~a~~le~~~~~~~- 153 (213)
T cd06099 80 EEI----GTP-KNEPAEAYIRKKLESKRVIMGFGHRVYKKYDPRATVLKKFAEELLKEDGDDPMFELAAELEKIAEEVL- 153 (213)
T ss_pred HHh----CCc-ccccHHHHHHHHHhCCCcccCCCCCCCCCCCcchHHHHHHHHHHHHhcCCCHHHHHHHHHHHHHHHHh-
Confidence 987 321 2368899999999999999999999999999999999999998753 3599999999999987633
Q ss_pred hcCCCCCCCCchhhHHHHHHhccCCCccccchhhhhhhhhhhHHHHHHHHHHcCCCccCCCccc
Q 012107 396 KLGKVKNPWPNVDAHSGVLLNHFGLAEARYYTVLFGVSRSLGICSQLIWDRALGLPLERPKSVT 459 (471)
Q Consensus 396 ~~~k~k~l~pNVD~~sg~l~~~lGlp~~~~~t~lF~vsR~~GwlAH~ieq~~~~~pI~RP~s~~ 459 (471)
+.|+++||||||+|+++++||||+ +++|++|++||++||+||++||+.++.+|+||++.|
T Consensus 154 ---~~r~l~~Nvd~~~a~l~~~lG~p~-~~~~~lf~~~R~~Gw~AH~~Eq~~~~~~l~RP~~~Y 213 (213)
T cd06099 154 ---YEKKLYPNVDFYSGVLYKAMGFPT-ELFTPLFAVARAVGWLAHLIEQLEDNFKIIRPRSEY 213 (213)
T ss_pred ---hccCCCCChHHHHHHHHHHcCcCH-HhhhHHHHHHHHHHHHHHHHHHHhCCCCccCCcccC
Confidence 238999999999999999999996 999999999999999999999999987899999987
No 37
>PRK06224 citrate synthase; Provisional
Probab=100.00 E-value=1.4e-57 Score=451.66 Aligned_cols=243 Identities=23% Similarity=0.241 Sum_probs=216.6
Q ss_pred ccccccceecCCCCeeecCCCHHHHhhhCCCCCCCCCCCHHHHHHHHHhCCCCCHHHHHHHHHHHHhhCCCcHHHHHHHH
Q 012107 84 GLLWETSLLDPDEGIRFRGLSIPECQKLLPAAKPDGEPLPEGLLWLLLTGKVPSKEQVDGLSKELRDRATVPDYVYKAID 163 (471)
Q Consensus 84 ~~~t~iS~lD~~~Gi~yRGy~I~eL~~~~p~~~~~~~~~~Eev~~LLl~G~lPt~~ql~~f~~~l~~~~~lp~~v~~~i~ 163 (471)
-.+|.||++|+++ ++||||+|.||+++. +|+|++||||+|++|+++|+
T Consensus 8 ~~~T~i~~~~~~~-l~yrG~~~~dL~~~~---------sf~e~~~lll~G~lP~~~e~---------------------- 55 (263)
T PRK06224 8 WWRTSISDVTPEE-IYVRGYDLEDLIGKL---------SFTDMIFLLLRGRLPTPNEA---------------------- 55 (263)
T ss_pred CCceeeeeecCCe-eEECCccHHHHhhcC---------CHHHHHHHHHcCCCCCHHHH----------------------
Confidence 4568999999987 999999999999886 49999999999999987664
Q ss_pred cCCCCCChHHHHHHHHHHhcccchhHHHhhhccCCCCCCcchHHHHHHHHhhhhHHHHHHHHHHhcCCcccCCCCCCCHH
Q 012107 164 ALPVTAHPMTQFASGVMALQVQSEFQEAYEKGIHKSKYWEPTYEDSLNLIARVPVVAAYVYQRIYKDGKIIPKDDSLDYG 243 (471)
Q Consensus 164 ~lP~~~hPM~~l~~avsal~~~s~f~~~y~~~~~k~~~~e~~~e~al~LiA~~p~i~a~iyr~~~~~~~~~~p~~~l~~~ 243 (471)
T Consensus 56 -------------------------------------------------------------------------------- 55 (263)
T PRK06224 56 -------------------------------------------------------------------------------- 55 (263)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred HHHHhhhcCCchHHHHHHHHHHHHhccCCCCCCchhHHHHhhccCCChHHHHHHHHhcccccccccchHHHHHHHHHHHH
Q 012107 244 GNFSHMLGFDDPKMLELMRLYVTIHSDHEGGNVSAHTGHLVASALSDPYLSFAAALNGLAGPLHGLANQEVLLWIKSVVD 323 (471)
Q Consensus 244 ~n~~~ml~~~~~~~~~~l~~~LvL~aDHeg~n~St~aarvvaSt~sd~y~avaAgl~aL~GplHGgA~e~v~~~l~~i~~ 323 (471)
++|+.+||++|||| +|||||++|+++||++|+|+|++||++++ ||+||||++.|++||.++.+
T Consensus 56 ---------------r~f~a~Lv~~adHg-~~~St~aar~~ast~~~l~~av~agl~a~-G~~hgGa~~~a~~~l~e~~~ 118 (263)
T PRK06224 56 ---------------RLLDAVLVALVDHG-LTPSAAAARMTASGGESLQGAVAAGLLAL-GSVHGGAGEQAAELLQEIAA 118 (263)
T ss_pred ---------------HHHHHHHHHHhccC-CCcHHHHHHHHHhcCccHHHHHHHHHhhc-ccccCChhHHHHHHHHHHHh
Confidence 24666789999998 99999999999999999999999999999 99999999999999999976
Q ss_pred hcCCCCC-hhhHHHHHHHHHhCCCcccccCCCCCCCCCchHHHHHHHHHhhCCCChHHHHHHHHHHhhhhhHHhcCCCCC
Q 012107 324 ECGENVT-TEQLKDYVWKTLNSGKVVPGFGHGVLRKTDPRYTCQREFALKHLPDDPLFQLVSKLFEVVPPILTKLGKVKN 402 (471)
Q Consensus 324 ~ig~~~~-~~~i~~~v~~~l~~g~~IpGfGH~vyk~~DPRa~~l~~~a~~~~~~~~~~~la~~le~~~~~~l~~~~k~k~ 402 (471)
.++++.+ +++++++|++.+++|++||||||++||..|||+++|+++++++...++++++++++++++.+. ++|+
T Consensus 119 ~~~~~~~~~~~~~~~v~~~~~~~~~ipGFGH~~y~~~DPRa~~L~~~~~~~~~~~~~~~~a~~~~~~~~~~-----~~~~ 193 (263)
T PRK06224 119 AADAGADLDAAARAIVAEYRAAGKRVPGFGHPLHKPVDPRAPRLLALAREAGVAGRHCRLAEALEAALAAA-----KGKP 193 (263)
T ss_pred hccccccHHHHHHHHHHHHHHcCCCcCCCCCCCCCCCCchHHHHHHHHHHhccCCHHHHHHHHHHHHHHHh-----cCCC
Confidence 5543223 357899999999999999999999999999999999999999887789999999999988652 3478
Q ss_pred CCCchhhHHHHHHhccCCCccccchhhhhhhhhhhHHHHHHHHHHcCCCccCCC------ccchhH
Q 012107 403 PWPNVDAHSGVLLNHFGLAEARYYTVLFGVSRSLGICSQLIWDRALGLPLERPK------SVTLDW 462 (471)
Q Consensus 403 l~pNVD~~sg~l~~~lGlp~~~~~t~lF~vsR~~GwlAH~ieq~~~~~pI~RP~------s~~~~~ 462 (471)
++||||+|+|+++++||||+ ++++++|++||++||+||++||+.++. .+||. ..|+|.
T Consensus 194 l~~Nvd~~~a~l~~~lG~p~-~~~~~lf~~~R~~G~~AH~~Eq~~~~~-~~r~~~~~~~~~~Y~G~ 257 (263)
T PRK06224 194 LPLNVDGAIAAILADLGFPP-ALARGLFVISRAAGLVAHVWEELQQPI-GFRIWDPAEEAVEYTGP 257 (263)
T ss_pred CCccHHHHHHHHHHHcCCCh-HHHhHHHHHHHHHHHHHHHHHHHhCCC-CcCCCCChhhcceecCC
Confidence 99999999999999999996 899999999999999999999999873 45555 677774
No 38
>PLN02522 ATP citrate (pro-S)-lyase
Probab=100.00 E-value=2.3e-50 Score=435.14 Aligned_cols=182 Identities=25% Similarity=0.332 Sum_probs=167.3
Q ss_pred HHHHHHHHHhccCCCCCCch-hHHHHhhccCCChHHHHHHHHhcccccccccchHHHHHHHHHHHHhcCCCCChhhHHHH
Q 012107 259 ELMRLYVTIHSDHEGGNVSA-HTGHLVASALSDPYLSFAAALNGLAGPLHGLANQEVLLWIKSVVDECGENVTTEQLKDY 337 (471)
Q Consensus 259 ~~l~~~LvL~aDHeg~n~St-~aarvvaSt~sd~y~avaAgl~aL~GplHGgA~e~v~~~l~~i~~~ig~~~~~~~i~~~ 337 (471)
++||++|||+|||| +|+|| |++|+++||++|+|+|++|||+++ ||+||||++.|++||+++.+ +.+++++|
T Consensus 401 ~~ld~~Lvl~ADHG-~~aSt~~aarv~AStg~dl~savaaGl~al-Gp~hGGA~e~a~~~l~ei~~------~~~~~~~~ 472 (608)
T PLN02522 401 KFIEMCIMLCADHG-PCVSGAHNTIVTARAGKDLVSSLVSGLLTI-GPRFGGAIDDAARYFKDAYD------RGLTPYEF 472 (608)
T ss_pred HHHHHHHHHhccCC-CCccHHHHHHHhhccCCcHHHHHHHHHHhc-CCcccchHHHHHHHHHHHhc------cccCHHHH
Confidence 57899999999998 99998 699999999999999999999998 99999999999999998742 23478999
Q ss_pred HHHHHhCCCcccccCCCCC--CCCCchHHHHHHHHHhhCCCChHHHHHHHHHHhhhhhHHhcCCCCCCCCchhhHHHHHH
Q 012107 338 VWKTLNSGKVVPGFGHGVL--RKTDPRYTCQREFALKHLPDDPLFQLVSKLFEVVPPILTKLGKVKNPWPNVDAHSGVLL 415 (471)
Q Consensus 338 v~~~l~~g~~IpGfGH~vy--k~~DPRa~~l~~~a~~~~~~~~~~~la~~le~~~~~~l~~~~k~k~l~pNVD~~sg~l~ 415 (471)
|++.+++|++|||||||+| ++.|||+++|+++++++++..+++++++++|+++.+ +.|+++||||||+|+++
T Consensus 473 V~~~~~~~~~IpGFGHrvy~~~~~DpRa~~L~~~~~~~~~~~~~~~~a~~vE~~~~~------~~k~L~~NVDga~a~i~ 546 (608)
T PLN02522 473 VEGMKKKGIRVPGIGHRIKSRDNRDKRVELLQKYARTHFPSVKYMEYAVQVETYTLS------KANNLVLNVDGAIGSLF 546 (608)
T ss_pred HHHHHhCCCccccCCCCCCCCCCCChhHHHHHHHHHHhccccHHHHHHHHHHHHHhh------ccCCCCcCcHhHHHHHH
Confidence 9999999999999999999 577999999999999998889999999999998643 34899999999999999
Q ss_pred hccCCCccccch--------------hhhhhhhhhhHHHHHHHHHHcCCCccCC
Q 012107 416 NHFGLAEARYYT--------------VLFGVSRSLGICSQLIWDRALGLPLERP 455 (471)
Q Consensus 416 ~~lGlp~~~~~t--------------~lF~vsR~~GwlAH~ieq~~~~~pI~RP 455 (471)
.+||+|. ++|| ++|++||++||+||++||+...+|++|-
T Consensus 547 ~~lg~p~-~~ft~~e~~~~~~~~~~~~lF~l~R~~GwiAH~~Eq~~~~~~~~r~ 599 (608)
T PLN02522 547 LDLLAGS-GMFTKQEIDEIVEIGYLNGLFVLARSIGLIGHTFDQKRLKQPLYRH 599 (608)
T ss_pred HHcCCCc-ccCccccccccccccccceEEEeehHHHHHHHHHHHHHhhCCcccC
Confidence 9999995 8888 8999999999999999999999888884
No 39
>cd06100 CCL_ACL-C Citryl-CoA lyase (CCL), the C-terminal portion of the single-subunit type ATP-citrate lyase (ACL) and the C-terminal portion of the large subunit of the two-subunit type ACL. CCL cleaves citryl-CoA (CiCoA) to acetyl-CoA (AcCoA) and oxaloacetate (OAA). ACL catalyzes an ATP- and a CoA- dependant cleavage of citrate to form AcCoA and OAA in a multistep reaction, the final step of which is likely to involve the cleavage of CiCoA to generate AcCoA and OAA. In fungi, yeast, plants, and animals ACL is cytosolic and generates AcCoA for lipogenesis. ACL may be required for fruiting body maturation in the filamentous fungus Sordaria macrospore. In several groups of autotrophic prokaryotes and archaea, ACL carries out the citrate-cleavage reaction of the reductive tricarboxylic acid (rTCA) cycle. In the family Aquificaceae this latter reaction in the rTCA cycle is carried out via a two enzyme system the second enzyme of which is CCL; the first enzyme is citryl-CoA synthetase (CC
Probab=100.00 E-value=3.3e-50 Score=391.05 Aligned_cols=207 Identities=26% Similarity=0.303 Sum_probs=189.6
Q ss_pred CCCHHHHHHhhhcC--CchHHHHHHHHHHHHhccCCCC-CCchhHHHHhhccC-CChHHHHHHHHhcccccccccchHHH
Q 012107 239 SLDYGGNFSHMLGF--DDPKMLELMRLYVTIHSDHEGG-NVSAHTGHLVASAL-SDPYLSFAAALNGLAGPLHGLANQEV 314 (471)
Q Consensus 239 ~l~~~~n~~~ml~~--~~~~~~~~l~~~LvL~aDHeg~-n~St~aarvvaSt~-sd~y~avaAgl~aL~GplHGgA~e~v 314 (471)
+.+|.+||++|+.+ |++.+.++|+.+|++++||| + |||||++|+++||+ +|+|+|++||++++ ||+||||++.+
T Consensus 10 ~~sf~e~~~lml~G~~P~~~e~~~f~~~Lvl~adhg-~~~~St~aar~~astg~~~~~~~vaag~~a~-G~~hgga~e~~ 87 (227)
T cd06100 10 KISFGDVLYLLLKGRLPTPYEARLLEALLVALADHG-PATPSAHAARLTASAGPEDLQSAVAAGLLGI-GDRFGGAGEGA 87 (227)
T ss_pred CCCHHHHHHHHhCCCCCCHHHHHHHHHHHHHhccCC-CCCchHHHHHHHHHcCCccHHHHHHHHHhcc-CCcccChHHHH
Confidence 56899999999976 88889999999999999999 6 99999999999999 99999999999999 99999999999
Q ss_pred HHHHHHHHHhcCCCCChhhHHHHHHHHHhCCCcccccCCCCCCCCCchHHHHHHHHHhhCCCChHHHHHHHHHHhhhhhH
Q 012107 315 LLWIKSVVDECGENVTTEQLKDYVWKTLNSGKVVPGFGHGVLRKTDPRYTCQREFALKHLPDDPLFQLVSKLFEVVPPIL 394 (471)
Q Consensus 315 ~~~l~~i~~~ig~~~~~~~i~~~v~~~l~~g~~IpGfGH~vyk~~DPRa~~l~~~a~~~~~~~~~~~la~~le~~~~~~l 394 (471)
++|++++.+..++ ..+++++||++.+++|++||||||++||..|||+++|+++++++...+|+++++.++++++.+.
T Consensus 88 ~~~l~~~~~~~~~--~~~~~~~~v~~~~~~~~~ipGfGH~v~~~~DPRa~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~- 164 (227)
T cd06100 88 ARLFKEAVDSGDA--LDAAAAEFVAEYRAAKKRIPGFGHPVHKNPDPRVPRLLELARELGPAGPHLDYALAVEKALTAA- 164 (227)
T ss_pred HHHHHHHHhcccc--hHHHHHHHHHHHHHcCCCCCCCCCCCCCCCCchHHHHHHHHHHhccCCHHHHHHHHHHHHHHhc-
Confidence 9999998653222 4579999999999999999999999999999999999999999988889999999999987541
Q ss_pred HhcCCCCCCCCchhhHHHHHHhccCCCccccchhhhhhhhhhhHHHHHHHHHHcCCCccCCC
Q 012107 395 TKLGKVKNPWPNVDAHSGVLLNHFGLAEARYYTVLFGVSRSLGICSQLIWDRALGLPLERPK 456 (471)
Q Consensus 395 ~~~~k~k~l~pNVD~~sg~l~~~lGlp~~~~~t~lF~vsR~~GwlAH~ieq~~~~~pI~RP~ 456 (471)
+.|+++||||+|+|+++++||||+ ++++++|++||++||+||++||+.+| ...||.
T Consensus 165 ----~~~~l~~Nvd~~~a~~~~~lG~p~-~~~~~lf~~~R~~G~~AH~~Eq~~~~-~~~~~~ 220 (227)
T cd06100 165 ----KGKPLPLNVDGAIAAILLDLGFPP-GALRGLFVLGRSPGLIAHALEEKRLG-QPLYRH 220 (227)
T ss_pred ----cCCCCcccHHHHHHHHHHHhCCCH-HHHHHHHHHHHHHHHHHHHHHHHhcc-CCCCCC
Confidence 346899999999999999999996 89999999999999999999999998 455664
No 40
>KOG1254 consensus ATP-citrate lyase [Energy production and conversion]
Probab=99.69 E-value=1.4e-17 Score=172.74 Aligned_cols=186 Identities=23% Similarity=0.217 Sum_probs=159.7
Q ss_pred hHHHHHHHHHHHHhccCCCCCCc-hhHHHHhhccCCChHHHHHHHHhcccccccccchHHHHHHHHHHHHhcCCCCChhh
Q 012107 255 PKMLELMRLYVTIHSDHEGGNVS-AHTGHLVASALSDPYLSFAAALNGLAGPLHGLANQEVLLWIKSVVDECGENVTTEQ 333 (471)
Q Consensus 255 ~~~~~~l~~~LvL~aDHeg~n~S-t~aarvvaSt~sd~y~avaAgl~aL~GplHGgA~e~v~~~l~~i~~~ig~~~~~~~ 333 (471)
+....+++.++.+.+||+ ..+| ++-+-+.+.++.|+++++++||.. .|++.|||-..+.|.+.+.-++ .-.
T Consensus 389 ~Ya~kfie~~~m~~aDhg-p~Vsga~ntI~~~ra~kdl~sslv~gLlt-igdRfggald~aaR~f~~ayd~------GL~ 460 (600)
T KOG1254|consen 389 QYARKFIEICTMLTADHG-PAVSGAGNTIANFRAGKDLFSSLVRGLLT-IGDRFGGALDIAARRFGPAYDK------GLA 460 (600)
T ss_pred HHHHHHHHHHhhccCCCC-ceeEeccCceEEeccHHHHHHHHHHHHhh-hhhhhcchhhHHHHhcChhhhc------cCc
Confidence 345689999999999998 7887 888889999999999999999999 6999999988888887544322 235
Q ss_pred HHHHHHHHHhCCCcccccCCCCCC--CCCchHHHHHHHHHhhCCCChHHHHHHHHHHhhhhhHHhcCCCCCCCCchhhHH
Q 012107 334 LKDYVWKTLNSGKVVPGFGHGVLR--KTDPRYTCQREFALKHLPDDPLFQLVSKLFEVVPPILTKLGKVKNPWPNVDAHS 411 (471)
Q Consensus 334 i~~~v~~~l~~g~~IpGfGH~vyk--~~DPRa~~l~~~a~~~~~~~~~~~la~~le~~~~~~l~~~~k~k~l~pNVD~~s 411 (471)
..++|.+.+..+..|||.||++-. +.|-|..+++++++++++..|+++.|.++|++... |..|+-.|||+..
T Consensus 461 ~m~fv~~~~k~~~~V~Gighriksi~n~d~rv~~lk~~~~~~fp~~~~~~yal~ve~~t~~------k~~nlilnvdg~i 534 (600)
T KOG1254|consen 461 PMRFVGKMRKVPIEVYGIGHRIKSINNPDKRVEILKAFARKNFPATPLLDYALEVEKITTS------KKPNLILNVDGAI 534 (600)
T ss_pred hHHHhhhhhCCCceecCCcceeeccCCcccchhhHHHHHHhhCCCchHHHhhhhheeeecc------CCCCEEEeccchh
Confidence 789999999999999999999974 56889999999999999999999999999998754 6679999999999
Q ss_pred HHHHhccCCCcccc--------------chhhhhhhhhhhHHHHHHHHHHcCCCccCC
Q 012107 412 GVLLNHFGLAEARY--------------YTVLFGVSRSLGICSQLIWDRALGLPLERP 455 (471)
Q Consensus 412 g~l~~~lGlp~~~~--------------~t~lF~vsR~~GwlAH~ieq~~~~~pI~RP 455 (471)
|++|.+|=-.. .+ ...+|+++|.+|++.|.+.|++...+++|-
T Consensus 535 ~~~fvd~l~~~-g~ft~~e~~e~i~ig~lng~fvl~rsig~igh~~dqkrlkq~lyrh 591 (600)
T KOG1254|consen 535 AVLFVDLLRNS-GMFTKEEADEYINIGALNGLFVLGRSIGFIGHYLDQKRLKQGLYRH 591 (600)
T ss_pred HHHHHHHHhcc-CCccHHHhhhheecccccceEEeeeecchhhhhccHhhhhCccccC
Confidence 99998753221 23 358999999999999999999998888874
No 41
>cd06100 CCL_ACL-C Citryl-CoA lyase (CCL), the C-terminal portion of the single-subunit type ATP-citrate lyase (ACL) and the C-terminal portion of the large subunit of the two-subunit type ACL. CCL cleaves citryl-CoA (CiCoA) to acetyl-CoA (AcCoA) and oxaloacetate (OAA). ACL catalyzes an ATP- and a CoA- dependant cleavage of citrate to form AcCoA and OAA in a multistep reaction, the final step of which is likely to involve the cleavage of CiCoA to generate AcCoA and OAA. In fungi, yeast, plants, and animals ACL is cytosolic and generates AcCoA for lipogenesis. ACL may be required for fruiting body maturation in the filamentous fungus Sordaria macrospore. In several groups of autotrophic prokaryotes and archaea, ACL carries out the citrate-cleavage reaction of the reductive tricarboxylic acid (rTCA) cycle. In the family Aquificaceae this latter reaction in the rTCA cycle is carried out via a two enzyme system the second enzyme of which is CCL; the first enzyme is citryl-CoA synthetase (CC
Probab=97.76 E-value=0.0014 Score=64.16 Aligned_cols=72 Identities=19% Similarity=0.251 Sum_probs=54.6
Q ss_pred CCCHHHHhhhCCCCCCCCCCCHHHHHHHHHhCCCCCHHHHHHHHHHHHhhCC--C-cHHHH--HHHH-cCCCCCChHHHH
Q 012107 102 GLSIPECQKLLPAAKPDGEPLPEGLLWLLLTGKVPSKEQVDGLSKELRDRAT--V-PDYVY--KAID-ALPVTAHPMTQF 175 (471)
Q Consensus 102 Gy~I~eL~~~~p~~~~~~~~~~Eev~~LLl~G~lPt~~ql~~f~~~l~~~~~--l-p~~v~--~~i~-~lP~~~hPM~~l 175 (471)
||+|.||+++. +|+|++|||++|++|+++|++.|...|..... + ...+. .+.. +.| .+|-..+
T Consensus 1 G~~~~dL~~~~---------sf~e~~~lml~G~~P~~~e~~~f~~~Lvl~adhg~~~~St~aar~~astg~--~~~~~~v 69 (227)
T cd06100 1 GYDLSDLIGKI---------SFGDVLYLLLKGRLPTPYEARLLEALLVALADHGPATPSAHAARLTASAGP--EDLQSAV 69 (227)
T ss_pred CCCHHHHHhCC---------CHHHHHHHHhCCCCCCHHHHHHHHHHHHHhccCCCCCchHHHHHHHHHcCC--ccHHHHH
Confidence 89999999876 49999999999999999999999998865542 3 33322 2222 233 6788888
Q ss_pred HHHHHHhcc
Q 012107 176 ASGVMALQV 184 (471)
Q Consensus 176 ~~avsal~~ 184 (471)
.+++++++.
T Consensus 70 aag~~a~G~ 78 (227)
T cd06100 70 AAGLLGIGD 78 (227)
T ss_pred HHHHhccCC
Confidence 888888843
No 42
>KOG2617 consensus Citrate synthase [Energy production and conversion]
Probab=95.15 E-value=0.01 Score=62.09 Aligned_cols=173 Identities=20% Similarity=0.142 Sum_probs=114.6
Q ss_pred ceeeccccccccc------------ccccccccceecCCCCeeecCCCHHHHhhhCCCCCCCCCCCHHHHHH-HHHhCCC
Q 012107 69 NITVDMVIGGMRG------------MTGLLWETSLLDPDEGIRFRGLSIPECQKLLPAAKPDGEPLPEGLLW-LLLTGKV 135 (471)
Q Consensus 69 ~~t~~~~~~Glrg------------v~~~~t~iS~lD~~~Gi~yRGy~I~eL~~~~p~~~~~~~~~~Eev~~-LLl~G~l 135 (471)
-.+|+.-.++|+| +.++.-.++-++.++.|+|++.-++|+-+..++++- .|.+| .|..|++
T Consensus 257 ~gnVsAh~~HLvGSaldpyls~aa~~~GLaGPLHGlAnqEvl~~L~~~~~Eig~~~s~e~i------keyiw~~ln~~rv 330 (458)
T KOG2617|consen 257 GGNVSAHTGHLVGSALDPYLSFAAGMNGLAGPLHGLANQEVLRFLGKLIEEIGKDLSKENI------KEYIWKTLNSGRV 330 (458)
T ss_pred cCcHHHHhccccccccchhHHHHHhhcccccccccCchHHHHHHHHHhHHHhccccchhhh------hHhhHHhhccccc
Confidence 5577788899999 888888999999999999999999999987765422 23344 3333332
Q ss_pred ----------CCHHHHHHHHHHHHhhCCCcHH-HHHHHHcCCCCCChHHHHHHHHHHhcccchhHHHhhhccCCCCCCcc
Q 012107 136 ----------PSKEQVDGLSKELRDRATVPDY-VYKAIDALPVTAHPMTQFASGVMALQVQSEFQEAYEKGIHKSKYWEP 204 (471)
Q Consensus 136 ----------Pt~~ql~~f~~~l~~~~~lp~~-v~~~i~~lP~~~hPM~~l~~avsal~~~s~f~~~y~~~~~k~~~~e~ 204 (471)
+|..+....++.+.++ +|++ .+++...+ .-++|.++....-+.+.+..+...+.-...-.-+||.
T Consensus 331 vpGyGHavlr~tDPR~~~~~efA~k~--~~~d~l~~l~~~l--~~~~p~vl~e~gk~knp~PNVD~~SGvll~~yGl~e~ 406 (458)
T KOG2617|consen 331 VPGYGHAVLRKTDPRYKVQREFALKH--LPDDPLFLLVSAL--YKIAPGVLTEHGKVKNPYPNVDAHSGVLLQYYGLPEL 406 (458)
T ss_pred ccccccccccCCCchhhHHHHHHHhc--CCCCcchhhhHHH--HHhChHHHHHhcccCCCCCcHHHHHHHHHHhcCCcHH
Confidence 5666666655555555 4432 33333332 3466777777666666655554322222344567999
Q ss_pred hHHHHHHHHhhhhHHHHHHHHHHhcCCccc-CCCCCCCHHHHHHhhhc
Q 012107 205 TYEDSLNLIARVPVVAAYVYQRIYKDGKII-PKDDSLDYGGNFSHMLG 251 (471)
Q Consensus 205 ~~e~al~LiA~~p~i~a~iyr~~~~~~~~~-~p~~~l~~~~n~~~ml~ 251 (471)
.|.+.+-.+++++-+++-+++.+.-+..+. |-+-..+|..+|..+.+
T Consensus 407 ~fyTVLFgVsRa~Gvlsqliw~ralg~pieRPks~~t~~~~~~~~~~~ 454 (458)
T KOG2617|consen 407 FFYTVLFGVSRALGVLSQLIWDRALGLPIERPKSVSTDWLHRFTNMVR 454 (458)
T ss_pred HHHHHHHHHhhhHHHHHHHHHHHHhCCcccCccccchHHHHHHHHHhh
Confidence 999999999999999988666554443333 34567788888877653
No 43
>cd06099 CS_ACL-C_CCL Citrate synthase (CS), citryl-CoA lyase (CCL), the C-terminal portion of the single-subunit type ATP-citrate lyase (ACL) and the C-terminal portion of the large subunit of the two-subunit type ACL. CS catalyzes the condensation of acetyl coenzyme A (AcCoA) and oxalacetate (OAA) from citrate and coenzyme A (CoA), the first step in the oxidative citric acid cycle (TCA or Krebs cycle). Peroxisomal CS is involved in the glyoxylate cycle. Some CS proteins function as a 2-methylcitrate synthase (2MCS). 2MCS catalyzes the condensation of propionyl-CoA (PrCoA) and OAA to form 2-methylcitrate and CoA during propionate metabolism. CCL cleaves citryl-CoA (CiCoA) to AcCoA and OAA. ACLs catalyze an ATP- and a CoA- dependant cleavage of citrate to form AcCoA and OAA; they do this in a multistep reaction, the final step of which is likely to involve the cleavage of CiCoA to generate AcCoA and OAA. The overall CS reaction is thought to proceed through three partial reactions and i
Probab=79.48 E-value=7.3 Score=37.86 Aligned_cols=61 Identities=18% Similarity=0.166 Sum_probs=44.5
Q ss_pred HHHHHHHHHhCCCCCHHHHHHHHHHHHhhC--CCcHHHHHHHHcCCCCCChHHHHHHHHHHhc
Q 012107 123 PEGLLWLLLTGKVPSKEQVDGLSKELRDRA--TVPDYVYKAIDALPVTAHPMTQFASGVMALQ 183 (471)
Q Consensus 123 ~Eev~~LLl~G~lPt~~ql~~f~~~l~~~~--~lp~~v~~~i~~lP~~~hPM~~l~~avsal~ 183 (471)
|-+.+|++++|+.|+++|.+.|..-|.-.. .++..+....-.--..++|-.-+.++++++.
T Consensus 2 ~~~~fl~ml~g~~p~~~~~~~l~~~lvl~aDHg~~~St~aar~~aSt~ad~~~av~Agl~al~ 64 (213)
T cd06099 2 YAENFLYMLGGEEPDPEFARAMDLALILHADHEGNASTFTARVVGSTGSDPYSAIAAAIGALK 64 (213)
T ss_pred HHHHHHHHhcCCCCCHHHHHHHHHHHHHhcCCCCchhhHHHHHHhccCCCHHHHHHHHHHHcC
Confidence 558899999999999999999999876554 2455433333233344688888889999884
No 44
>PRK14037 citrate synthase; Provisional
Probab=69.52 E-value=16 Score=38.82 Aligned_cols=62 Identities=16% Similarity=0.157 Sum_probs=47.6
Q ss_pred CHHHHHHHHHhCCCCCHHHHHHHHHHHHhhC--CCcHHHHHHHHcCCCCCChHHHHHHHHHHhc
Q 012107 122 LPEGLLWLLLTGKVPSKEQVDGLSKELRDRA--TVPDYVYKAIDALPVTAHPMTQFASGVMALQ 183 (471)
Q Consensus 122 ~~Eev~~LLl~G~lPt~~ql~~f~~~l~~~~--~lp~~v~~~i~~lP~~~hPM~~l~~avsal~ 183 (471)
+|-+.+|++++|+.|++++.+.|..-|--+. .++..+....-.--..++|-..+++|+.+|.
T Consensus 151 s~a~nfl~ml~G~~p~~~~~~~l~~~Lil~ADHg~naST~aarv~aSt~ad~ysav~agi~al~ 214 (377)
T PRK14037 151 SFAESFLLASFAREPTAEEIKAMDAALILYTDHEVPASTTAALVAASTLSDMYSCITAALAALK 214 (377)
T ss_pred CHHHHHHHHHhccCCcHHHHHHHHHHHhHhcccCCchHhHHHHHhhccCCCHHHHHHHHHHhcc
Confidence 5779999999999999999999998875554 3676665543333345688899999999984
No 45
>PRK14035 citrate synthase; Provisional
Probab=61.42 E-value=22 Score=37.69 Aligned_cols=61 Identities=15% Similarity=0.218 Sum_probs=45.1
Q ss_pred CCHHHHHHHHHhCCCCCHHHHHHHHHHHHhhC--CCc--HHHHHHHHcCCCCCChHHHHHHHHHHhc
Q 012107 121 PLPEGLLWLLLTGKVPSKEQVDGLSKELRDRA--TVP--DYVYKAIDALPVTAHPMTQFASGVMALQ 183 (471)
Q Consensus 121 ~~~Eev~~LLl~G~lPt~~ql~~f~~~l~~~~--~lp--~~v~~~i~~lP~~~hPM~~l~~avsal~ 183 (471)
-+|-+.+|++++|+.|++.|.+.|..-|--+. .+. .....++.+ ..++|...+.+|+.+|.
T Consensus 150 ls~~~nfl~ml~g~~p~~~~~~~l~~~LvL~ADHg~naST~aaRv~aS--t~ad~~sav~Agi~al~ 214 (371)
T PRK14035 150 LSYAANFLYMLRGELPTDIEVEAFNKALVLHADHELNASTFTARCAVS--SLSDMYSGVVAAVGSLK 214 (371)
T ss_pred CCHHHHHHHHhccCCCCHHHHHHHHHHHHHhccCCCCchHHHHHHHHh--cCCcHHHHHHHHHHhcc
Confidence 35789999999999999999999998875553 233 333344443 34578899999998874
No 46
>PRK12349 citrate synthase 3; Provisional
Probab=60.15 E-value=30 Score=36.57 Aligned_cols=60 Identities=17% Similarity=0.264 Sum_probs=45.7
Q ss_pred CHHHHHHHHHhCCCCCHHHHHHHHHHHHhhC--CCcHHHHH--HHHcCCCCCChHHHHHHHHHHhc
Q 012107 122 LPEGLLWLLLTGKVPSKEQVDGLSKELRDRA--TVPDYVYK--AIDALPVTAHPMTQFASGVMALQ 183 (471)
Q Consensus 122 ~~Eev~~LLl~G~lPt~~ql~~f~~~l~~~~--~lp~~v~~--~i~~lP~~~hPM~~l~~avsal~ 183 (471)
+|-+.+|++++|+.|++++.+.|..-|.-.. .++..++. ++.+ .-++|-..+.+|+.+|.
T Consensus 154 ~~a~nfl~ml~g~~p~~~~~~~~~~~Lvl~ADH~lnaStfa~Rv~aS--t~ad~~~av~agl~al~ 217 (369)
T PRK12349 154 SYSANFLYMLTGKKPTELEEKIFDRSLVLYSEHEMPNSTFTARVIAS--TQSDLYGALTGAVASLK 217 (369)
T ss_pred CHHHHHHHHHhCCCCCHHHHHHHHHHHHHHhCcCccHHHHHHHHHHc--cCccHHHHHHHHHHhcc
Confidence 4779999999999999999999999875554 35555443 4444 34678888889999884
No 47
>PRK14034 citrate synthase; Provisional
Probab=59.31 E-value=24 Score=37.29 Aligned_cols=61 Identities=16% Similarity=0.228 Sum_probs=45.1
Q ss_pred CHHHHHHHHHhCCCCCHHHHHHHHHHHHhhC--CCc--HHHHHHHHcCCCCCChHHHHHHHHHHhcc
Q 012107 122 LPEGLLWLLLTGKVPSKEQVDGLSKELRDRA--TVP--DYVYKAIDALPVTAHPMTQFASGVMALQV 184 (471)
Q Consensus 122 ~~Eev~~LLl~G~lPt~~ql~~f~~~l~~~~--~lp--~~v~~~i~~lP~~~hPM~~l~~avsal~~ 184 (471)
+|-+.+|++++|+.|++.|.+.|..-|.-+. .+. ..+..++.+ ..++|-..+++|+.+|..
T Consensus 151 s~a~nfl~ml~g~~p~~~~~~~l~~~Lvl~aDHg~n~ST~aaRv~aS--t~~d~ysav~agi~al~G 215 (372)
T PRK14034 151 SLAANFLYMLNGEEPDEVEVEAFNKALVLHADHELNASTFTARVCVA--TLSDVYSGITAAIGALKG 215 (372)
T ss_pred CHHHHHHHHhcCCCCCHHHHHHHHHHHhHhccCCCCccHHHHHHHhc--cCCcHHHHHHHHhcccCC
Confidence 5789999999999999999999998875554 233 334444444 446788888888888754
No 48
>cd06112 citrate_synt_like_1_1 Citrate synthase (CS) catalyzes the condensation of acetyl coenzyme A (AcCoA) and oxalacetate (OAA) to form citrate and coenzyme A (CoA), the first step in the oxidative citric acid cycle (TCA or Krebs cycle). Peroxisomal CS is involved in the glyoxylate cycle. This group also includes CS proteins which functions as a 2-methylcitrate synthase (2MCS). 2MCS catalyzes the condensation of propionyl-CoA (PrCoA) and OAA to form 2-methylcitrate and CoA during propionate metabolism. This group contains proteins which functions exclusively as either a CS or a 2MCS, as well as those with relaxed specificity which have dual functions as both a CS and a 2MCS. The overall CS reaction is thought to proceed through three partial reactions and involves both closed and open conformational forms of the enzyme: a) the carbanion or equivalent is generated from AcCoA by base abstraction of a proton, b) the nucleophilic attack of this carbanion on OAA to generate citryl-CoA, an
Probab=59.20 E-value=18 Score=38.22 Aligned_cols=61 Identities=18% Similarity=0.130 Sum_probs=45.2
Q ss_pred CHHHHHHHHHhCCCCCHHHHHHHHHHHHhhC--CCcH--HHHHHHHcCCCCCChHHHHHHHHHHhcc
Q 012107 122 LPEGLLWLLLTGKVPSKEQVDGLSKELRDRA--TVPD--YVYKAIDALPVTAHPMTQFASGVMALQV 184 (471)
Q Consensus 122 ~~Eev~~LLl~G~lPt~~ql~~f~~~l~~~~--~lp~--~v~~~i~~lP~~~hPM~~l~~avsal~~ 184 (471)
+|-+.+|++++|+.|++++.+.|..-|--+. .+.. ....++.+ ..++|...+.+|+.+|..
T Consensus 152 s~~~nfl~ml~g~~p~~~~~~~l~~~Lil~aDHg~n~STfaaRvvaS--t~ad~~s~~~aai~al~G 216 (373)
T cd06112 152 DYAENFLYMLFGEEPDPATAKILDACLILHAEHTMNASTFSALVTGS--TLADPYAVISSAIGTLSG 216 (373)
T ss_pred CHHHHHHHHHhCCCCCHHHHHHHHHHHhhcccCCCCchHHHHHHHHh--cCCcHHHHHHHHHHhccC
Confidence 5779999999999999999999998875554 2333 34444444 346788888888888843
No 49
>PRK14036 citrate synthase; Provisional
Probab=57.56 E-value=29 Score=36.79 Aligned_cols=61 Identities=18% Similarity=0.107 Sum_probs=44.8
Q ss_pred CHHHHHHHHHhCCCCCHHHHHHHHHHHHhhC--CCcHH--HHHHHHcCCCCCChHHHHHHHHHHhcc
Q 012107 122 LPEGLLWLLLTGKVPSKEQVDGLSKELRDRA--TVPDY--VYKAIDALPVTAHPMTQFASGVMALQV 184 (471)
Q Consensus 122 ~~Eev~~LLl~G~lPt~~ql~~f~~~l~~~~--~lp~~--v~~~i~~lP~~~hPM~~l~~avsal~~ 184 (471)
+|-+.+|++++|+.|++.+.+.|..-|--+. .+... ...++.+ .-++|-..+.+|+.+|..
T Consensus 153 ~~a~nfl~ml~g~~p~~~~~~~l~~~Lil~ADHg~naST~aaRv~aS--t~ad~ys~v~agi~aL~G 217 (377)
T PRK14036 153 DYAANFLYMLTEREPDPLAARIFDRCLILHAEHTINASTFSARVTAS--TLTDPYAVIASAVGTLAG 217 (377)
T ss_pred CHHHHHHHHhcCCCCCHHHHHHHHHHHhhhccCCCCchHHHHHHHHh--cCCcHHHHHHHHHHHccC
Confidence 5779999999999999999999999875543 23333 3333333 346788888888888753
No 50
>PRK12351 methylcitrate synthase; Provisional
Probab=49.84 E-value=57 Score=34.67 Aligned_cols=60 Identities=22% Similarity=0.251 Sum_probs=45.2
Q ss_pred CHHHHHHHHHhCCCCCHHHHHHHHHHHHhhC--CCcH--HHHHHHHcCCCCCChHHHHHHHHHHhc
Q 012107 122 LPEGLLWLLLTGKVPSKEQVDGLSKELRDRA--TVPD--YVYKAIDALPVTAHPMTQFASGVMALQ 183 (471)
Q Consensus 122 ~~Eev~~LLl~G~lPt~~ql~~f~~~l~~~~--~lp~--~v~~~i~~lP~~~hPM~~l~~avsal~ 183 (471)
++-|.+|++++|+.|++.+.+.|..-|--+. .+.. ....+..+- -++|-..+++|+.+|.
T Consensus 158 s~a~Nfl~ml~g~~p~~~~~~~l~~~LvL~ADH~~naST~aaRvvaSt--~ad~~sav~agi~aL~ 221 (378)
T PRK12351 158 SIGGHFLHLLHGKKPSESWVKAMHTSLILYAEHEFNASTFTARVIAGT--GSDMYSAITGAIGALR 221 (378)
T ss_pred CHHHHHHHHhcCCCCCHHHHHHHHHHHHHhcccCCchHHHHHHHHhcc--CCCHHHHHHHHHHhcc
Confidence 4778999999999999999999999876554 2333 344455553 4678888888999884
No 51
>PRK14033 citrate synthase; Provisional
Probab=47.65 E-value=61 Score=34.34 Aligned_cols=60 Identities=17% Similarity=0.157 Sum_probs=44.5
Q ss_pred CHHHHHHHHHhCCCCCHHHHHHHHHHHHhhC--CCcH--HHHHHHHcCCCCCChHHHHHHHHHHhc
Q 012107 122 LPEGLLWLLLTGKVPSKEQVDGLSKELRDRA--TVPD--YVYKAIDALPVTAHPMTQFASGVMALQ 183 (471)
Q Consensus 122 ~~Eev~~LLl~G~lPt~~ql~~f~~~l~~~~--~lp~--~v~~~i~~lP~~~hPM~~l~~avsal~ 183 (471)
+|-+.+|++++|+.|++.+.+.|..-|--.. .+.. .+..++.+- .++|-..+.+|+++|.
T Consensus 158 s~a~nfl~ml~g~~p~~~~~~~l~~~Lvl~ADHgln~StfaaRv~aSt--~adl~~av~agl~al~ 221 (375)
T PRK14033 158 GYAENFLHMCFGEVPEPEVVRAFEVSLILYAEHSFNASTFTARVITST--LSDIYSAVTGAIGALK 221 (375)
T ss_pred CHHHHHHHHHhCCCCCHHHHHHHHHHHHHHhccCCCcHHHHHHHHhcc--CCCHHHHHHHHHhhcc
Confidence 5779999999999999999999998775443 2333 344455553 4678888888888884
No 52
>cd06111 DsCS_like Cold-active citrate synthase (CS) from an Antarctic bacterial strain DS2-3R (Ds)-like. CS catalyzes the condensation of acetyl coenzyme A (AcCoA) and oxalacetate (OAA) to form citrate and coenzyme A (CoA), the first step in the citric acid cycle (TCA or Krebs cycle). 2-methylcitrate synthase (2MCS) catalyzes the condensation of propionyl-coenzyme A (PrCoA) and OAA to form 2-methylcitrate and coenzyme A (CoA) during propionate metabolism. The overall CS reaction is thought to proceed through three partial reactions: a) the carbanion or equivalent is generated from AcCoA by base abstraction of a proton, b) the nucleophilic attack of this carbanion on OAA to generate citryl-CoA, and c) the hydrolysis of citryl-CoA to produce citrate and CoA. DsCS, compared with CS from the hyperthermophile Pyrococcus furiosus (not included in this group), has an increase in the size of surface loops, a higher proline content in the loop regions, a more accessible active site, and a highe
Probab=46.81 E-value=62 Score=34.11 Aligned_cols=61 Identities=18% Similarity=0.153 Sum_probs=44.5
Q ss_pred CHHHHHHHHHhCCCCCHHHHHHHHHHHHhhC--CCc--HHHHHHHHcCCCCCChHHHHHHHHHHhcc
Q 012107 122 LPEGLLWLLLTGKVPSKEQVDGLSKELRDRA--TVP--DYVYKAIDALPVTAHPMTQFASGVMALQV 184 (471)
Q Consensus 122 ~~Eev~~LLl~G~lPt~~ql~~f~~~l~~~~--~lp--~~v~~~i~~lP~~~hPM~~l~~avsal~~ 184 (471)
+|-+.+|++++|+.|++++.+.|..-|--+. .+. ..+..++.+-. ++|-..+.+++++|..
T Consensus 148 s~a~nfl~m~~g~~p~~~~~~~l~~~Lvl~ADHg~n~St~aaR~~aSt~--ad~~~av~agl~aL~G 212 (362)
T cd06111 148 GIAENFLHMCFGEVPSPEVVRAFDVSLILYAEHSFNASTFTARVITSTL--SDIYSAITGAIGALKG 212 (362)
T ss_pred CHHHHHHHHhhCCCCCHHHHHHHHHHHHHHhccCCchhHHHHHHHHccC--CCHHHHHHHHHhhccC
Confidence 5779999999999999999999998764443 233 33445555543 5788888888888743
No 53
>cd06108 Ec2MCS_like Escherichia coli (Ec) 2-methylcitrate synthase (2MCS)_like. 2MCS catalyzes the condensation of propionyl-coenzyme A (PrCoA) and oxalacetate (OAA) to form 2-methylcitrate and coenzyme A (CoA) during propionate metabolism. Citrate synthase (CS) catalyzes the condensation of acetyl coenzyme A (AcCoA) and OAA to form citrate and coenzyme A (CoA), the first step in the citric acid cycle (TCA or Krebs cycle). This group contains proteins similar to the E. coli 2MCS, EcPrpC. EcPrpC is one of two CS isozymes in the gram-negative E. coli. EcPrpC is a dimeric (type I ) CS; it is induced during growth on propionate and prefers PrCoA as a substrate though it has partial CS activity with AcCoA. This group also includes Salmonella typhimurium PrpC and Ralstonia eutropha (Re) 2-MCS1 which are also induced during growth on propionate and prefer PrCoA as substrate, but can also use AcCoA. Re 2-MCS1 can use butyryl-CoA and valeryl-CoA at a lower rate. A second Ralstonia eutropha 2MC
Probab=45.59 E-value=64 Score=34.06 Aligned_cols=60 Identities=15% Similarity=0.214 Sum_probs=45.3
Q ss_pred CHHHHHHHHHhCCCCCHHHHHHHHHHHHhhC--CCc--HHHHHHHHcCCCCCChHHHHHHHHHHhc
Q 012107 122 LPEGLLWLLLTGKVPSKEQVDGLSKELRDRA--TVP--DYVYKAIDALPVTAHPMTQFASGVMALQ 183 (471)
Q Consensus 122 ~~Eev~~LLl~G~lPt~~ql~~f~~~l~~~~--~lp--~~v~~~i~~lP~~~hPM~~l~~avsal~ 183 (471)
+|-+.+|.+++|+.|++++.+.|..-|.-+. .+. .....++.+ ..++|-..+++|+.+|.
T Consensus 146 s~a~nfl~ml~g~~p~~~~~~~l~~~LvL~ADH~~n~St~aaRv~aS--t~ad~~sav~agi~al~ 209 (363)
T cd06108 146 SIAGHFLHLLHGKKPGELEIKAMDVSLILYAEHEFNASTFAARVTAS--TLSDFYSAITGAIGTLR 209 (363)
T ss_pred CHHHHHHHHhcCCCCCHHHHHHHHHHhhhhccCCCcchHHHHHHHhc--cCCCHHHHHHHHHHhcc
Confidence 5789999999999999999999998875553 233 334445554 44688888888998884
No 54
>cd06113 citrate_synt_like_1_2 Citrate synthase (CS) catalyzes the condensation of acetyl coenzyme A (AcCoA) and oxalacetate (OAA) to form citrate and coenzyme A (CoA), the first step in the oxidative citric acid cycle (TCA or Krebs cycle). Peroxisomal CS is involved in the glyoxylate cycle. This group also includes CS proteins which functions as a 2-methylcitrate synthase (2MCS). 2MCS catalyzes the condensation of propionyl-CoA (PrCoA) and OAA to form 2-methylcitrate and CoA during propionate metabolism. This group contains proteins which functions exclusively as either a CS or a 2MCS, as well as those with relaxed specificity which have dual functions as both a CS and a 2MCS. The overall CS reaction is thought to proceed through three partial reactions and involves both closed and open conformational forms of the enzyme: a) a carbanion or equivalent is generated from AcCoA by base abstraction of a proton, b) nucleophilic attack of this carbanion on OAA to generate citryl-CoA, and c) h
Probab=44.33 E-value=67 Score=34.42 Aligned_cols=60 Identities=12% Similarity=0.078 Sum_probs=45.1
Q ss_pred CHHHHHHHHHhC-CCCCHHHHHHHHHHHHhhC--C-CcH--HHHHHHHcCCCCCChHHHHHHHHHHhc
Q 012107 122 LPEGLLWLLLTG-KVPSKEQVDGLSKELRDRA--T-VPD--YVYKAIDALPVTAHPMTQFASGVMALQ 183 (471)
Q Consensus 122 ~~Eev~~LLl~G-~lPt~~ql~~f~~~l~~~~--~-lp~--~v~~~i~~lP~~~hPM~~l~~avsal~ 183 (471)
+|-+.||++++| +.|++++.+.|..-|.-+. . ++. ....++.+- -++|-..+++|+.+|.
T Consensus 175 s~a~nfl~ml~g~~~p~~~~~~~l~~~Lvl~ADHg~~naST~aaRv~aSt--~ad~~~avaagi~al~ 240 (406)
T cd06113 175 STAENILSMLRPDKKYTELEAKLLDLCLVLHAEHGGGNNSTFTTRVVSSS--GTDTYSAIAAAIGSLK 240 (406)
T ss_pred CHHHHHHHHhccCCCCCHHHHHHHHHHHhhhhccCCCcchHHHHHHHHcc--CCCHHHHHHHHHHHcc
Confidence 577999999999 5999999999998875332 2 333 344555554 3688899999999984
No 55
>cd06117 Ec2MCS_like_1 Subgroup of Escherichia coli (Ec) 2-methylcitrate synthase (2MCS)_like. 2MCS catalyzes the condensation of propionyl-coenzyme A (PrCoA) and oxalacetate (OAA) to form 2-methylcitrate and coenzyme A (CoA) during propionate metabolism. Citrate synthase (CS) catalyzes the condensation of acetyl coenzyme A (AcCoA) and OAA to form citrate and coenzyme A (CoA), the first step in the citric acid cycle (TCA or Krebs cycle). This group contains proteins similar to the E. coli 2MCS, EcPrpC. EcPrpC is one of two CS isozymes in the gram-negative E. coli. EcPrpC is a dimeric (type I ) CS; it is induced during growth on propionate and prefers PrCoA as a substrate, but has a partial CS activity with AcCoA. This group also includes Salmonella typhimurium PrpC and Ralstonia eutropha (Re) 2-MCS1 which are also induced during growth on propionate, prefer PrCoA as substrate, but can also can use AcCoA. Re 2-MCS1 at a low rate can use butyryl-CoA and valeryl-CoA. A second Ralstonia eu
Probab=42.94 E-value=84 Score=33.24 Aligned_cols=60 Identities=18% Similarity=0.199 Sum_probs=45.0
Q ss_pred CHHHHHHHHHhCCCCCHHHHHHHHHHHHhhC--CCcH--HHHHHHHcCCCCCChHHHHHHHHHHhc
Q 012107 122 LPEGLLWLLLTGKVPSKEQVDGLSKELRDRA--TVPD--YVYKAIDALPVTAHPMTQFASGVMALQ 183 (471)
Q Consensus 122 ~~Eev~~LLl~G~lPt~~ql~~f~~~l~~~~--~lp~--~v~~~i~~lP~~~hPM~~l~~avsal~ 183 (471)
++-|.||.+++|+.|++++.+.|..-|.-+. .+.. ....++.+- .++|-..+++|+.+|.
T Consensus 149 s~a~Nfl~ml~g~~p~~~~~~~l~~~LvL~ADHg~n~ST~aarv~aSt--~ad~~sav~agi~aL~ 212 (366)
T cd06117 149 SIGGHFLHLLHGEKPSESWEKAMHISLILYAEHEFNASTFTARVIAGT--GSDMYSAITGAIGALR 212 (366)
T ss_pred CHHHHHHHHhcCCCCCHHHHHHHHHHHHHhcccCCchHHHHHHHHHcc--CCcHHHHHHHHHHhcc
Confidence 4678899999999999999999999875554 2333 344455553 4678888888888884
No 56
>TIGR01800 cit_synth_II 2-methylcitrate synthase/citrate synthase II. Members of this family are dimeric enzymes with activity as 2-methylcitrate synthase, citrate synthase, or both. Many Gram-negative species have a hexameric citrate synthase, termed citrate synthase I (TIGR01798). Members of this family (TIGR01800) appear as a second citrate synthase isozyme but typically are associated with propionate metabolism and synthesize 2-methylcitrate from propionyl-CoA; citrate synthase activity may be incidental. A number of species, including Thermoplasma acidophilum, Pyrococcus furiosus, and the Antarctic bacterium DS2-3R have a bifunctional member of this family as the only citrate synthase isozyme.
Probab=42.07 E-value=90 Score=32.94 Aligned_cols=62 Identities=16% Similarity=0.217 Sum_probs=46.2
Q ss_pred CCCHHHHHHHHHhCCCCCHHHHHHHHHHHHhhC--CCc--HHHHHHHHcCCCCCChHHHHHHHHHHhc
Q 012107 120 EPLPEGLLWLLLTGKVPSKEQVDGLSKELRDRA--TVP--DYVYKAIDALPVTAHPMTQFASGVMALQ 183 (471)
Q Consensus 120 ~~~~Eev~~LLl~G~lPt~~ql~~f~~~l~~~~--~lp--~~v~~~i~~lP~~~hPM~~l~~avsal~ 183 (471)
..+|.+.+|++++|+.|++++.+.|..-|.-+. .+. ..+..++.+- .++|-..+.+++.+|.
T Consensus 146 ~~~~~~n~l~ml~g~~p~~~~~~~l~~~Lvl~ADHg~n~St~aaRv~aSt--~adl~~av~agl~al~ 211 (368)
T TIGR01800 146 DDSHAANFLYMLHGEEPSKEEEKAMDIALILYAEHEFNASTFAARVAAST--LSDMYSAITAAIGALK 211 (368)
T ss_pred CccHHHHHHHHhcCCCCCHHHHHHHHHHHhHhccCCCchHHHHHHHHhcc--CCCHHHHHHHHHhhcC
Confidence 346888999999999999999999998875543 233 3344555554 4688888888998884
No 57
>PRK14032 citrate synthase; Provisional
Probab=39.49 E-value=94 Score=33.81 Aligned_cols=60 Identities=10% Similarity=0.048 Sum_probs=45.2
Q ss_pred CHHHHHHHHHhCC-CCCHHHHHHHHHHHHhhC--C-CcHH--HHHHHHcCCCCCChHHHHHHHHHHhc
Q 012107 122 LPEGLLWLLLTGK-VPSKEQVDGLSKELRDRA--T-VPDY--VYKAIDALPVTAHPMTQFASGVMALQ 183 (471)
Q Consensus 122 ~~Eev~~LLl~G~-lPt~~ql~~f~~~l~~~~--~-lp~~--v~~~i~~lP~~~hPM~~l~~avsal~ 183 (471)
+|-+.||.+++|+ .|++.+.+.|..-|--+. . ++.. ...++.+- .++|-..+++|+.+|.
T Consensus 205 s~a~nfl~ml~g~~~p~~~~~~~ld~~LiL~ADHg~~naSTfaaRv~aSt--~ad~ysavaagi~aL~ 270 (447)
T PRK14032 205 STAENILYMLRPDNKYTELEARLLDLALVLHAEHGGGNNSTFTTRVVSSS--GTDTYSAIAAAIGSLK 270 (447)
T ss_pred CHHHHHHHHhccCCCCCHHHHHHHHHHHHHHhccCCCchhHHHHHHHHcc--CCcHHHHHHHHHHhcc
Confidence 4778999999999 999999999998875443 2 4443 44455553 4688899999999984
No 58
>cd06118 citrate_synt_like_1 Citrate synthase (CS) catalyzes the condensation of acetyl coenzyme A (AcCoA) and oxalacetate (OAA) to form citrate and coenzyme A (CoA), the first step in the oxidative citric acid cycle (TCA or Krebs cycle). Peroxisomal CS is involved in the glyoxylate cycle. This group also includes CS proteins which functions as a 2-methylcitrate synthase (2MCS). 2MCS catalyzes the condensation of propionyl-CoA (PrCoA) and OAA to form 2-methylcitrate and CoA during propionate metabolism. This group contains proteins which functions exclusively as either a CS or a 2MCS, as well as those with relaxed specificity which have dual functions as both a CS and a 2MCS. The overall CS reaction is thought to proceed through three partial reactions and involves both closed and open conformational forms of the enzyme: a) the carbanion or equivalent is generated from AcCoA by base abstraction of a proton, b) the nucleophilic attack of this carbanion on OAA to generate citryl-CoA, and
Probab=38.26 E-value=1e+02 Score=32.34 Aligned_cols=60 Identities=15% Similarity=0.198 Sum_probs=46.5
Q ss_pred CHHHHHHHHHhCCCCCHHHHHHHHHHHHhhC--CCcH--HHHHHHHcCCCCCChHHHHHHHHHHhc
Q 012107 122 LPEGLLWLLLTGKVPSKEQVDGLSKELRDRA--TVPD--YVYKAIDALPVTAHPMTQFASGVMALQ 183 (471)
Q Consensus 122 ~~Eev~~LLl~G~lPt~~ql~~f~~~l~~~~--~lp~--~v~~~i~~lP~~~hPM~~l~~avsal~ 183 (471)
+|-+.+|.+++|+.|++++.+.|..-|.-+. .++. .+..++.+-. ++|-..+++|+.+|.
T Consensus 148 ~~~~~~~~~~~g~~p~~~~~~~l~~~Lvl~aDH~~n~Stfa~R~~aSt~--ad~~~av~agl~al~ 211 (358)
T cd06118 148 SYAENFLYMLFGEEPDPEEAKAMDLALILHADHEGNASTFTARVVASTL--SDMYSAIAAAIAALK 211 (358)
T ss_pred cHHHHHHHHhcCCCCCHHHHHHHHHHHhhhcCCCCChHHHHHHHHHccC--CCHHHHHHHHHHHcc
Confidence 3678899999999999999999999876554 3444 3555666644 689999999999984
No 59
>cd06110 BSuCS-II_like Bacillus subtilis (Bs) citrate synthase (CS)-II_like. CS catalyzes the condensation of acetyl coenzyme A (AcCoA) and oxalacetate (OAA) to form citrate and coenzyme A (CoA), the first step in the citric acid cycle (TCA or Krebs cycle). 2MCS catalyzes the condensation of propionyl-coenzyme A (PrCoA) and OAA to form 2-methylcitrate and CoA during propionate metabolism. The overall CS reaction is thought to proceed through three partial reactions: a) the carbanion or equivalent is generated from AcCoA by base abstraction of a proton, b) the nucleophilic attack of this carbanion on OAA to generate citryl-CoA, and c) the hydrolysis of citryl-CoA to produce citrate and CoA. This group contains proteins similar to BsCS-II, the major CS of the gram-positive bacterium Bacillus subtilis. A mutation in the gene which encodes BsCS-II (citZ gene) has been described which resulted in a significant loss of CS activity, partial glutamate auxotrophy, and a sporulation deficiency, a
Probab=38.10 E-value=1e+02 Score=32.38 Aligned_cols=60 Identities=17% Similarity=0.253 Sum_probs=45.5
Q ss_pred CHHHHHHHHHhCCCCCHHHHHHHHHHHHhhC--CC--cHHHHHHHHcCCCCCChHHHHHHHHHHhc
Q 012107 122 LPEGLLWLLLTGKVPSKEQVDGLSKELRDRA--TV--PDYVYKAIDALPVTAHPMTQFASGVMALQ 183 (471)
Q Consensus 122 ~~Eev~~LLl~G~lPt~~ql~~f~~~l~~~~--~l--p~~v~~~i~~lP~~~hPM~~l~~avsal~ 183 (471)
+|-+.+|++++|+.|++++.+.|..-|.-+. .+ +..+..++.+-. ++|-..+.+++.+|.
T Consensus 148 ~~a~~~l~~l~g~~p~~~~~~~l~~~Lvl~aDHg~n~Stfa~Rv~aSt~--ad~~~av~agl~al~ 211 (356)
T cd06110 148 SHAANFLYMLTGEKPSEEAARAFDVALILHADHELNASTFAARVVASTL--SDMYSAVTAAIGALK 211 (356)
T ss_pred CHHHHHHHHhcCCCCCHHHHHHHHHHHHHhccCCCchhHHHHHHHHhcC--CCHHHHHHHHHhhcC
Confidence 4678898899999999999999998875543 23 334555777655 578888888888884
No 60
>cd06101 citrate_synt Citrate synthase (CS) catalyzes the condensation of acetyl coenzyme A (AcCoA) and oxalacetate (OAA) to form citrate and coenzyme A (CoA), the first step in the oxidative citric acid cycle (TCA or Krebs cycle). Peroxisomal CS is involved in the glyoxylate cycle. This group also includes CS proteins which functions as a 2-methylcitrate synthase (2MCS). 2MCS catalyzes the condensation of propionyl-CoA (PrCoA) and OAA to form 2-methylcitrate and CoA during propionate metabolism. This group contains proteins which functions exclusively as either a CS or a 2MCS, as well as those with relaxed specificity which have dual functions as both a CS and a 2MCS. The overall CS reaction is thought to proceed through three partial reactions and involves both closed and open conformational forms of the enzyme: a) the carbanion or equivalent is generated from AcCoA by base abstraction of a proton, b) the nucleophilic attack of this carbanion on OAA to generate citryl-CoA, and c) the
Probab=36.56 E-value=1.5e+02 Score=29.88 Aligned_cols=76 Identities=20% Similarity=0.250 Sum_probs=53.3
Q ss_pred CCHHHHhhhCCCCCCCCCCCHHHHHHHHHhCCCCCHHHHHHHHHHHHhhC--CCcH--HHHHHHHcCCCCCChHHHHHHH
Q 012107 103 LSIPECQKLLPAAKPDGEPLPEGLLWLLLTGKVPSKEQVDGLSKELRDRA--TVPD--YVYKAIDALPVTAHPMTQFASG 178 (471)
Q Consensus 103 y~I~eL~~~~p~~~~~~~~~~Eev~~LLl~G~lPt~~ql~~f~~~l~~~~--~lp~--~v~~~i~~lP~~~hPM~~l~~a 178 (471)
.+.+|.+-.+= .|+-|++-+.++.+++|+-|+++|.+.|..-|--+. .+.. .+..+..+ ..++|-..+.++
T Consensus 37 ~~f~ev~~LL~---~G~lP~~~~nfl~m~~g~~p~~~~~~~l~~~Lvl~aDHg~naST~aaRv~aS--t~ad~~~av~ag 111 (265)
T cd06101 37 SSFEEVAYLLL---TGELPSYAENFLYMLGGEEPDPEFAKAMDLALILHADHEGNASTFTARVVGS--TLSDPYSAIAAA 111 (265)
T ss_pred CCHHHHHHHHH---cCCCCcHHHHHHHHhcCCCCCHHHHHHHHHHHhhhcCCCCchHHHHHHHHHc--cCCcHHHHHHHH
Confidence 56666665442 244556788999999999999999999998775543 2333 33344444 446888888889
Q ss_pred HHHhc
Q 012107 179 VMALQ 183 (471)
Q Consensus 179 vsal~ 183 (471)
+++|.
T Consensus 112 l~al~ 116 (265)
T cd06101 112 IAALK 116 (265)
T ss_pred HHhCC
Confidence 98884
No 61
>PF07583 PSCyt2: Protein of unknown function (DUF1549); InterPro: IPR011444 The function is not known. It is found associated with IPR022655 from INTERPRO. It is also found associated with the Planctomycete cytochrome C domain IPR011429 from INTERPRO.
Probab=36.34 E-value=43 Score=32.57 Aligned_cols=36 Identities=33% Similarity=0.457 Sum_probs=25.6
Q ss_pred HHHHHHHhCCCCCHHHHHHHHHHHHhhCCCcHHHHHHHHcC
Q 012107 125 GLLWLLLTGKVPSKEQVDGLSKELRDRATVPDYVYKAIDAL 165 (471)
Q Consensus 125 ev~~LLl~G~lPt~~ql~~f~~~l~~~~~lp~~v~~~i~~l 165 (471)
==++|=|+|.+||.+|+++|.+. .=|+.-.++|+.|
T Consensus 29 RRv~LDL~G~~PT~eEv~~Fl~d-----~~~~kr~~lVd~L 64 (208)
T PF07583_consen 29 RRVYLDLTGLPPTPEEVRAFLAD-----PSPDKREKLVDRL 64 (208)
T ss_pred HHHHHHHhCCCcCHHHHHHHHhC-----CChhHHHHHHHHH
Confidence 34689999999999999999874 1244444555543
No 62
>cd06109 BsCS-I_like Bacillus subtilis (Bs) citrate synthase CS-I_like. CS catalyzes the condensation of acetyl coenzyme A (AcCoA) and oxalacetate (OAA) to form citrate and coenzyme A (CoA), the first step in the citric acid cycle (TCA or Krebs cycle). 2MCS catalyzes the condensation of propionyl-coenzyme A (PrCoA) and OAA to form 2-methylcitrate and coenzyme A (CoA) during propionate metabolism. The overall CS reaction is thought to proceed through three partial reactions and involves both closed and open conformational forms of the enzyme: a) the carbanion or equivalent is generated from AcCoA by base abstraction of a proton, b) the nucleophilic attack of this carbanion on OAA to generate citryl-CoA, and c) the hydrolysis of citryl-CoA to produce citrate and CoA. This group contains proteins similar to BsCS-I, one of two CS isozymes in the gram-positive B. subtilis. The majority of CS activity in B. subtilis is provided by the other isozyme, BsCS-II (not included in this group). BsCS-
Probab=36.26 E-value=1.1e+02 Score=32.22 Aligned_cols=60 Identities=22% Similarity=0.240 Sum_probs=45.2
Q ss_pred CHHHHHHHHHhCCCCCHHHHHHHHHHHHhhC---C-CcHHHHHHHHcCCCCCChHHHHHHHHHHhc
Q 012107 122 LPEGLLWLLLTGKVPSKEQVDGLSKELRDRA---T-VPDYVYKAIDALPVTAHPMTQFASGVMALQ 183 (471)
Q Consensus 122 ~~Eev~~LLl~G~lPt~~ql~~f~~~l~~~~---~-lp~~v~~~i~~lP~~~hPM~~l~~avsal~ 183 (471)
++-+.||.+++|+.|++++.+.|..-|.-+. . .+..+..++.+- -++|-..+++|+.+|.
T Consensus 137 s~a~nfl~ml~g~~p~~~~~~~l~~~Lvl~ADHg~n~ST~aaRv~aSt--~ad~~savaagi~al~ 200 (349)
T cd06109 137 SHAADYLRMLTGEPPSEAHVRALDAYLVTVADHGMNASTFTARVIAST--EADLTSAVLGAIGALK 200 (349)
T ss_pred CHHHHHHHHhCCCCCChHHHHHHHHHHhHhcccCCCchhhHHHHHhcc--CCcHHHHHHHHHHhcc
Confidence 5778899999999999999999999875443 2 233444555553 4688899999999884
No 63
>PTZ00096 40S ribosomal protein S15; Provisional
Probab=34.67 E-value=29 Score=31.93 Aligned_cols=22 Identities=27% Similarity=0.436 Sum_probs=17.4
Q ss_pred eeecCCCHHHHhhhCCCCCCCCCCCHHHHHHH
Q 012107 98 IRFRGLSIPECQKLLPAAKPDGEPLPEGLLWL 129 (471)
Q Consensus 98 i~yRGy~I~eL~~~~p~~~~~~~~~~Eev~~L 129 (471)
..|||++++||.+. ..||++=|
T Consensus 15 f~yRG~~l~~L~~m----------~~~e~~~L 36 (143)
T PTZ00096 15 FTYRGVELEKLLAL----------PEEELVEL 36 (143)
T ss_pred eeeecCCHHHHHcC----------CHHHHHHH
Confidence 47999999999986 36776655
No 64
>cd04448 DEP_PIKfyve DEP (Dishevelled, Egl-10, and Pleckstrin) domain found in fungal RhoGEF (GDP/GTP exchange factor) PIKfyve-like proteins. PIKfyve contains N-terminal Fyve finger and DEP domains, a central chaperonin-like domain and a C-terminal PIPK (phosphatidylinositol phosphate kinase) domain. PIKfyve-like proteins are important phosphatidylinositol (3)-monophosphate (PtdIns(3)P)-5-kinases, producing PtdIns(3,5)P2, which plays a major role in multivesicular body (MVB) sorting and control of retrograde traffic from the vacuole back to the endosome and/or Golgi. PIKfyve itself has been shown to be play a role in regulating early-endosome-to-trans-Golgi network (TGN) retrograde trafficking.
Probab=32.57 E-value=67 Score=26.43 Aligned_cols=51 Identities=25% Similarity=0.412 Sum_probs=37.3
Q ss_pred cCCCCe-----eecCCCHHHHhhhCCCCCCCCCCCHHHHHHHHHhCCCCCHHHHHHHHHHHHhhCCC
Q 012107 93 DPDEGI-----RFRGLSIPECQKLLPAAKPDGEPLPEGLLWLLLTGKVPSKEQVDGLSKELRDRATV 154 (471)
Q Consensus 93 D~~~Gi-----~yRGy~I~eL~~~~p~~~~~~~~~~Eev~~LLl~G~lPt~~ql~~f~~~l~~~~~l 154 (471)
|++.|+ +|+....+.|.-- .|-|-||+=.|+..|.+|.-.+-+.|.+.+.+
T Consensus 8 ~~~~gv~i~drr~~~~~y~~cF~G-----------selVdWL~~~~~~~~R~eAv~~gq~Ll~~g~i 63 (81)
T cd04448 8 RSSTGIEFQDHRYRLRTYTNCILG-----------KELVNWLIRQGKAATRVQAIAIGQALLDAGWI 63 (81)
T ss_pred CcCCCCeeEEEEECCEEcCcccCh-----------HHHHHHHHHcCCCCCHHHHHHHHHHHHHCCCE
Confidence 455564 4555555555432 47899999999999999999999988877654
No 65
>PRK04038 rps19p 30S ribosomal protein S19P; Provisional
Probab=31.29 E-value=36 Score=30.96 Aligned_cols=14 Identities=29% Similarity=0.710 Sum_probs=12.7
Q ss_pred eeecCCCHHHHhhh
Q 012107 98 IRFRGLSIPECQKL 111 (471)
Q Consensus 98 i~yRGy~I~eL~~~ 111 (471)
..|||++++||.+.
T Consensus 7 f~yrG~~l~~L~~m 20 (134)
T PRK04038 7 FTYRGYTLEELQEM 20 (134)
T ss_pred eeecccCHHHHHcC
Confidence 47999999999986
No 66
>PF00285 Citrate_synt: Citrate synthase; InterPro: IPR002020 Citrate synthase 2.3.3.1 from EC is a member of a small family of enzymes that can directly form a carbon-carbon bond without the presence of metal ion cofactors. It catalyses the first reaction in the Krebs' cycle, namely the conversion of oxaloacetate and acetyl-coenzyme A into citrate and coenzyme A. This reaction is important for energy generation and for carbon assimilation. The reaction proceeds via a non-covalently bound citryl-coenzyme A intermediate in a 2-step process (aldol-Claisen condensation followed by the hydrolysis of citryl-CoA). Citrate synthase enzymes are found in two distinct structural types: type I enzymes (found in eukaryotes, Gram-positive bacteria and archaea) form homodimers and have shorter sequences than type II enzymes, which are found in Gram-negative bacteria and are hexameric in structure. In both types, the monomer is composed of two domains: a large alpha-helical domain consisting of two structural repeats, where the second repeat is interrupted by a small alpha-helical domain. The cleft between these domains forms the active site, where both citrate and acetyl-coenzyme A bind. The enzyme undergoes a conformational change upon binding of the oxaloacetate ligand, whereby the active site cleft closes over in order to form the acetyl-CoA binding site []. The energy required for domain closure comes from the interaction of the enzyme with the substrate. Type II enzymes possess an extra N-terminal beta-sheet domain, and some type II enzymes are allosterically inhibited by NADH []. This entry represents types I and II citrate synthase enzymes, as well as the related enzymes 2-methylcitrate synthase and ATP citrate synthase. 2-methylcitrate (2.3.3.5 from EC) synthase catalyses the conversion of oxaloacetate and propanoyl-CoA into (2R,3S)-2-hydroxybutane-1,2,3-tricarboxylate and coenzyme A. This enzyme is induced during bacterial growth on propionate, while type II hexameric citrate synthase is constitutive []. ATP citrate synthase (2.3.3.8 from EC) (also known as ATP citrate lyase) catalyses the MgATP-dependent, CoA-dependent cleavage of citrate into oxaloacetate and acetyl-CoA, a key step in the reductive tricarboxylic acid pathway of CO2 assimilation used by a variety of autotrophic bacteria and archaea to fix carbon dioxide []. ATP citrate synthase is composed of two distinct subunits. In eukaryotes, ATP citrate synthase is a homotetramer of a single large polypeptide, and is used to produce cytosolic acetyl-CoA from mitochondrial produced citrate [].; GO: 0046912 transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer, 0044262 cellular carbohydrate metabolic process; PDB: 2C6X_D 3L96_B 1OWB_B 1NXG_A 1K3P_A 1OWC_B 3L97_B 1NXE_A 3L98_A 3L99_A ....
Probab=30.58 E-value=1.8e+02 Score=30.39 Aligned_cols=61 Identities=21% Similarity=0.260 Sum_probs=42.5
Q ss_pred CHHHHHHHHH--hCCCCCHHHHHHHHHHHHhhC--CCcH--HHHHHHHcCCCCCChHHHHHHHHHHhcc
Q 012107 122 LPEGLLWLLL--TGKVPSKEQVDGLSKELRDRA--TVPD--YVYKAIDALPVTAHPMTQFASGVMALQV 184 (471)
Q Consensus 122 ~~Eev~~LLl--~G~lPt~~ql~~f~~~l~~~~--~lp~--~v~~~i~~lP~~~hPM~~l~~avsal~~ 184 (471)
++-|.++.+| +|+-|++++.+.|..-|.-+. .+.. .+..++.+ ..++|-..+.+|+++|..
T Consensus 148 ~~~~n~l~~l~~~g~~p~~~~~~~l~~~lvl~aDH~~~~St~aaR~~aS--t~~~~~~av~agl~al~G 214 (356)
T PF00285_consen 148 SYAENFLYMLGVTGREPDPEEARALDAALVLHADHGLNPSTFAARVAAS--TGADLYSAVAAGLAALSG 214 (356)
T ss_dssp SHHHHHHHHHH-HSSB--HHHHHHHHHHHHHHS--SSSHHHHHHHHHHT--TT--HHHHHHHHHHHHCS
T ss_pred HHHHHHHHHhhccccCCChHHHHHHHHHHHhhcCCCCCccchhhhhhhc--cCcchhHHHHhhhhhccC
Confidence 4667788888 999999999999999886554 3443 34455554 457899999999999853
No 67
>cd07622 BAR_SNX4 The Bin/Amphiphysin/Rvs (BAR) domain of Sorting Nexin 4. BAR domains are dimerization, lipid binding and curvature sensing modules found in many different proteins with diverse functions. Sorting nexins (SNXs) are Phox homology (PX) domain containing proteins that are involved in regulating membrane traffic and protein sorting in the endosomal system. SNXs differ from each other in their lipid-binding specificity, subcellular localization and specific function in the endocytic pathway. A subset of SNXs also contain BAR domains. The PX-BAR structural unit determines the specific membrane targeting of SNXs. SNX4 is involved in recycling traffic from the sorting endosome (post-Golgi endosome) back to the late Golgi. It is also implicated in the regulation of plasma membrane receptor trafficking and interacts with receptors for EGF, insulin, platelet-derived growth factor and leptin. BAR domains form dimers that bind to membranes, induce membrane bending and curvature, and
Probab=30.40 E-value=1.4e+02 Score=28.78 Aligned_cols=81 Identities=14% Similarity=0.153 Sum_probs=52.1
Q ss_pred CCCCchHHHHHHHHHhhCCC-ChHHHHHHHHHHhhhhhHHhcCCCCCCCCchhhHHHHHHhccCCCccccchhhhhhhhh
Q 012107 357 RKTDPRYTCQREFALKHLPD-DPLFQLVSKLFEVVPPILTKLGKVKNPWPNVDAHSGVLLNHFGLAEARYYTVLFGVSRS 435 (471)
Q Consensus 357 k~~DPRa~~l~~~a~~~~~~-~~~~~la~~le~~~~~~l~~~~k~k~l~pNVD~~sg~l~~~lGlp~~~~~t~lF~vsR~ 435 (471)
|++|||+.-+++++.++-.. +.+.++..++.+-..++..++ .=.|.+|..++..+..+..+|=.+|+.
T Consensus 10 ~~~d~~F~~ikey~~~L~~~l~~iekv~~Rl~~r~~~l~~~~-----------~e~g~~f~~ls~~E~~l~~~le~~g~~ 78 (201)
T cd07622 10 RNPDKRFEDLKNYSDELQTNLNNLLKVRARLAERLYGVYKIH-----------ANYGRVFSEWSAIEKEMGDGLQKAGHY 78 (201)
T ss_pred CCCCHhHHHHHHHHHHHHHHhHHHHHHHHHHHHHHHHHHHHH-----------HHHHHHHHHHHhcchhHHHHHHHHHHH
Confidence 47899999999999886321 223444444433332222111 334667777777777788888888888
Q ss_pred hhHHHHHHHHHHc
Q 012107 436 LGICSQLIWDRAL 448 (471)
Q Consensus 436 ~GwlAH~ieq~~~ 448 (471)
++-++-.+++...
T Consensus 79 ~d~~~~~~~~~~~ 91 (201)
T cd07622 79 MDSYAASIDNGLE 91 (201)
T ss_pred HHHHHHHHHHHHH
Confidence 8888777777554
No 68
>PRK13890 conjugal transfer protein TrbA; Provisional
Probab=28.32 E-value=2.8e+02 Score=24.38 Aligned_cols=40 Identities=23% Similarity=0.223 Sum_probs=18.7
Q ss_pred ecCCCHHHHhhhCCCCCCCCCCCHHHHHHHHHhCC-CCCHHHHHHHHHH
Q 012107 100 FRGLSIPECQKLLPAAKPDGEPLPEGLLWLLLTGK-VPSKEQVDGLSKE 147 (471)
Q Consensus 100 yRGy~I~eL~~~~p~~~~~~~~~~Eev~~LLl~G~-lPt~~ql~~f~~~ 147 (471)
-||++.+||++.+- .-.+.++-+..|+ -|+.+-+..+.+.
T Consensus 16 ~~Glsq~eLA~~~G--------is~~~is~iE~g~~~ps~~~l~kIa~a 56 (120)
T PRK13890 16 ERHMTKKELSERSG--------VSISFLSDLTTGKANPSLKVMEAIADA 56 (120)
T ss_pred HcCCCHHHHHHHHC--------cCHHHHHHHHcCCCCCCHHHHHHHHHH
Confidence 45566666665531 1123344444444 3555555444443
No 69
>TIGR01025 rpsS_arch ribosomal protein S19(archaeal)/S15(eukaryotic). This model represents eukaryotic ribosomal protein S15 and its archaeal equivalent. It excludes bacterial and organellar ribosomal protein S19. The nomenclature for the archaeal members is unresolved and given variously as S19 (after the more distant bacterial homologs) or S15.
Probab=28.25 E-value=43 Score=30.55 Aligned_cols=14 Identities=36% Similarity=0.809 Sum_probs=12.6
Q ss_pred eeecCCCHHHHhhh
Q 012107 98 IRFRGLSIPECQKL 111 (471)
Q Consensus 98 i~yRGy~I~eL~~~ 111 (471)
..|||++++||.+.
T Consensus 5 f~yrG~~l~~L~~m 18 (135)
T TIGR01025 5 FRYRGYTLEELQDM 18 (135)
T ss_pred EeecccCHHHHHcC
Confidence 47999999999986
No 70
>PLN00179 acyl- [acyl-carrier protein] desaturase
Probab=26.79 E-value=8.1e+02 Score=26.26 Aligned_cols=83 Identities=12% Similarity=0.053 Sum_probs=49.2
Q ss_pred HHHHhhccCCChHHHHHHHHhcccccccccchHHHHHHHHHHHHhcCCCCChhhHHHHHHHHHhCCCcccccCCCCCCCC
Q 012107 280 TGHLVASALSDPYLSFAAALNGLAGPLHGLANQEVLLWIKSVVDECGENVTTEQLKDYVWKTLNSGKVVPGFGHGVLRKT 359 (471)
Q Consensus 280 aarvvaSt~sd~y~avaAgl~aL~GplHGgA~e~v~~~l~~i~~~ig~~~~~~~i~~~v~~~l~~g~~IpGfGH~vyk~~ 359 (471)
|+|+++-.+ |+-++-..|.-|..--+|--+-....+-+.++ +++..-..+.++++++=..| ||-.+-..
T Consensus 231 TarlA~~~g-Dp~la~icg~IAaDE~rHe~fY~~iV~~~le~--------dPd~tm~Aiadmm~~ki~MP--a~~m~dg~ 299 (390)
T PLN00179 231 TARLAKEHG-DAKLAKICGTIAADEKRHETAYTRIVEKLFEI--------DPDGAVLAFADMMRKKITMP--AHLMYDGR 299 (390)
T ss_pred HHHHHHhcC-ChHHHHHHHHHhccHHHHHHHHHHHHHHHHhh--------CccHHHHHHHHHHHhcCCCC--cccCCCCC
Confidence 455555544 66555444444446667755544444444433 45666677788888888888 57777777
Q ss_pred Cch-HHHHHHHHHhh
Q 012107 360 DPR-YTCQREFALKH 373 (471)
Q Consensus 360 DPR-a~~l~~~a~~~ 373 (471)
||. +...-..+.+.
T Consensus 300 d~~lF~~fsavaqr~ 314 (390)
T PLN00179 300 DDNLFDHFSAVAQRL 314 (390)
T ss_pred cchHHHHHHHHHHHh
Confidence 875 44444444444
No 71
>PRK08558 adenine phosphoribosyltransferase; Provisional
Probab=25.33 E-value=1.4e+02 Score=29.61 Aligned_cols=56 Identities=21% Similarity=0.277 Sum_probs=42.9
Q ss_pred CCHHHHhhhCCCCCCCCCCCHHHHHHHHHhCC-CCCHHHHHHHHHHHHhhCCCcHHHHHHHHcCC
Q 012107 103 LSIPECQKLLPAAKPDGEPLPEGLLWLLLTGK-VPSKEQVDGLSKELRDRATVPDYVYKAIDALP 166 (471)
Q Consensus 103 y~I~eL~~~~p~~~~~~~~~~Eev~~LLl~G~-lPt~~ql~~f~~~l~~~~~lp~~v~~~i~~lP 166 (471)
||-+||.+.+- .+|.++|==.+|+ +|+.++.++|-++|..+..+.+.+.+-+.-+|
T Consensus 24 ~ty~el~~~~g--------~p~~~l~RYv~g~~~P~~~~a~~~~~~l~~~~~~~~~l~~ri~~~~ 80 (238)
T PRK08558 24 YTYEELSSITG--------LPESVLNRYVNGHVLPSVERAREIVEKLGPYYNLEEEVKARIKVDD 80 (238)
T ss_pred cCHHHHHHHHC--------CCHHHHHHHHcCCcCCCHHHHHHHHHHHHHhhhhHHHHHhhcccCC
Confidence 58889987752 6899999888998 69999999999999887666555555444344
No 72
>PF03461 TRCF: TRCF domain; InterPro: IPR005118 This domain is found in proteins necessary for strand-specific repair in DNA such as TRCF in Escherichia coli. A lesion in the template strand blocks the RNA polymerase complex (RNAP). The RNAP-DNA-RNA complex is specifically recognised by the transcription-repair-coupling factor (TRCF) which releases RNAP and the truncated transcript.; GO: 0003684 damaged DNA binding, 0004386 helicase activity, 0005524 ATP binding, 0006281 DNA repair; PDB: 2QSR_A 2EYQ_A.
Probab=24.55 E-value=1e+02 Score=26.29 Aligned_cols=43 Identities=23% Similarity=0.380 Sum_probs=28.5
Q ss_pred CCCCHHHHHHHHHHHHhh-CCCcHHHHHHHHcCCCCCChHHHHHHHHHHhcc
Q 012107 134 KVPSKEQVDGLSKELRDR-ATVPDYVYKAIDALPVTAHPMTQFASGVMALQV 184 (471)
Q Consensus 134 ~lPt~~ql~~f~~~l~~~-~~lp~~v~~~i~~lP~~~hPM~~l~~avsal~~ 184 (471)
.+-|.+|++++..+|..+ +.+|+.|..++.- ..++.....++-
T Consensus 28 ~~~~~~el~~l~~El~DRFG~~P~ev~~L~~~--------~~lk~~a~~~gi 71 (101)
T PF03461_consen 28 SAESEEELEDLREELIDRFGPLPEEVENLLEL--------ARLKILARKLGI 71 (101)
T ss_dssp C--SHHHHHHHHHHHHHHH-S--HHHHHHHHH--------HHHHHHHHHCTE
T ss_pred hCCCHHHHHHHHHHHHHHcCCCcHHHHHHHHH--------HHHHHHHHHCCC
Confidence 346889999999999877 6899999998863 345555555544
No 73
>PRK13755 putative mercury transport protein MerC; Provisional
Probab=24.17 E-value=53 Score=29.59 Aligned_cols=23 Identities=22% Similarity=0.411 Sum_probs=18.6
Q ss_pred chhhhhhhhhhhHHHHHHHHHHc
Q 012107 426 YTVLFGVSRSLGICSQLIWDRAL 448 (471)
Q Consensus 426 ~t~lF~vsR~~GwlAH~ieq~~~ 448 (471)
|.++-.++-..||.+|..|+|..
T Consensus 57 FA~iALlanalgW~sHRQW~Rs~ 79 (139)
T PRK13755 57 FAAIALLANALGWFSHRQWLRSA 79 (139)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHh
Confidence 34555678899999999999975
No 74
>PF10805 DUF2730: Protein of unknown function (DUF2730); InterPro: IPR020269 This entry represents a family of various hypothetical proteins. The proteins, which include HI1498 and Gp25, from phage Mu, are currently uncharacterised.
Probab=21.13 E-value=1.8e+02 Score=25.02 Aligned_cols=61 Identities=16% Similarity=0.372 Sum_probs=45.5
Q ss_pred HHHHHHHHHhCCCCCHHHHHHHHHHHHhhCCCcHHHHHHHHcCCCCCChHHHHHHHHHHhcc
Q 012107 123 PEGLLWLLLTGKVPSKEQVDGLSKELRDRATVPDYVYKAIDALPVTAHPMTQFASGVMALQV 184 (471)
Q Consensus 123 ~Eev~~LLl~G~lPt~~ql~~f~~~l~~~~~lp~~v~~~i~~lP~~~hPM~~l~~avsal~~ 184 (471)
+=.++|+++.....++++++.+.+++.....==..+..-++.+|. ..-+..|...++-+..
T Consensus 19 ~~~~~~~~l~~~~a~~~~~~~l~~~~~~~~~Rl~~lE~~l~~LPt-~~dv~~L~l~l~el~G 79 (106)
T PF10805_consen 19 AGGIFWLWLRRTYAKREDIEKLEERLDEHDRRLQALETKLEHLPT-RDDVHDLQLELAELRG 79 (106)
T ss_pred HHHHHHHHHHHhhccHHHHHHHHHHHHHHHHHHHHHHHHHHhCCC-HHHHHHHHHHHHHHHh
Confidence 346789989999999999999987776553211347788999994 6677788877777754
No 75
>PF09702 Cas_Csa5: CRISPR-associated protein (Cas_Csa5); InterPro: IPR010157 Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) are a family of DNA direct repeats separated by regularly sized non-repetitive spacer sequences that are found in most bacterial and archaeal genomes []. CRISPRs appear to provide acquired resistance against bacteriophages, possibly acting with an RNA interference-like mechanism to inhibit gene functions of invasive DNA elements [, ]. Differences in the number and type of spacers between CRISPR repeats correlate with phage sensitivity. It is thought that following phage infection, bacteria integrate new spacers derived from phage genomic sequences, and that the removal or addition of particular spacers modifies the phage-resistance phenotype of the cell. Therefore, the specificity of CRISPRs may be determined by spacer-phage sequence similarity. In addition, there are many protein families known as CRISPR-associated sequences (Cas), which are encoded in the vicinity of CRISPR loci []. CRISPR/cas gene regions can be quite large, with up to 20 different, tandem-arranged cas genes next to a CRISPR cluster or filling the region between two repeat clusters. Cas genes and CRISPRs are found on mobile genetic elements such as plasmids, and have undergone extensive horizontal transfer. Cas proteins are thought to be involved in the propagation and functioning of CRISPRs. Some Cas proteins show similarity to helicases and repair proteins, although the functions of most are unknown. Cas families can be divided into subtypes according to operon organisation and phylogeny. This entry represents a minor family of Cas protein found in various species of Sulfolobus and Pyrococcus (all archaeal). It is found with two different CRISPR loci in Sulfolobus solfataricus.
Probab=20.15 E-value=1e+02 Score=26.79 Aligned_cols=19 Identities=21% Similarity=0.569 Sum_probs=16.3
Q ss_pred hCCCCCHHHHHHHHHHHHh
Q 012107 132 TGKVPSKEQVDGLSKELRD 150 (471)
Q Consensus 132 ~G~lPt~~ql~~f~~~l~~ 150 (471)
.|.|||.+|++.|-+...+
T Consensus 69 ~g~lPt~~eVe~Fl~~v~~ 87 (105)
T PF09702_consen 69 VGYLPTDEEVEDFLDDVER 87 (105)
T ss_pred cCCCCChHHHHHHHHHHHH
Confidence 5999999999999888654
Done!